<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">90006</article-id><article-id pub-id-type="doi">10.7554/eLife.90006</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Coordination between ECM and cell-cell adhesion regulates the development of islet aggregation, architecture, and functional maturation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-293811"><name><surname>Tixi</surname><given-names>Wilma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-293812"><name><surname>Maldonado</surname><given-names>Maricela</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4682-6900</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-293813"><name><surname>Chang</surname><given-names>Ya-Ting</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293815"><name><surname>Chiu</surname><given-names>Amy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321736"><name><surname>Yeung</surname><given-names>Wilson</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-321737"><name><surname>Parveen</surname><given-names>Nazia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293816"><name><surname>Nelson</surname><given-names>Michael S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0480-5597</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177763"><name><surname>Hart</surname><given-names>Ryan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293817"><name><surname>Wang</surname><given-names>Shihao</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293818"><name><surname>Hsu</surname><given-names>Wu Jih</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5385-9079</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-282586"><name><surname>Fueger</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293819"><name><surname>Kopp</surname><given-names>Janel L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1875-3401</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87179"><name><surname>Huising</surname><given-names>Mark O</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293820"><name><surname>Dhawan</surname><given-names>Sangeeta</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-293821"><name><surname>Shih</surname><given-names>Hung Ping</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3035-5841</contrib-id><email>hshih@coh.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z1vct10</institution-id><institution>Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope</institution></institution-wrap><addr-line><named-content content-type="city">Duarte</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0080fxk18</institution-id><institution>Department of Biomedical Engineering, College of Engineering, California State University, Long Beach</institution></institution-wrap><addr-line><named-content content-type="city">Long Beach</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z1vct10</institution-id><institution>Light Microscopy Core, Beckman Research Institute, City of Hope</institution></institution-wrap><addr-line><named-content content-type="city">Duarte</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>Department of Neurobiology, Physiology and Behavior, University of California, Davis</institution></institution-wrap><addr-line><named-content content-type="city">Davis</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rmrcq20</institution-id><institution>Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia</institution></institution-wrap><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z1vct10</institution-id><institution>Department of Molecular &amp; Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope</institution></institution-wrap><addr-line><named-content content-type="city">Duarte</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis</institution></institution-wrap><addr-line><named-content content-type="city">Davis</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sussel</surname><given-names>Lori</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03wmf1y16</institution-id><institution>University of Colorado Anschutz Medical Campus</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>08</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e90006</elocation-id><history><date date-type="received" iso-8601-date="2023-06-07"><day>07</day><month>06</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-07-12"><day>12</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-04-28"><day>28</day><month>04</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.04.27.489466"/></event></pub-history><permissions><copyright-statement>© 2023, Tixi, Maldonado, Chang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Tixi, Maldonado, Chang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-90006-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-90006-figures-v2.pdf"/><abstract><p>Pancreatic islets are three-dimensional cell aggregates consisting of unique cellular composition, cell-to-cell contacts, and interactions with blood vessels. Cell aggregation is essential for islet endocrine function; however, it remains unclear how developing islets establish aggregation. By combining genetic animal models, imaging tools, and gene expression profiling, we demonstrate that islet aggregation is regulated by extracellular matrix signaling and cell-cell adhesion. Islet endocrine cell-specific inactivation of extracellular matrix receptor integrin β1 disrupted blood vessel interactions but promoted cell-cell adhesion and the formation of larger islets. In contrast, ablation of cell-cell adhesion molecule α-catenin promoted blood vessel interactions yet compromised islet clustering. Simultaneous removal of integrin β1 and α-catenin disrupts islet aggregation and the endocrine cell maturation process, demonstrating that establishment of islet aggregates is essential for functional maturation. Our study provides new insights into understanding the fundamental self-organizing mechanism for islet aggregation, architecture, and functional maturation.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>ECM</kwd><kwd>islet</kwd><kwd>endocrine cells</kwd><kwd>cell adhesion</kwd><kwd>integrin</kwd><kwd>α-Catenin</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000900</institution-id><institution>California Institute for Regenerative Medicine</institution></institution-wrap></funding-source><award-id>Training Grant EDUC4-12772</award-id><principal-award-recipient><name><surname>Tixi</surname><given-names>Wilma</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000901</institution-id><institution>JDRF</institution></institution-wrap></funding-source><award-id>Postdoctoral fellowship 3-PDF-2019-742-A-N</award-id><principal-award-recipient><name><surname>Maldonado</surname><given-names>Maricela</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000038</institution-id><institution>Natural Sciences and Engineering Research Council of Canada</institution></institution-wrap></funding-source><award-id>Discovery Grant RGPIN-2016-04276</award-id><principal-award-recipient><name><surname>Kopp</surname><given-names>Janel L</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>New Investigator Award Msh-147794</award-id><principal-award-recipient><name><surname>Kopp</surname><given-names>Janel L</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000245</institution-id><institution>Michael Smith Foundation for Health Research</institution></institution-wrap></funding-source><award-id>Scholar Award 18309</award-id><principal-award-recipient><name><surname>Kopp</surname><given-names>Janel L</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>1R01DK110276</award-id><principal-award-recipient><name><surname>Huising</surname><given-names>Mark O</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>1R01DK120523</award-id><principal-award-recipient><name><surname>Dhawan</surname><given-names>Sangeeta</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100017868</institution-id><institution>Human Islet Research Network</institution></institution-wrap></funding-source><award-id>New investigator award UC4DK104162</award-id><principal-award-recipient><name><surname>Dhawan</surname><given-names>Sangeeta</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>Wanek Family Foundation to Cure Type 1 Diabetes</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Dhawan</surname><given-names>Sangeeta</given-names></name><name><surname>Shih</surname><given-names>Hung Ping</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>1R01DK119590</award-id><principal-award-recipient><name><surname>Shih</surname><given-names>Hung Ping</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>ECM-Itgb1 signaling and cell-cell adhesion are pivotal and coordinate together to regulate pancreatic islet aggregation, architecture, and functional maturation during development.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>To control various physiological responses, groups of endocrine cells cluster together with vasculature, mesenchymal cells, and neuronal cells to form a highly organized ‘mini-organ’ in the pancreatic epithelium: the islet of Langerhans. The islet endocrine cells emerge from a domain of multipotent progenitors in the embryonic pancreatic epithelium. Initially, the multipotent pancreatic progenitors resolve into a pre-acinar domain, and a bipotent endocrine/ductal progenitor domain of the developing pancreas (<xref ref-type="bibr" rid="bib50">Larsen and Grapin-Botton, 2017</xref>; <xref ref-type="bibr" rid="bib66">Romer and Sussel, 2015</xref>; <xref ref-type="bibr" rid="bib79">Shih et al., 2013</xref>). Endocrine cell progenitors are specified by the expression of the proendocrine gene <italic>Neurogenin 3</italic> (<italic>Ngn3</italic>) (<xref ref-type="bibr" rid="bib33">Gu et al., 2002</xref>). Following endocrine cell specification, the Ngn3<sup>+</sup> precursors undergo delamination (<xref ref-type="bibr" rid="bib10">Bechard et al., 2016</xref>; <xref ref-type="bibr" rid="bib32">Gouzi et al., 2011</xref>; <xref ref-type="bibr" rid="bib68">Rosenberg et al., 2010</xref>). Delaminated endocrine precursors remain associated with the ducts as they migrate and join other endocrine cells and aggregate into immature islets (<xref ref-type="bibr" rid="bib76">Sharon et al., 2019a</xref>). These immature islets form long interconnected cords along the ductal epithelium. Later the islet cords change morphology and undergo fission to form distinct spherical islets (<xref ref-type="bibr" rid="bib44">Jo et al., 2011</xref>; <xref ref-type="bibr" rid="bib75">Seymour et al., 2004</xref>; <xref ref-type="bibr" rid="bib88">Sznurkowska et al., 2020</xref>). Throughout the differentiation and morphological changes, endocrine cells are intimately associated with the vasculature, which facilitates functional control of hormone release (<xref ref-type="bibr" rid="bib64">Reinert et al., 2014</xref>). To coordinate the hormone release of endocrine cells within each islet, autocrine and paracrine interactions, as well as direct cell contacts, are required (<xref ref-type="bibr" rid="bib14">Campbell and Newgard, 2021</xref>). These interactions are established by the aggregation process during development (<xref ref-type="bibr" rid="bib3">Adams and Blum, 2022</xref>). Defects in the aggregation processes may lead to defects in endocrine cell development, and eventually, islet dysfunction. Supporting this notion<italic>,</italic> human pluripotent stem cell (hPSC)-derived β-cells acquire more functional maturity in vitro if clustered together (<xref ref-type="bibr" rid="bib18">Cottle et al., 2021</xref>; <xref ref-type="bibr" rid="bib60">Nair et al., 2019</xref>). However, the mechanism by which this process is regulated in vivo has largely remained elusive.</p><p>Self-organization of a group of cells into a higher-order, multicellular functional unit relies on an array of cell interactions regulated by cell-cell adhesions (<xref ref-type="bibr" rid="bib27">Fagotto, 2014</xref>). For example, a calcium-dependent adhesion molecule, neural cell adhesion molecule (N-CAM), has been shown to be critical for murine endocrine cells to cluster (<xref ref-type="bibr" rid="bib26">Esni et al., 1999</xref>). In rodents, islets form a stereotypical core-mantle architecture in which the insulin (Ins) secreting β-cells are located mainly in the central core, with glucagon (Gcg) secreting α-cells and somatostatin (Sst) secreting δ-cells localizing in the periphery to form a mantle (<xref ref-type="bibr" rid="bib3">Adams and Blum, 2022</xref>; <xref ref-type="bibr" rid="bib5">Arrojo e Drigo et al., 2015</xref>; <xref ref-type="bibr" rid="bib45">Kim et al., 2009</xref>). In culture, dissociated rat endocrine cells can self-organize into the core-mantle architecture, suggesting that the islet structure is established by factors intrinsic to endocrine cells (<xref ref-type="bibr" rid="bib34">Halban et al., 1987</xref>). N-CAM-deleted mice show abnormal islet architecture, with α-cells spread throughout the islet core and abnormal assembly of adherens junction proteins N- and E-cadherin (Ncad and Ecad) (<xref ref-type="bibr" rid="bib26">Esni et al., 1999</xref>). In addition, ectopic expression of a dominant negative Ecad in mouse β-cells interferes with their clustering and islet formation (<xref ref-type="bibr" rid="bib19">Dahl et al., 1996</xref>); and loss of <italic>Ecad</italic> results in abnormal blood glucose homeostasis (<xref ref-type="bibr" rid="bib96">Wakae-Takada et al., 2013</xref>). Intracellularly, adherens junctions are stabilized by β-catenin (<italic>Ctnnb1</italic>) and α-catenin (<italic>Ctnna1</italic>) (<xref ref-type="bibr" rid="bib41">Jamora and Fuchs, 2002</xref>). The function of <italic>Ctnnb1</italic> has been extensively studied in the developing pancreas (<xref ref-type="bibr" rid="bib25">Elghazi et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Murtaugh et al., 2005</xref>; <xref ref-type="bibr" rid="bib69">Rulifson et al., 2007</xref>) and in hPSC-derived β-cells, because of its role in cell proliferation via Wnt signaling (<xref ref-type="bibr" rid="bib77">Sharon et al., 2019b</xref>); yet genetic studies show that <italic>Ctnnb1</italic> is not essential for islet clustering and architecture (<xref ref-type="bibr" rid="bib25">Elghazi et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Murtaugh et al., 2005</xref>). In the developing pancreas, inactivation of <italic>Ctnna1</italic> results in defects in endocrine progenitor differentiation due to an expansion of pancreatic ductal progenitors (<xref ref-type="bibr" rid="bib43">Jimenez-Caliani et al., 2017</xref>). Whether the process of islet clustering and architecture requires <italic>Ctnna1</italic> is unknown.</p><p>The regulation of cell-cell adhesion is often coupled with cell-extracellular matrix (ECM) interaction and integrin signaling (<xref ref-type="bibr" rid="bib57">Mui et al., 2016</xref>; <xref ref-type="bibr" rid="bib99">Weber et al., 2011</xref>). Upon ECM binding, integrins activate signal transduction pathways and regulate (1) cytoskeleton dynamics, (2) cell movement, (3) cell differentiation, and (4) functional maturation of epithelial cells, vasculature, and neurons (<xref ref-type="bibr" rid="bib8">Barros et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Li et al., 2008</xref>; <xref ref-type="bibr" rid="bib71">Scheppke et al., 2012</xref>). During angiogenesis, ECM receptor integrin β1 (Itgb1) is required to control the localization of cell-cell adhesion molecule VE-cadherin and maintain cell-cell junction integrity (<xref ref-type="bibr" rid="bib101">Yamamoto et al., 2015</xref>). In salivary glands and early embryonic pancreas, Itgb1-mediated ECM adhesions regulate Ecad to control cell clustering and regulate budding epithelial branching (<xref ref-type="bibr" rid="bib81">Shih et al., 2016</xref>; <xref ref-type="bibr" rid="bib98">Wang et al., 2021</xref>; <xref ref-type="bibr" rid="bib97">Wang et al., 2017</xref>). Whether islet morphogenesis also requires ECM-integrin signaling remains to be investigated.</p><p>In the present study, we examine how loss of <italic>Itgb1</italic> and <italic>Ctnna1</italic> in Ngn3-expressing endocrine progenitors affects islet morphogenesis. We show that <italic>Itgb1</italic> and <italic>Ctnna1</italic> have collaborative roles during islet aggregation: ECM-Itgb1 signaling modulates islet aggregation by negatively regulating cell-cell adhesions; and α-catenin promotes endocrine cell clustering and modulates vascularization during islet development. We also provide evidence that the islet architecture is regulated by differential adhesion in endocrine subtypes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The morphogenesis and functional maturation of islet endocrine cells depend on ECM-Itgb1 signaling during development</title><p>To investigate the process of islet aggregation, embryonic day 15.5 (E15.5) pancreas was stained for blood vessel maker platelet endothelial cell adhesion molecule-1 (PECAM), ductal marker Spp1, and endocrine cell marker chromogranin A (ChrA). Confocal microscopy and three-dimensional (3D) whole-mount immunofluorescence (IF) imaging revealed that at E15.5 endocrine cells had started aggregating, and the vascular and ductal networks were already highly similar (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). This close relation between the ducts and blood vessels at the stage prior to islet aggregation suggests that blood vessels could readily interact and provide instructive cues to regulate endocrine progenitor aggregation into islets. Blood vessels in islets produce ECM-rich basal membrane to support and organize endocrine cells (<xref ref-type="bibr" rid="bib49">Lammert et al., 2003</xref>; <xref ref-type="bibr" rid="bib67">Roscioni et al., 2016</xref>). Thus, we hypothesized that ECM signaling, provided by the vasculature, plays a key role in the initiation steps of islet aggregation. Supporting this notion, published work using single-cell gene expression profiling has shown that the ECM-Itgb1 signaling gene ontology (GO) categories are most significantly enriched in the Ngn3<sup>+</sup> endocrine progenitors (<xref ref-type="bibr" rid="bib9">Bastidas-Ponce et al., 2019</xref>). IF analysis validated that both the Ngn3<sup>+</sup> endocrine progenitors and their progenies (eYFP<sup>+</sup> cells in <italic>Ngn3-Cre; Rosa26-eYFP</italic> pancreas) expressed Itgb1 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). To investigate the role of Itgb1 during endocrine cell aggregation, we used the <italic>Ngn3-Cre</italic> allele to recombine the <italic>Itgb1-flox</italic> alleles in endocrine progenitors (<italic>Ngn3-Cre; Itgb1<sup>f/f</sup></italic>; hereafter <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup>). Expression of Itgb1 was almost entirely absent throughout the islet endocrine cells in comparison to control littermates at 6 weeks of age (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). We first examined whether inactivation of ECM-Itgb1 signaling affected vascular interaction. Electron microscope ultrastructure analysis revealed tight attachment in basal membranes between vascular and endocrine cells in control islets (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). In contrast, in the <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets, the endocrine cells were detached from the basal membranes of blood vessels (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>, red arrows). Despite the vascular defects with Itgb1 loss, all four endocrine cell subtypes, α-, β-, δ-, and Ppy- (pancreatic polypeptide) cells, were present at similar proportions in control and <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D–G</xref>). In addition, the expression of β-cell lineage markers Nkx6.1 and Pdx1 were present in the Ins<sup>+</sup> cells of control and <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>). Although the populations of endocrine cell lineages were unaffected by the loss of <italic>Itgb1</italic>, morphometrical analysis revealed drastic morphological changes. In control islets, β-cells were organized in a central core and surrounded by α- and δ-cells in the periphery (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Conversely, in <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice, several individual islets appeared to agglomerate, resulting in larger islet sizes and aberrant distribution of α- and δ-cells in the central core (<xref ref-type="fig" rid="fig1">Figure 1E and G</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I</xref>). Thus, the inactivation of Itgb1 has a profound impact on islet morphogenesis, but not endocrine cell fate choice.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>ECM-Itgb1 signaling in endocrine progenitors is required for normal islet morphology and function.</title><p>(<bold>A</bold>) Immunofluorescence staining for Itgb1 and Ngn3 in pancreas sections of <italic>Ngn3-Cre; Rosa26eYFP</italic> reporter mice at E15.5. Cyan arrows indicate Ngn3<sup>+</sup> cells and lineage-traced endocrine cells expressing Itgb1. (<bold>B–C</bold>) Immunofluorescence staining for Itgb1, Ins, and DAPI on pancreas sections, demonstrating significant <italic>Itgb1</italic> deletion in an <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islet at 6 weeks of age. Fields demarcated by white boxes in (<bold>B–C</bold>) are shown with individual color channels in (<bold>B’–C’</bold>) side panels. (<bold>D–G</bold>) Immunofluorescence staining for Gcg, Ins, Sst, Nkx6.1, Pdx1, and DAPI on pancreas sections of (<bold>D, F</bold>) control and (<bold>E, G</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice at 6 weeks of age. Individual islets are outlined by dotted lines. Fields demarcated by yellow boxes in (<bold>D–G</bold>) are shown at higher magnification in (<bold>D’–G’</bold>) side panels. (<bold>H</bold>) Gene-set enrichment analysis of the differentially expressed genes, indicating top enriched pathways for control versus <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets at 6 weeks of age. Gene sample sizes and FDRs are indicated by the size and color of the dots. (<bold>I</bold>) Heatmap demonstrating down-regulation (Group 1) and up-regulation (Group 2) of functional maturation genes in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets compared to controls. (<bold>J–L</bold>) Intraperitoneal glucose tolerance test (<bold>J, L</bold>) and stimulated insulin secretion at T15 (<bold>K</bold>) on 6- to 16-week-old (<bold>J, K</bold>) and (<bold>L</bold>) 6- to 12-month-old control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. Ngn3, neurogenin 3; Gcg, glucagon; Ins, insulin; DAPI, 4’,6-diamidino-2-phenylindole; Sst, somatostatin; IPGTT, intraperitoneal glucose tolerance test; FDR, false discovery rate; E15.5, embryonic day 15.5. Data are shown as mean ± SEM. *p&lt;0.05 and **p&lt;0.01.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig1">Figure 1J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig1">Figure 1K</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig1">Figure 1L</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Deletion of <italic>Itgb1</italic> in endocrine progenitors results in abnormal interactions with blood vessels and decreased expression of functional maturation markers within islets.</title><p>(<bold>A</bold>) Whole-mount immunofluorescence staining for PECAM, ChrA, and Spp1 in a wild-type pancreas at E15.5. (<bold>B–C</bold>) Transmission electron microscope images showing blood vessels in 6-week-old islets. Deletion of <italic>Itgb1</italic> disrupts the attachment of endocrine cells to blood vessels (red arrows) in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets. (<bold>D–G</bold>) Quantification of the percentage of (<bold>D</bold>) Gcg<sup>+</sup>, (<bold>E</bold>) Ins<sup>+</sup>, (<bold>F</bold>) Sst<sup>+</sup>, and (<bold>G</bold>) Ppy<sup>+</sup> cells relative to measured islet area of 6-week-old control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. (<bold>H–I</bold>) Immunofluorescence staining for ChrA and DAPI in 6-week-old (<bold>H</bold>) control and (<bold>I</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. (<bold>J–K</bold>) Quantification of (<bold>J</bold>) average islet size and (<bold>K</bold>) islet size distribution based on ChrA staining of 6-week-old control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. (<bold>L</bold>) Heatmap showing hypoxia pathway genes are up-regulated in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets. (<bold>M–N</bold>) Immunofluorescence staining for EpCAM, Ecad, and Lam1 on 3-month-old pancreas sections showing reduced islet vasculature indicated by Lam1<sup>+</sup> cells (yellow arrows). (<bold>O</bold>) Quantification of islet blood vessel density in control or <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islet area at 8 weeks and 3 months of age. PECAM, platelet endothelial cell adhesion molecule-1; ChrA, chromogranin A; Spp1, secreted phosphoprotein 1; Gcg, glucagon; Ins, insulin; Sst, somatostatin; Ppy, pancreatic polypeptide; Ecad, E-cadherin; epithelial cellular adhesion molecule, EpCAM; Lam1, laminin1; BV, blood vessels; E15.5, embryonic day 15.5. Data are shown as mean ± SEM. *p&lt;0.05, **p&lt;0.01, ****p&lt;0.0001.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata4"><label>Figure 1—figure supplement 1—source data 4.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp1-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata5"><label>Figure 1—figure supplement 1—source data 5.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp1-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata6"><label>Figure 1—figure supplement 1—source data 6.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp1-data6-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata7"><label>Figure 1—figure supplement 1—source data 7.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1O</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp1-data7-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Deletion of <italic>Itgb1</italic> in endocrine progenitors results in abnormal interactions with blood vessels and decreased expression of functional maturation markers within islets.</title><p>(<bold>A</bold>) Quantification of selected differentially expressed genes involved in islet functional maturation using real-time qPCR analysis in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets and compared to controls. The relative quantification of gene expression levels was determined using the 2<sup>-∆∆Ct</sup> method and is reported as an RQ value relative to the control group. The genes selected for validation were chosen based on their known roles in islet function and maturation. (<bold>B–E</bold>) Immunofluorescence staining for MafA, Ins, Ucn3, Glut2, and DAPI on 6-week-old (<bold>B, D</bold>) control and (<bold>C, E</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. Individual islets are outlined by dotted yellow lines in (<bold>D’, D”, E’, E”</bold>). RQ, relative quantification; Ins, insulin; Ucn3, urocortin 3; PECAM, platelet endothelial cell adhesion molecule-1; DAPI, 4’,6-diamidino-2-phenylindole; E15.5, embryonic day 15.5. Data are shown as mean ± SEM. *p&lt;0.05.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig1-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig1-figsupp2-v2.tif"/></fig></fig-group><p>We next investigated whether the loss of <italic>Itgb1</italic> had any impact on the expression of genes related to islet function. Islets from 6-week-old control and <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice were isolated and subjected to RNA-sequencing (RNA-seq) and differential gene expression analysis. A comparison of gene expression profiles between <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> and control islets revealed 417 differentially expressed genes (DEGs) with false discovery rate (FDR)&lt;0.05 and fold change (FC) &gt;2 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), of which 332 were up-regulated and 85 were down-regulated. Gene-set enrichment analysis (GSEA) of DEGs between control and <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets showed up-regulation of pathways associated with hypoxia, epithelial mesenchymal transition, glycolysis, and inflammatory response (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). The analysis of GO of DEGs related to hypoxia showed that the genes responsible for hypoxia response were up-regulated in <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets when compared to the control group (as shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1L</xref>). The IF analysis indicated that the <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets at 2–3 months of age displayed a significant reduction in blood vessels (as shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1M–O</xref>), which suggests that the lack of vascular interaction could lead to hypoxia responses. On the other hand, the down-regulated genes were associated with spermatogenesis, pancreas β-cells, and E2F targets (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). GO analysis of DEGs in the pancreas β-cells category further revealed that functional maturation genes for β-cells (e.g., <italic>Slc2a2</italic> [<italic>Glut2</italic>], <italic>Ucn3</italic>, and <italic>Mafa</italic>) and for α-cells (e.g., <italic>Arx</italic>, <italic>Mafb</italic>, and <italic>Etv1</italic>), were drastically down-regulated in the <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets (<xref ref-type="fig" rid="fig1">Figure 1I</xref>, Group 1; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). IF analysis also validated the reduced expression of Mafa, Ucn3, and Glut2 in β-cells of <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>endo</italic></sup> islets (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B–E</xref>). Furthermore, several ‘disallowed’ genes for β-cells, including <italic>Ldha1</italic>, <italic>Aldh1a3</italic>, and <italic>Hk1</italic> (<xref ref-type="bibr" rid="bib51">Lemaire et al., 2016</xref>), were significantly up-regulated in the <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets (<xref ref-type="fig" rid="fig1">Figure 1I</xref>, Group 2; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Hence, it is likely that the functional maturation of endocrine cells within <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets is compromised. This notion is supported by the observation that, by 6 weeks of age, these mice exhibit glucose intolerance and reduced insulin secretion in response to glucose stimulation (<xref ref-type="fig" rid="fig1">Figure 1J–K</xref>). The impairment in glycemic regulation further deteriorates in mice older than 6 months (<xref ref-type="fig" rid="fig1">Figure 1L</xref>). Together, these observations indicate that ECM-integrin interactions are critical for islet vascularization, morphogenesis, and the functional maturation of endocrine cells.</p></sec><sec id="s2-2"><title>ECM signaling regulates endocrine progenitor cell migration and cell-cell adhesion to control islet aggregation during development</title><p>Our initial analysis of the pancreatic sections from <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice revealed larger islet sizes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J</xref>). Consistently, the islets isolated from <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice appeared larger in size as well (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>); however, the total islet area was similar between control and <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The increased size was mainly attributed to a greater number of large islets (&gt;50 µm<sup>2</sup> × 10<sup>3</sup>, as shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1K</xref> and <xref ref-type="fig" rid="fig1s2">2E</xref>). Therefore, the enlarged islet size is likely a result of a morphological change independent of the expansion of total endocrine cells. Furthermore, in the control pancreata, the islets were located near the ducts, but contained a very small number of ductal cells (<xref ref-type="fig" rid="fig2">Figure 2F and H</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). In contrast, the islets in the <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> pancreata contained a substantial number of ductal cells (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). As the endocrine progenitors arise and migrate away from the ducts, we hypothesized that there might be deficiencies in this process for Itgb1-deficient endocrine cells. To investigate this, we conducted segmentation analysis of 3D whole-mount IF on E15.5 pancreata, the stage at which the majority of endocrine progenitor migration occurs (<xref ref-type="bibr" rid="bib68">Rosenberg et al., 2010</xref>). Our results showed that most of the Itgb1-deleted endocrine progenitor cell aggregates had a greater tendency to cluster within the ductal cords during development (<xref ref-type="fig" rid="fig2">Figure 2I and J</xref> and <xref ref-type="video" rid="video1">Video 1</xref>; the green color represents zero distance from ducts). These findings imply that there might be deficiencies in both endocrine cell migration and premature islet aggregation in <italic>Itgb1</italic>-deleted endocrine cells. To further confirm this, we conducted live imaging analysis on pancreas explants obtained from E16.5 <italic>Ngn3-Cre; Rosa26mT/mG; Itgb1<sup>+/+</sup></italic> (control) and <italic>Ngn3-Cre; Rosa26mT/mG; Itgb1<sup>f/f</sup></italic> (<italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic>) mice. We tracked the movement and aggregation of Ngn3-progeny (mGFP<sup>+</sup>) endocrine progenitor cells in explant cultures for up to 3 days (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>; <xref ref-type="video" rid="video2">Videos 2</xref> and <xref ref-type="video" rid="video3">3</xref>). Our observations showed that in contrast to the controls, where endocrine progenitor cells migrated and aggregated outside of ductal cords, the mGFP<sup>+</sup> cells in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> explants readily aggregated before moving away from the cords (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>, white arrows). In contrast to our findings, previous studies using <italic>Ins-Cre</italic> or <italic>RIP-Cre</italic> to ablate <italic>Itgb1</italic> after endocrine progenitors have differentiated into insulin-producing cells did not report any observable islet aggregation or migration defects (<xref ref-type="bibr" rid="bib21">Diaferia et al., 2013</xref>; <xref ref-type="bibr" rid="bib100">Win et al., 2020</xref>). However, <italic>Ngn3-Cre</italic>-mediated <italic>Itgb1</italic> deletion would occur much earlier in embryonic stages (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), suggesting that Itgb1 signaling regulates the migration and aggregation of progenitor cells in the endocrine lineage during the islet developmental process.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Itgb1 signaling is required for proper endocrine progenitor aggregation.</title><p>(<bold>A–B</bold>) Brightfield images of isolated islets from control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice at 8 weeks of age. (<bold>C–E</bold>) Quantification of (<bold>C</bold>) average islet size, (<bold>D</bold>) total islet area, and (<bold>E</bold>) islet size distribution based on morphometric analysis of 8-week-old control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> isolated islets. (<bold>F–G</bold>) Immunofluorescence staining for Spp1, Ins, and DAPI on 6-week-old control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. Islets are outlined by white dotted lines. (<bold>H</bold>) The ratio of ductal cell areas within the islets is quantified based on Spp1 and ChrA staining of pancreas sections from 6-week-old control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>I–J</bold>) Three-dimensional (3D) segmentation analysis on whole-mount immunofluorescence images of E15.5 control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreata stained for ChrA and Spp1 (white colored) reveals that the endocrine cells in the <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas are mostly retained within ducts, and the distance between endocrine cells and ducts is represented by a color scale. (<bold>K–L</bold>) Airyscan super-resolution images depict immunofluorescence staining for Ecad and ductal marker DBA in P7 mT/mG reporter mice showing up-regulation of Ecad in the <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas. The dot-like Ecad expression pattern in super-resolution imaging represents adherens junction structures. The yellow boxes in (<bold>K–L</bold>) demarcate fields shown at higher magnification in (<bold>K’–L’</bold>) side panels. (<bold>M</bold>) The schematic depicts the experimental design for the in vitro aggregation assay. (<bold>N</bold>) Aggregate size is quantified after a 2 hr incubation with or without extracellular matrix (ECM). (<bold>O–R</bold>) Fluorescence images of mGFP<sup>+</sup> endocrine progenitor aggregates after 2 hr of culture show that mGFP<sup>+</sup> control endocrine progenitors clustered (<bold>O</bold>) without ECM but remained single cells (<bold>P</bold>) with ECM. Alternatively, <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> endocrine progenitors clustered (<bold>Q</bold>) without ECM or (<bold>R</bold>) with ECM. Spp1, secreted phosphoprotein 1; Ins, insulin; DAPI, 4’,6-diamidino-2-phenylindole; Ecad, E-cadherin; DBA, <italic>Dolichos biflorus</italic> agglutinin; P7, postnatal day 7; E15.5, embryonic day 15.5. Data are shown as mean ± SEM. *p&lt;0.05, **p&lt;0.01, and ****p&lt;0.0001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig2-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig2-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig2-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata5"><label>Figure 2—source data 5.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2N</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig2-data5-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Itgb1 is required for normal islet architecture.</title><p>(<bold>A–B</bold>) Immunofluorescence staining for Sox9, Ins, and DAPI on 6-week-old (<bold>A</bold>) control and (<bold>B</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. The individual channels for Sox9 and Ins are displayed in panels (<bold>A' and A&quot;</bold>), and (<bold>B' and B&quot;</bold>), respectively. In the <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets, Sox9-positive ductal cells were observed throughout the sections (<bold>B’</bold>). (<bold>C–D</bold>) Schematic of the time-lapse confocal microscope imaging of endocrine progenitor cell behaviors in E16.5 embryonic pancreas explants. The first 24 hr were monitored to observe cell movement in (<bold>C1–C4</bold>) control and (<bold>D1–D4</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas explants. White arrows indicate prematurely clustered islets in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> explants. (<bold>E–H</bold>) Immunofluorescence staining for Ins, PECAM, Itgb1, and DAPI on 8-week-old (<bold>E, G</bold>) control and (<bold>F, H</bold>) <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> pancreas sections. Individual channels are displayed as Ins/PECAM in (E’, F’), and Itgb1 in (E”, F”). In <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> islets the presence of Itgb1 and vasculature in the islet is abolished. The overall size and insulin expression are not altered in the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> islets. (<bold>I</bold>) Quantification of total islet area based on morphometric analysis of 8-week-old control and <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> pancreas sections. Note no significant differences in islet size were observed between the two groups. Ins, insulin; PECAM, platelet endothelial cell adhesion molecule-1; DAPI, 4’,6-diamidino-2-phenylindole; E16.5, embryonic day 16.5. Data are shown as mean ± SEM.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Itgb1 controls cytoskeleton regulation and organization in islets.</title><p>(<bold>A</bold>) Schematic of experimental design for in vitro aggregation assay. (<bold>B</bold>) Quantification of aggregate size after 48 hr incubation with or without extracellular matrix (ECM) in control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> endocrine progenitors. (<bold>C–F</bold>) Fluorescence images of mGFP<sup>+</sup> endocrine progenitor aggregates after 48 hr culture. mGFP<sup>+</sup> control endocrine progenitors clustered (<bold>C</bold>) without ECM but remained single cells (<bold>D</bold>) with ECM after 48 hr. Alternatively, <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> endocrine progenitors clustered (<bold>E</bold>) without ECM or (<bold>F</bold>) with ECM after 48 hr. (<bold>G–J</bold>) Airyscan super-resolution three-dimensional (3D) projection and cut-view images depict immunofluorescence staining for Ins and F-actin on 8-week-old control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. The 3D images (<bold>G–H</bold>) and cut-view images (<bold>I–J</bold>) also demonstrated hexagonal cell shapes and increased F-actin assembly in the <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets. Ins, insulin; PECAM, platelet endothelial cell adhesion molecule-1. Data are shown as mean ± SEM. ***p&lt;0.001.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig2-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig2-figsupp2-v2.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-90006-video1.mp4" id="video1"><label>Video 1.</label><caption><title>Three-dimensional (3D) segmentation analysis on whole-mount immunofluorescence images of embryonic day 15.5 (E15.5) control and <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> pancreata.</title><p>This file presents a 3D segmentation analysis based on the chromogranin A (ChrA) and secreted phosphoprotein 1 (Spp1) staining, revealing islet clusters and pancreatic ducts. It includes movie clips showcasing the 3D segmentation from various viewing angles. A color scale illustrates the distance between endocrine cells and ducts, with cooler colors indicating shorter distances.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-90006-video2.mp4" id="video2"><label>Video 2.</label><caption><title>Time-lapse confocal microscope imaging of endocrine progenitor cell behaviors in embryonic day 15.5 (E16.5) control (<italic>Ngn3Cre; Rosa26<sup>mT/mG</sup></italic>) embryonic pancreas explants.</title><p>This file contains a time-lapse video showcasing the dynamic behaviors of endocrine progenitor cells. The green cell clusters visible in the footage represent <italic>Ngn3Cre</italic>-expressing progenies, which are the islet endocrine cells. The 8 s video clip encapsulates the changes observed over a 24 hr period.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-90006-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Time-lapse confocal microscope imaging of endocrine progenitor cell behaviors in embryonic day 15.5 (E16.5) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> (<italic>Ngn3Cre; Itgb1<sup>f/f</sup>; Rosa26<sup>mT/mG</sup></italic>) embryonic pancreas explants.</title><p>This file includes a time-lapse video illustrating the behavior dynamics of <italic>Itgb1</italic>-deleted endocrine progenitor cells. The green cell clusters depicted in the footage represent <italic>Ngn3Cre</italic>-expressing progenies deficient in Itgb1. Changes observed over a 24 hr period are captured in an 8 s video clip. Notably, the <italic>Itgb1</italic>-deleted endocrine progenitor cells prematurely cluster into larger aggregates and maintain a close association with ductal epithelial cords.</p></caption></media><p>To further investigate this notion, we sought to inactivate Itgb1 only after the endocrine cells had fully differentiated and matured. Urocortin 3 (Ucn3) is a late β-cell-specific maturity marker in mouse islets that is expressed after <italic>Ins1</italic> and <italic>Ins2</italic> and starts perinatally. Most β-cells express Ucn3 by 3 weeks of age (<xref ref-type="bibr" rid="bib12">Blum et al., 2014</xref>; <xref ref-type="bibr" rid="bib92">van der Meulen and Huising, 2014</xref>). The expression pattern of Cre recombinase under the control of the <italic>Ucn3</italic> promoter aligns with this timeline (<xref ref-type="bibr" rid="bib94">van der Meulen et al., 2017</xref>). Therefore, <italic>Ucn3-Cre</italic>-mediated deletion of <italic>Itgb1</italic> is not expected to occur until islet development has completed in the presence of functional Itgb1 alleles and normal Itgb1 expression. To test whether Itgb1 signaling also maintains islet cell aggregation after β-cell maturation and islet formation, we crossed <italic>Ucn3-Cre</italic> with <italic>Itgb1<sup>f/f</sup></italic> mice to inactivate Itgb1 exclusively in mature β-cells (referred to as <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic>). Our analysis revealed that, similar to <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice, <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> mice exhibited vasculature exclusion from islets (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E’ and F</xref>’), but islet size remained similar to control mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E–1I</xref>). These results suggest that Itgb1 signaling specifically regulates islet cell aggregation during pancreatic development.</p><p>During the early stages of pancreas development, the expression of Itgb1 in pancreatic progenitor cells has been identified as a crucial factor in controlling pancreas branching morphogenesis through its regulation of cell-cell adhesion (<xref ref-type="bibr" rid="bib81">Shih et al., 2016</xref>). As the process of endocrine progenitor cell differentiation and islet formation commences, cell-cell adhesion is typically down-regulated to facilitate the migration and interaction of endocrine cells with non-endocrine cells (<xref ref-type="bibr" rid="bib32">Gouzi et al., 2011</xref>). Given the established role of Itgb1 in regulating cell-cell adhesion in the context of pancreas development, we were prompted to investigate whether Itgb1 signaling also plays a role in instructing endocrine progenitor cells to modulate their adhesion behavior and thereby control the islet aggregation process. To address this question, we took Airyscan super-resolution images of Ecad IF on endocrine cells in <italic>Ngn3-Cre; Rosa26mT/mG; Itgb1<sup>f/f</sup></italic> islets at P7, since islet aggregation is complete by the neonatal stages (<xref ref-type="bibr" rid="bib88">Sznurkowska et al., 2020</xref>). The Airyscan images provide sufficient resolution to show adherens junctions between cells by visualizing Ecad<sup>+</sup> clusters (<xref ref-type="bibr" rid="bib31">Gonschior et al., 2020</xref>; white dots in <xref ref-type="fig" rid="fig2">Figure 2K and L</xref>). The lineage-traced endocrine cells (mGFP<sup>+</sup>) in control islets displayed low amounts of Ecad<sup>+</sup> clusters (<xref ref-type="fig" rid="fig2">Figure 2K’</xref>). However, the amount of Ecad<sup>+</sup> clusters was drastically increased in mutant islets (<xref ref-type="fig" rid="fig2">Figure 2L’</xref>), suggesting that Itgb1 signaling negatively regulates cell adhesion in developing islets. To further test whether the increased cell adhesiveness is responsible for the increased islet size when Itgb1 signaling is disrupted, we performed an in vitro cell aggregation assay. Live mGFP<sup>+</sup> endocrine cells, from neonatal (P2-P4) <italic>Ngn3-Cre; Rosa26mT/mG; Itgb1<sup>+/f</sup></italic> or <italic>Ngn3-Cre; Rosa26mT/mG; Itgb1<sup>f/f</sup></italic> pancreata, were completely dissociated, then collected by fluorescence-activated cell sorting (FACS). 3000 mGFP<sup>+</sup> cells were allowed to aggregate in wells of a 96-well plate that were coated with bovine serum albumin (BSA) (no ECM) or Matrigel and fibronectin (+ECM) (<xref ref-type="fig" rid="fig2">Figure 2M</xref>). Within 2 hr of cell seeding, the control mGFP<sup>+</sup> endocrine cells rapidly aggregated in wells with no ECM coating, but formed no aggregates in the ECM-coated wells (<xref ref-type="fig" rid="fig2">Figure 2N–P</xref>). Within the same amount of time, the mutant mGFP<sup>+</sup> endocrine cells clustered into larger aggregates in wells without ECM coating and maintained aggregation in the ECM-coated wells (<xref ref-type="fig" rid="fig2">Figure 2N, Q and R</xref>). After 48 hr, the mGFP<sup>+</sup> cells isolated from both the controls and mutants progressively clustered into larger aggregates in wells without ECM coating (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A, C, E</xref>). In contrast, in the ECM-coated wells, only the mutant mGFP<sup>+</sup> cells clustered, while control mGFP<sup>+</sup> cells remained unaggregated (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D and F</xref>). Together, these findings demonstrate that ECM-Itgb1 signaling negatively regulates islet aggregation. As integrins play a crucial role in linking the actin cytoskeleton, we examined whether the inactivation of Itgb1 in endocrine progenitors affects the organization of the actin cytoskeleton in islet cells. In <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets, we observed pronounced foci of condensed F-actin between the endocrine cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2G–J</xref>), indicating increased cell-cell adhesion. These findings suggest that the loss of Itgb1 in endocrine cells leads to alterations in the actin cytoskeleton, resulting in enhanced cell-cell adhesion within the islet microenvironment. The concentrated F-actin foci between the endocrine cells indicate a potential mechanism through which Itgb1 regulates cell-cell interactions and influences islet development and aggregation.</p></sec><sec id="s2-3"><title>α-Catenin promotes endocrine cell aggregation and regulates vascularization during islet development</title><p>Our study revealed that Itgb1 plays a critical role in islet development by regulating endocrine cell-cell adhesion. However, the mechanism by which cell-cell adhesion regulates islet formation remains unclear. Although Ecad and Ncad-mediated adherens junctions are believed to be the primary cell-cell adhesion mechanisms linking islet cells into aggregates, our findings and other studies have shown that deletions of Ecad or Ncad alone do not affect islet aggregation, suggesting functional redundancy between these cell adhesion molecules.</p><p>α-Catenin (Ctnna1) is an essential hub protein linking Ecad-mediated adherens junctions to the cytoskeleton and has been demonstrated to be indispensable for the formation of adherens junctions (<xref ref-type="bibr" rid="bib41">Jamora and Fuchs, 2002</xref>). Therefore, to investigate the requirement of cell adhesion in islet formation, we conditionally ablated Ctnna1 in endocrine progenitors by generating <italic>Ngn3-Cre; Ctnna1<sup>f/f</sup></italic> mice (hereafter referred to as <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup>). To determine whether <italic>Ctnna1</italic> deletion affects islet development, ChrA staining on pancreas sections from 8-week-old mice were imaged, and the total relative islet area was measured (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Compared to their wild-type littermates, islet area (relative to the total pancreas area) in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice was unchanged (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), but there was a significant reduction in average islet size (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). The proportion of larger islets was significantly reduced, while the proportion of small islets was increased (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>), suggesting that <italic>Ctnna1</italic> is required for proper islet aggregation, but not for the development of total islet cell mass. In <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets, we observe diminished Ecad expression and a decrease in the density of F-actin at cell junctions. These findings imply a disruption of cell junctions and a reduction in cell adhesion among Ctnna1-deficient endocrine cells (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Ctnna1-mediated cell-cell adhesion is required for normal islet morphology and endocrine cell aggregation.</title><p>(<bold>A–B</bold>) Immunofluorescence staining for ChrA and DAPI in 8-week-old pancreas sections showing smaller islet sizes in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>C–D</bold>) Quantification of (<bold>C</bold>) the percentage of islet area in pancreas area and (<bold>D</bold>) average islet size based on ChrA staining on 8-week-old control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. (<bold>E–F</bold>) Airyscan images of immunofluorescence staining for Ecad, ChrA, F-actin, and DAPI for control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. Fields demarcated by yellow boxes are shown at higher magnification with individual color channels in (<bold>E’–F’</bold>) middle panels, showing reduced expression of Ecad and F-actin in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets. Individual endocrine cell shape is delineated by yellow lines in (<bold>E”–F”</bold>), demonstrating the enlarged endocrine cell sizes in the islets of <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>G</bold>) Heatmap showing genes for extracellular matrix (ECM) signaling and blood vessel interactions are up-regulated in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets at 8 weeks of age. Groups 1–7 represent gene ontologies of: (1) metalloproteases, (2) vascular adhesion, (3) collagens, (4) integrins, (5) laminins, (6) glycoproteins, and (7) thrombospondins. (<bold>H–I</bold>) Immunofluorescence staining of Ins and PECAM on 8-week-old control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. (<bold>J</bold>) Quantification of islet blood vessel density based on Ins and PECAM staining on 8-week-old control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. (<bold>K–L</bold>) Immunofluorescence staining of Ins and PECAM on P14 control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections showing increased vasculature in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets. Islet area is outlined by dotted lines. ChrA, chromogranin A; DAPI, 4’,6-diamidino-2-phenylindole; Ecad, E-cadherin; Ins, insulin; PECAM, platelet endothelial cell adhesion molecule-1; P14, postnatal day 14. Data are shown as mean ± SEM. ****p&lt;0.0001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig3">Figure 3D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig3-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig3">Figure 3J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig3-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Ctnna1</italic>-deleted pancreatic islet endocrine cells display cytoskeleton anomalies.</title><p>(<bold>A–B</bold>) Immunofluorescence staining for Sst, Ins, and DAPI on pancreas sections from 8-week-old mice. In <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice, the islet clusters appear much smaller compared to the control mice. (<bold>C</bold>) Quantification of islet size distribution based on chromogranin A (ChrA) staining for 8-week-old control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. The islet size quantification analysis excluded endocrine cell clusters with fewer than five cells. (<bold>D</bold>) Gene-set enrichment analysis of the differentially expressed genes, indicating top enriched pathways for control versus <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets at 8 weeks of age. Gene sample sizes and false discovery rates (FDRs) are indicated by the size and color of the dots. (<bold>E–F</bold>) Three-dimensional (3D) Airyscan images of immunofluorescence staining for PECAM, Ins, and F-actin on 8-week-old control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. Fields demarcated by yellow boxes in (<bold>E, F</bold>) are shown at higher magnification in (<bold>E’, F’</bold>). The images showed the separation of F-actin between Ins-expressing endocrine cells. This separation is highlighted by the yellow arrows in (<bold>F’</bold>). (<bold>G–H</bold>) Airyscan images of immunofluorescence staining for PECAM, Ins, and F-actin in P14 control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. In control islets (<bold>G'</bold>), the F-actin assemblies appear condensed, as indicated by the yellow arrows. However, in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets (<bold>H'</bold>), the same F-actin assemblies appear to be diffused within the insulin-expressing cells. (<bold>I</bold>) Graphical summary showing cell-cell adhesion and cell-blood vessel (BV) interaction differences observed in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets. PECAM, platelet endothelial cell adhesion molecule-1; Ins, insulin; P14, postnatal day 14; BV, blood vessels. Data are shown as mean ± SEM. **p&lt;0.01 and ***p&lt;0.001.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To investigate how <italic>Ctnna1</italic> deletion impacts islet development, we compared transcriptional profiling of <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> and control islets at 8 weeks. A comparison of gene expression profiles between <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> and control islets revealed significant differences in the expression of 319 genes with FDR &lt;0.05 and FC &gt;2, of which 245 were up-regulated and 74 were down-regulated (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Among all GO categories, one of the most up-regulated groups in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets is genes associated with ECM signaling and blood vessel interactions (<xref ref-type="fig" rid="fig3">Figure 3G</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). These include metalloproteases, vascular adhesion, collagens, integrins, laminins, glycoproteins, and thrombospondins (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). These findings suggest that <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets have augmented ECM signaling and blood vessel interaction. IF for blood vessels confirmed an increase in blood vessel density in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets at 8 weeks (<xref ref-type="fig" rid="fig3">Figure 3H–J</xref>). The increase in islet vasculature was observed as early as P14 (<xref ref-type="fig" rid="fig3">Figure 3K–L</xref>). These findings demonstrated that the inactivation of <italic>Ctnna1</italic> in endocrine progenitor cells led to a decrease of endocrine cell-cell adhesion and an increase in blood vessel interaction.</p><p>Alongside the increased interaction with blood vessels, we observed abnormal organization of F-actin fibers within <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and F</xref>). These alterations in F-actin fiber organization were evident as early as P14 in the <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets, concurrent with the onset of enhanced interaction with blood vessels (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G and H</xref>). These findings demonstrate that the loss of Ctnna1 compromises endocrine cell aggregation and perturbs the organization of the actin cytoskeleton and cell-cell adhesion. Together, these findings suggest that the balance between cell-cell adhesion and blood vessel interaction is crucial for islet cell aggregation during development (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1I</xref>).</p></sec><sec id="s2-4"><title>Inactivation of Ctnna1 in differentiating endocrine cells affects the assembly and maintenance of non-β-endocrine cells in islets</title><p>To further investigate the impact of Ctnna1-dependent islet cell aggregation on the islet development process, we compared the gene expression profiles of <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> and control islets. Our analysis revealed significant misregulation of genes crucial for endocrine cell functions. Specifically, we observed a down-regulation of <italic>Slc27a2</italic>, <italic>Tmsb15b1</italic>, and <italic>Etv1</italic> expression, which are genes required for glycemic control and insulin secretion (<xref ref-type="fig" rid="fig4">Figure 4A</xref> Group 1; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>,). Conversely, we found an up-regulation of <italic>Hk1</italic>, <italic>Ldha</italic>, <italic>Aldh1a1</italic>, and <italic>Cxcl14</italic> expression, which are genes known to be ‘disallowed’ in mature functional β-cells (<xref ref-type="bibr" rid="bib51">Lemaire et al., 2016</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref> Group 2; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). These findings suggest that the function of β-cells may be negatively impacted in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Ctnna1 is required for proper islet functionality and α-cell survival.</title><p>(<bold>A</bold>) Heatmap showing the top up-regulated (Group 1) and down-regulated (Group 2) endocrine cell lineage and functional genes in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets from 8-week-old mice. (<bold>B–D</bold>) The figure shows the results of the intraperitoneal glucose tolerance test (<bold>B, D</bold>) and stimulated insulin secretion assay (<bold>C</bold>) performed on control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice at 8 weeks of age (<bold>B, C</bold>) and 12 months of age (<bold>D</bold>). The <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice exhibited glucose intolerance, but no detectable difference in insulin secretion compared to control littermates. The <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice are glucose intolerant with non-detectable insulin secretion defects. (<bold>E–F</bold>) Immunofluorescence staining for Gcg, Ins, and DAPI on 8-week-old (<bold>E</bold>) control and (<bold>F</bold>) <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections showing a reduction of α-cells. (<bold>G–H</bold>) Quantification of (<bold>G</bold>) Ins<sup>+</sup> and (<bold>H</bold>) Gcg<sup>+</sup> area relative to total pancreas area in 8-week-old control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. (<bold>I–K</bold>) Quantification of endocrine cell area (<bold>I</bold>), Gcg<sup>+</sup> (<bold>J</bold>), and Sst<sup>+</sup> (<bold>K</bold>) relative to total pancreas area in control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections at P0 and P7. Note that there was no significant difference observed between the control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections at P0 and P7. (<bold>L–N</bold>) Immunofluorescence staining for Gcg, TUNEL, and DAPI on P7 control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> pancreas sections. White arrows indicate TUNEL<sup>+</sup>/Gcg<sup>+</sup> cells. The percentage of TUNEL<sup>+</sup>/Gcg<sup>+</sup> co-positive cells relative to total Gcg<sup>+</sup> cell numbers in P7 control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets is shown in panel (<bold>N</bold>), and compared to controls, the <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets exhibited significantly more TUNEL<sup>+</sup>/Gcg<sup>+</sup> cells at P7. Gcg, glucagon; Ins, insulin; DAPI, 4’,6-diamidino-2-phenylindole; IPGTT, intraperitoneal glucose tolerance test; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; P0, postnatal day 0; P7, postnatal day 7. Data are shown as mean ± SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata5"><label>Figure 4—source data 5.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata6"><label>Figure 4—source data 6.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4I</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data6-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata7"><label>Figure 4—source data 7.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data7-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata8"><label>Figure 4—source data 8.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4K</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data8-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata9"><label>Figure 4—source data 9.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4N</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-data9-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Ctnna1 is required for proper islet functionality and normal islet aggregation.</title><p>(<bold>A</bold>) Quantification of selected differentially expressed genes involved in islet functional maturation using real-time qPCR analysis in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets and compared to controls. The relative quantification of gene expression levels was determined using the 2<sup>-∆∆Ct</sup> method and is reported as an RQ value relative to the control group. The genes selected for validation were chosen based on their known roles in islet function and maturation. (<bold>B–C</bold>) Whole-blood glucose (<bold>B</bold>; mg/dL) and insulin secretion (<bold>C</bold>; ng/ml) during 120 min in euglycemic clamp experiments in 5-hr-fasted, surgically catheterized control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice at 8 weeks of age. At 5–15 min after glucose infusion, <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice showed slightly elevated glucose levels compared to controls (p=0.15). The amount of insulin secretion in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice decreased at 90 and 120 min after glucose infusion (p=0.09 and 0.051, respectively). These results suggest that <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice may have impaired glucose metabolism and insulin secretion. (<bold>D–E</bold>) Immunofluorescence staining for Sst (red), Ins (green), and DAPI (blue) in pancreas sections of 8-week-old control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>F</bold>) Quantification of the Sst<sup>+</sup> area relative to the total pancreas area shows a decrease in the number of Sst<sup>+</sup> cells in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice compared with their control. (<bold>G–J</bold>) Immunofluorescence staining for Gcg (red), Ins (green), and DAPI (blue) in pancreas sections of P0 (<bold>G and H</bold>) and P7 (<bold>I and J</bold>) control and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice. The fields demarcated by yellow boxes in (<bold>G–J</bold>) are shown at higher magnification in (<bold>G’–J’</bold>). (<bold>K–L</bold>) Transmission electron microscope images of P7 control (<bold>K</bold>) and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> (<bold>L</bold>) endocrine areas. Red arrows indicate detachment of an α-cell from an islet aggregate. RQ, relative quantification; Sst, somatostatin; Gcg, glucagon; Ins, insulin; DAPI, 4’,6-diamidino-2-phenylindole; P0, postnatal day 0; P7, postnatal day 7; BV, blood vessels. Data are shown as mean ± SEM. *p&lt;0.05, ****p&lt;0.0001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-figsupp1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-figsupp1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata4"><label>Figure 4—figure supplement 1—source data 4.</label><caption><title>Related to <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig4-figsupp1-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig4-figsupp1-v2.tif"/></fig></fig-group><p>To support this notion, we conducted glucose tolerance tests, which revealed mild glucose intolerance in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice at 8 weeks (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). However, the quantification of insulin content in serum after glucose challenge did not reveal any noticeable insulin secretion defect in the <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). We reasoned that the conventional serum insulin measurement may not reflect the changes in β-cell function, given that the <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice exhibit only mild glucose intolerance. Therefore, we performed quantification of insulin secretion in vivo using hyperglycemic clamps, which is a more sensitive detection method. In this assay, we observed a trend toward lower overall insulin secretion in the <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice at 8 weeks (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B and C</xref>), providing additional evidence that Ctnna1-dependent islet cell aggregation has an impact on β-cell function. In addition, the glucose intolerance phenotype became even more pronounced at 1 year of age, as evidenced by the glucose tolerance test (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These findings indicate that Ctnna1-dependent islet cell aggregation is crucial for the proper development of β-cells and their function in maintaining glucose homeostasis.</p><p>In addition to suggested functional defects in β-cells, we found that genes for non-β-endocrine cell lineages, including α-cell genes <italic>Gcg, MafB, Arx, Peg10,</italic> and <italic>Etv1,</italic> and the δ-cell gene <italic>Sst</italic>, were significantly down-regulated in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), suggesting the requirement of <italic>Ctnna1</italic> for the presence of non-β-endocrine cells in islets. Interestingly, <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets did not show a reduced area of β-cells, as β-cells were still loosely organized in the core of islets (<xref ref-type="fig" rid="fig4">Figure 4E–G</xref>). However, there was a severe reduction of α-cell and δ-cell populations in the <italic>Ctnna1</italic>-deleted islets (<xref ref-type="fig" rid="fig4">Figure 4H</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D–F</xref>). To determine whether the loss of non-β-endocrine cells was the result of differentiation defects during development, we examined the population of α- and β-cells in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets at P0 and P7. At these ages, the islets of <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> mice exhibited normal endocrine cell mass, Gcg<sup>+</sup> α-cell and Sst<sup>+</sup> δ-cell areas (<xref ref-type="fig" rid="fig4">Figure 4I–K</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G–J</xref>), demonstrating that the loss of α- and δ-cell was not due to differentiation defects prior to these early stages. However, the detachment of α-cells from the mantle of <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets was observed by P7. By this timepoint, α-cells had formed tight interactions with other endocrine cells in control islets (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I and K</xref>), but <italic>Ctnna1</italic>-deficient α-cells detached from other cell types (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1J and L</xref>). To investigate whether cell detachment promotes cell death, thus resulting in α-cell loss, TUNEL analysis on P7 <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets was conducted to analyze cell apoptosis. Compared to the control, <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets display three times more TUNEL<sup>+</sup> apoptotic α-cells (<xref ref-type="fig" rid="fig4">Figure 4L–N</xref>), indicating that <italic>Ctnna1</italic> is required for α-cell survival. Thus, the loss of the α-cells in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets during adulthood is not due to endocrine cell differentiation defects; instead, a drastic increase in apoptosis explains the loss of α-cells in the <italic>Ctnna1</italic>-deleted islets.</p></sec><sec id="s2-5"><title>Differential adhesion in endocrine cells controls the formation of islet architecture</title><p>Since the reduction of cell-cell adhesion caused distinctive outcomes in different endocrine cell subtypes, we hypothesized that the endocrine cells in the mantle or core of islets may have different adhesiveness. We re-analyzed publicly available gene expression profiles (<xref ref-type="bibr" rid="bib22">DiGruccio et al., 2016</xref>) to examine the expression of key cell adhesion molecules <italic>E-cadherin</italic>, <italic>N-cadherin</italic>, <italic>α-catenin</italic>, and <italic>β-catenin</italic> between the subtypes of endocrine cells. These adhesion genes were expressed at the highest level in β-cells, while their expression was comparatively lower in endocrine cells located in the mantle of islets (α-cells and δ-cells, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). These observations suggest that the adhesive properties may differ between endocrine cell subtypes. According to the differential adhesion hypothesis (DAH), a population of cells with different adhesive properties will tend to spontaneously sort themselves to maximize adhesive bonding (<xref ref-type="bibr" rid="bib28">Foty and Steinberg, 2005</xref>). Stronger adhesion between β-cells may lead them to bundle into islet cores, while the weaker adhesion between non-β-cells results in their dispersion into islet mantles.</p><p>Based on the DAH, if the cell adhesion is altered in different endocrine subpopulations, the stereotypical islet architecture will also be affected. To alter the cell adhesion in different endocrine subpopulations, we crossed <italic>Ins1-Cre</italic> and <italic>Gcg-iCre</italic> lines to <italic>Ctnna1-flox</italic> mice and traced the <italic>Ctnna1-</italic>deleted β- or α-cells with the lineage tracer <italic>Rosa26-mT/mG</italic> (<italic>Ins1-Cre; Ctnna1<sup>f/f</sup>; Rosa26-mT/mG</italic> and <italic>Gcg-iCre; Ctnna1<sup>f/f</sup>; Rosa26-mT/mG,</italic> hereafter <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> and <italic>Ctnna1<sup>Δα/Δα</sup></italic> mice, respectively). The <italic>Rosa26-mT/mG</italic> lineage-tracing allele faithfully reported the <italic>Ins1-Cre</italic> and <italic>Gcg-iCre</italic> cell lineages at P7 (<xref ref-type="fig" rid="fig5">Figure 5A–H</xref>), allowing examination of the respectively labeled β- and α-cells using mGFP expression. The mGFP<sup>+</sup> β-cells of <italic>Ctnna1<sup>Δβ/+</sup></italic> mice are mostly located on the islet core (<xref ref-type="fig" rid="fig5">Figure 5A and E</xref>), and the mGFP<sup>+</sup> α-cells of <italic>Ctnna1<sup>Δα/+</sup></italic> mice are mostly located in the islet mantle (<xref ref-type="fig" rid="fig5">Figure 5C and G</xref>). Additionally, we found that β-cells exhibited strong F-actin condensed cellular junctions with well-organized rosette structures (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>, yellow arrows). In contrast, α-cells displayed loosely bundled F-actin assemblies without focal-condensed junctional structures found in control mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>, yellow arrows), supporting the notion that α-cells may have relatively low adhesive properties. Inactivation of Ctnna1 in β-cells and α-cells significantly diminished the formation of F-actin, as indicated in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C and E</xref> (highlighted by yellow arrows). This suggests a substantial decrease in cell adhesion assemblies within the β-cells of <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> and the α-cells of <italic>Ctnna1<sup>Δα/α</sup></italic> islets.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Loss of Ctnna1 in α- and β-cells leads to disrupted islet architecture.</title><p>(<bold>A–H</bold>) Airyscan images of immunofluorescence staining for Ins (<bold>A–D</bold>), Gcg (<bold>E–H</bold>), and DAPI in pancreas sections of P7 mT/mG reporter mice: Heterozygous <italic>Ctnna1<sup>Δβ/+</sup></italic> (<bold>A, E</bold>), homozygous <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> (<bold>B, F</bold>), heterozygous <italic>Ctnna1<sup>Δα/+</sup></italic> (<bold>C, G</bold>), and homozygous <italic>Ctnna1<sup>Δα/Δα</sup></italic> (<bold>D, H</bold>). The yellow arrows in (<bold>F</bold>) showing α-cells in the islet core in <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> mice. The fields demarcated by yellow boxes are shown at higher magnification with individual color channels in the side panels. (<bold>I–J</bold>) Quantification of α-cell localization in the islets of <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> (<bold>I</bold>) and <italic>Ctnna1<sup>Δα/Δα</sup></italic> (<bold>J</bold>) mice. Compared to controls, <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> and <italic>Ctnna1<sup>Δα/Δα</sup></italic> mice exhibit a reduction in peripherally located α-cells and an increase in core-located α-cells. These results suggest that the loss of Ctnna1 in α- and β-cells affects the organization and localization of α-cells within the islet. Gcg, glucagon; DAPI, 4’,6-diamidino-2-phenylindole; Ins, insulin; P7, postnatal day 7. Data are shown as mean ± SEM. ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig5">Figure 5I</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig5">Figure 5J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig5-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Differential cell-cell adhesion in endocrine cells.</title><p>(<bold>A</bold>) Genome viewer plots comparing expression levels of adhesion molecules in α-, β-, and δ- cell transcriptomes (<xref ref-type="bibr" rid="bib22">DiGruccio et al., 2016</xref>). (<bold>B–E</bold>) Airyscan images of immunofluorescence staining of P7 mT/mG reporter mice stained for F-actin and DAPI in (<bold>B</bold>) heterozygous <italic>Ctnna1<sup>Δβ/+</sup></italic>, (<bold>C</bold>) homozygous <italic>Ctnna1<sup>Δβ/Δβ</sup></italic>, (<bold>D</bold>) heterozygous <italic>Ctnna1<sup>Δα/+</sup></italic>, and (<bold>E</bold>) homozygous <italic>Ctnna1<sup>Δα/Δα</sup></italic> mice. Fields demarcated by yellow boxes in (<bold>B–E</bold>) are shown at higher magnification with individual color channels in (B’–E’) side panels. Yellow arrows indicate expression of F-actin in (<bold>B, C</bold>) β- (<bold>D, E</bold>) and α-cells. DAPI, 4’,6-diamidino-2-phenylindole; P7, postnatal day 7.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Based on the DAH proposed by previous studies, we expected that Ctnna1-expressing α-cells would tend to cluster together and become more concentrated toward the center of <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> islets due to weaker adhesion in β-cells lacking Ctnna1. Our observations supported this hypothesis: in <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> islets, where only β-cell adhesion was affected but not α-cell adhesion, we observed a significant decrease in α-cells at the periphery and an increase in their density at the core of the islets (<xref ref-type="fig" rid="fig5">Figure 5B, F and I</xref>). Additionally, our data revealed that islet core-located α-cells had a higher tendency to form clusters (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). These results are consistent with the prediction of DAH that cells with stronger adhesion tend to exclude those with weaker adhesion and to form a cluster with a defined size.</p><p>However, in α-cell-specific Ctnna1 deletion (<italic>Ctnna1<sup>Δα/Δα</sup></italic>) mutants, we observed a reduction in α-cells at the periphery and an increase in their frequency in the islet core (<xref ref-type="fig" rid="fig5">Figure 5D, H and J</xref>), which was unexpected based on the predictions of DAH. Nevertheless, the core-located Ctnna1-deficient α-cells were mostly scattered as single cells without clustering together in the islet of <italic>Ctnna1<sup>Δα/Δα</sup></italic> mice (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). This suggests that the role of Ctnna1 in regulating cellular distribution within the islets may be more complex than the simple attractor-repeller mechanism proposed by DAH. These observations support the idea that differential adhesion between endocrine subtypes is a contributing factor for establishing the islet architecture during development; and the weaker cell adhesion in the peripheral islet layers leads to the specific loss of these cell types in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets.</p></sec><sec id="s2-6"><title>Coordination of ECM and cell-cell adhesion regulates islet vascularization, architecture, and functional maturation</title><p>Our studies have shown that the coordination of cell-ECM and cell-cell adhesion plays a vital role in regulating islet development. These adhesions work together to balance interactions between endocrine cells and blood vessels. When one of these adhesions is perturbed, islet endocrine cells may compensate with another interaction to maintain islet aggregation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). However, it is still unclear whether islet clustering relies solely on these two adhesions. To test this, we generated <italic>Ngn3-Cre; Ctnna1<sup>f/f</sup>; Itgb1<sup>f/f</sup></italic> (hereafter <italic>Ctnna1; Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup>) double knockout (DKO) mice, in which we simultaneously removed cell-ECM and cell-cell adhesion in all endocrine progenitor cells. We compared control, <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup><italic>, Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> and DKO islets at P7 to examine their morphology.</p><p>At P7, <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets displayed loosely aggregated endocrine cells, increased vascularization (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>), reduced F-actin assemblies, and more active-Itgb1<sup>+</sup> endothelial cells in the loosened islet aggregates (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>). Conversely, <italic>Itgb1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets clumped together (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), with strong F-actin assemblies and less active-Itgb1<sup>+</sup> endothelial cells in the tightly aggregated islets (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). However, the aggregation of endocrine cells was completely abrogated in the DKO mice (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). These DKO endocrine cells became suspended single cells scattered throughout the entire pancreatic epithelium, displaying rounded cell morphology (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). The DKO endocrine cells were larger and displayed weak F-actin assemblies (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). Despite the drastic changes in endocrine cell aggregation and morphology, the endocrine cell subtypes were still present in the P7 DKO islets (<xref ref-type="fig" rid="fig6">Figure 6D</xref> and data not shown), suggesting that the differentiation of endocrine subtypes is independent of the islet aggregation process.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Disruption of cell-extracellular matrix (ECM) and/or cell-cell adhesion results in abnormal islet vascular architecture, endocrine cell aggregation, and decreased expression of β-cell maturation markers at postnatal day 7.</title><p>(<bold>A–D</bold>) Immunofluorescence staining of PECAM, Ins, Gcg, and DAPI in P7 (<bold>A</bold>) control, (<bold>B</bold>) <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic>, (<bold>C</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic>, and (<bold>D</bold>) <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. Fields demarcated by yellow boxes in (A–D) are shown at higher magnification in (A’–D’) side panels. Individual islet shape is outlined by dashed yellow lines in (A’–C’). Endocrine cells are suspended and scattered throughout the pancreas of <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>E–L</bold>) Airyscan images of immunofluorescence staining for Ucn3, Glut2, Ins, and DAPI in P7 (<bold>E, I</bold>) control, (<bold>F, J</bold>) <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic>, (<bold>G, K</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic>, and (<bold>H, L</bold>) <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. Arrows indicate reduced expression of Ucn3 or Glut2 in β-cells of the mutant mice. PECAM, platelet endothelial cell adhesion molecule-1; Ins, insulin; Gcg, glucagon; DAPI, 4’,6-diamidino-2-phenylindole; Ucn3, urocortin 3; Glut2, Slc2a2; P7, postnatal day 7.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Aberrant endocrine cell clustering and up-regulation of islet progenitor markers upon disruption of cell adhesion.</title><p>Related to <xref ref-type="fig" rid="fig6">Figure 6</xref>. (<bold>A–D</bold>) Airyscan images showing immunofluorescence staining for active-Itgb1, Lam1, F-actin, and ChrA in pancreas sections from (<bold>A</bold>) control, (<bold>B</bold>) <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic>, (<bold>C</bold>) <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic>, and (<bold>D</bold>) <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice at P7. The yellow boxes in (<bold>A–D</bold>) indicate the fields shown at higher magnification in (<bold>A’–D’</bold>) side panels. The yellow arrows point to F-actin expression in endocrine cells. The <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> (<bold>B’</bold>) and <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> (<bold>D’</bold>) islet cells exhibit a round cell shape and reduced F-actin-enriched junctional structures. (<bold>E–H</bold>) Immunofluorescence staining for endocrine cell marker ChrA (green), ductal marker DBA (white in <bold>E, F</bold>), and progenitor markers Sox9 (red in <bold>E, F</bold>) and Spp1 (red in <bold>G, H</bold>) on pancreas sections from control (<bold>E, G</bold>) and <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> (<bold>F, H</bold>) mice at P7. The yellow boxes in (<bold>E–H</bold>) indicate the fields shown at higher magnification in (<bold>E’–H’</bold>) side panels. Compared to controls, in which ChrA<sup>+</sup> endocrine cells do not express progenitor markers Sox9 and Spp1 (<bold>E’ and G’</bold>), a subpopulation of ChrA<sup>+</sup> endocrine cells in the islets of <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice exhibit up-regulated expression of Sox9 and Spp1 (yellow cells indicated by arrows in F' and H'). Lam1, laminin1; ChrA; chromogranin A; P7, postnatal day 7; DBA, <italic>Dolichos biflorus</italic> agglutinin.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig6-figsupp1-v2.tif"/></fig></fig-group><p>We next investigated whether the failure in islet aggregation affected endocrine cell maturation by performing IF for β-cell maturation markers. In P7 control mice, Ucn3 and Glut2 were robustly expressed in the cytosol and cell surface of β-cells, respectively (<xref ref-type="fig" rid="fig6">Figure 6E and I</xref>). Deletion of <italic>Ctnna1</italic> or <italic>Itgb1</italic> in endocrine progenitor cells led to reduced expression of Ucn3 and Glut2 in β-cells (<xref ref-type="fig" rid="fig6">Figure 6F, G, J, and K</xref>), which was consistent with gene profiling analysis from 8-week-old mice. Finally, DKO islets displayed a severe loss of β-cell maturation markers in P7 β-cells (<xref ref-type="fig" rid="fig6">Figure 6H and L</xref>). In addition, while endocrine cells in normal islets do not express progenitor markers Sox9 or Spp1 at P7 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E and G</xref>), the endocrine cells in the DKO islets exhibited elevated expression of these markers at P7 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F and H</xref>). These findings suggest that β-cell maturation is linked to the cell adhesion-mediated islet aggregation process.</p><p>To investigate whether the islet aggregation and β-cell maturation defects in DKO mice at P7 were due to developmental delays, we examined islets during later adulthood stages. At 8 weeks, normal endocrine cells form tightly aggregated islets (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), but in DKO mice, endocrine cells remain mostly scattered, forming smaller and loosely attached clusters (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). These smaller clusters of endocrine cells abnormally express progenitor markers Sox9 and Spp1 (<xref ref-type="fig" rid="fig7">Figure 7B</xref>; and data not shown). While the endocrine cells appear to be located closely to each other in lower resolution images, Airyscan super-resolution images of F-actin IF on endocrine cells in DKO islets showed that the endocrine cells are completely separated from each other without forming discernible junction structures (<xref ref-type="fig" rid="fig7">Figure 7C and D</xref>, yellow arrows). Furthermore, the endocrine cells also exhibit separation from the vasculatures in the DKO islets (<xref ref-type="fig" rid="fig7">Figure 7C and D</xref>, red arrows). These observations indicate that both the islet aggregation and the β-cell maturation defects in DKO mice persist into adulthood. Supporting this, low expression of β-cell maturation markers Ucn3 and Glut2 persisted in 8-week-old DKO islets (<xref ref-type="fig" rid="fig7">Figure 7F–H</xref>). These mice were severely glucose intolerant (<xref ref-type="fig" rid="fig7">Figure 7I</xref>) and exhibit very low insulin secretion upon glucose stimulation (<xref ref-type="fig" rid="fig7">Figure 7J</xref>). Together, our findings support a model in which islet morphogenesis, vasculature interaction, endocrine cell aggregation, and the β-cell maturation process depend on cell-ECM and cell-cell adhesion during development (<xref ref-type="fig" rid="fig7">Figure 7K</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Abnormal islet aggregation, mis-regulation of β-cell maturation markers, and insulin secretion defects persist in <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice into adulthood.</title><p>(<bold>A–B</bold>) Immunofluorescence staining for endocrine cell marker ChrA and progenitor marker Spp1 on pancreas sections from control (<bold>A</bold>) and <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> (<bold>B</bold>) mice at 8 weeks of age. The yellow boxes in (A, B) indicate the fields shown at higher magnification in (A’, B’) side panels. In the islets of <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice, a subpopulation of ChrA<sup>+</sup> endocrine cells expresses progenitor markers Spp1 (yellow cells in <bold>B and B’</bold>). (<bold>C–D</bold>) Airyscan images of immunofluorescence staining for Ins, F-actin, and DAPI in pancreatic sections from 8-week-old control and <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice are shown. In control islets (<bold>C, C'</bold>), the F-actin assemblies appear aligned with cell membranes and condensed in cellular junctions, as indicated by the yellow and red arrows, respectively. In contrast, diffused distribution of F-actin (red arrows in <bold>D’</bold>) and separation of F-actin assemblies (yellow arrows in <bold>D’</bold>) between Ins<sup>+</sup> β-cells are observed in the <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>E–F</bold>) Immunofluorescence staining of Ucn3, Ins, and DAPI in pancreatic sections of 8-week-old (<bold>E</bold>) control and (<bold>F</bold>) <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. Fields demarcated by white boxes in (E and F) are shown at higher magnification in (<bold>E’ and F’</bold>), and individual islet shape is outlined by dashed white lines. The reduction of Ucn3 expression persists in adult <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>G–H</bold>) Immunofluorescence staining of Glut2, Ins, and DAPI in 8-week-old (<bold>G</bold>) control and (<bold>H</bold>) <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mouse pancreas. Fields demarcated by white boxes in (G and H) are shown at higher magnification in (G’ and H’), and individual islet shape is outlined by dashed white lines. The reduction of Glut2 expression persists in adult <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice. (<bold>I–J</bold>) Intraperitoneal glucose tolerance test was performed on 8-week-old mice (<bold>I</bold>), and glucose-stimulated insulin secretion was measured at T15 in 20- to 38-week-old mice (<bold>J</bold>) from control and <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> groups. <italic>Ctnna1; Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice exhibited severe glucose intolerance and defects in insulin secretion. (<bold>K</bold>) Graphical summary of the islet phenotypes observed after disruption of cell-cell and cell-extracellular matrix (ECM) adhesion. Ins, insulin; ChrA, chromogranin A; Spp1, secreted phosphoprotein 1; Ucn3, urocortin 3; IPGTT, intraperitoneal glucose tolerance test. Data are shown as mean ± SEM. *p&lt;0.05 and **p&lt;0.01.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig7">Figure 7I</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig7-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig7">Figure 7J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90006-fig7-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90006-fig7-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study reveals the combinatorial roles of cell-ECM and cell-cell adhesion in regulating the aggregation of endocrine cells into islets. Mechanistically, islet cell aggregation depends on endocrine cell-cell adhesion, which is negatively regulated by cell-ECM adhesion through vascular interaction. These two adhesion properties are reciprocally regulated: lowering cell-ECM adhesion promotes endocrine cell-cell adhesion; and, conversely, lowering cell-cell adhesion promotes cell-ECM adhesion. Importantly, the aggregation and functional maturation processes of endocrine cells are affected by the loss of either adhesion property and are further affected by the loss of both.</p><p>In this study, we aimed to elucidate the role of ECM signaling by specifically deleting the essential ECM receptor Itgb1 during endocrine specification. Our findings demonstrate that while the morphology and function of <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets were impacted, the total islet area remained unaffected, suggesting that Itgb1 deletion may not result in overt cell death in islets, unlike in other organ systems (<xref ref-type="bibr" rid="bib15">Carlson et al., 2008</xref>; <xref ref-type="bibr" rid="bib84">Speicher et al., 2014</xref>). These observations indicate the involvement of other mediators of cell-ECM interactions in islet maintenance. Although Itgb1 is a key player in cell-ECM interactions, compensatory mechanisms involving other integrins, such as β3, β4, β5, β6; and α3, α6, αV integrins, may be operative in Itgb1-deficient islets. Previous studies have highlighted the critical roles of these integrins in cell-ECM interactions and islet biology (<xref ref-type="bibr" rid="bib17">Cirulli et al., 2000</xref>; <xref ref-type="bibr" rid="bib47">Krishnamurthy et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Schiesser et al., 2021</xref>; <xref ref-type="bibr" rid="bib102">Yashpal et al., 2005</xref>). It is plausible that these integrins compensate for cell-ECM interactions, ensuring the survival and function of Itgb1-deficient islets. Further investigations are warranted to comprehensively understand the compensatory mechanisms and contributions of other integrins in Itgb1-deficient islets.</p><p>Both <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> and <italic>Itgb1</italic><sup>Δ<italic>Matureβ/</italic>Δ<italic>Matureβ</italic></sup> mice demonstrate reduced vascularization, highlighting the importance of ECM signaling in vascular interactions throughout stages from embryonic endocrine cells to mature β-cells. This aligns with previous research using <italic>MIP-Cre</italic> to create <italic>Itgb1</italic>-knockout mice, which also exhibited decreased islet vascularization (<xref ref-type="bibr" rid="bib100">Win et al., 2020</xref>). The critical role of Itgb1 signaling in organ vascularization seems universal; studies indicate that Itgb1 inactivation in pituitary endocrine epithelial cells and kidney cells leads to a loss of vasculature (<xref ref-type="bibr" rid="bib56">Mohamed et al., 2020</xref>; <xref ref-type="bibr" rid="bib74">Scully et al., 2016</xref>). Reduced vascular interaction can instigate hypoxia responses, which have been tied to β-cell maturation processes (<xref ref-type="bibr" rid="bib7">Balboa et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Heinis et al., 2010</xref>; <xref ref-type="bibr" rid="bib103">Zeng et al., 2017</xref>). We thus propose that the impaired β-cell maturation observed in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice could stem from a hypoxic state caused by vascular loss. However, this hypothesis requires further empirical investigation for validation.</p><p>The expression of <italic>Vegfa</italic>, an essential growth factor for islet vasculature, is not affected in <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> islets (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Thus, the reduced vascularization in Itgb1-deficient islets may not be explained by the lack of Vegfa. Downstream of integrin signaling, integrin-linked kinase (ILK) is activated upon integrin-ECM binding to regulate actin organization, cell migration, and other cellular processes (<xref ref-type="bibr" rid="bib35">Hannigan et al., 2005</xref>). Genetic deletion of ILK in the developing pancreas leads to the failure of ILK-inactivated endocrine cells to adhere to the basement membrane, and a drastic reduction of intra-islet blood vessel density (<xref ref-type="bibr" rid="bib46">Kragl et al., 2016</xref>). This study further showed that cortical actomyosin contraction was significantly increased, thus increasing cortex tension in both the ILK-deleted islets and in Itgb1-inactivated cultured β-cells. Our analyses showed aberrant organization of F-actin fibers and compaction of individual endocrine cells, as well as dysregulated cytoskeleton genes in <italic>Itgb1</italic>-deleted islets. Thus, it is likely that both the <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> and <italic>Itgb1</italic><sup>Δ<italic>Matureβ/</italic>Δ<italic>Matureβ</italic></sup> islets fail to interact with vasculature resulting in the same alteration of the actomyosin regulation seen in ILK-deleted islet cells. In contrast, the <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> model shows increased islet vascularization without affecting the expression of <italic>Vegfa</italic> (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). We posit that weakened adhesion between endocrine cells in <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets may allow greater penetration of vasculature through islet clusters, leading to augmented islet vascularization. Supporting this notion, salivary gland patterning allows vessel penetration via an epithelial ‘cleft’ created by weakened cell-cell adhesion (<xref ref-type="bibr" rid="bib48">Kwon et al., 2017</xref>). Interestingly, the initial steps of cleft formation requires ECM-Itgb1 signaling (<xref ref-type="bibr" rid="bib70">Sakai et al., 2003</xref>); conversely, reducing cell-cell adhesion promotes cell-ECM adhesion during budding morphogenesis (<xref ref-type="bibr" rid="bib98">Wang et al., 2021</xref>). Thus, our proposed model, in which ECM signaling in concert with cell-cell adhesion controls islet aggregation, may reflect a fundamental mechanism of organ morphogenesis.</p><p>In the context of our findings, it is crucial to consider the potential role of vascular alignment in islet cell function. The vasculature system within the islet plays an indispensable role not only in delivering nutrients to the cells but also in facilitating the efficient distribution of hormones into the peripheral circulation (<xref ref-type="bibr" rid="bib29">Gan et al., 2018</xref>). The functional maturation of β-cells and their efficiency in hormone secretion are likely influenced by their proximity to and interaction with the vasculature. In our <italic>Itgb1-</italic> and <italic>Ctnna1</italic>-deficient models, we observed an abnormal aggregation of islet cells, resulting in scattered cells that appear misaligned with the vasculature. This disorganization could potentially impair nutrient delivery and hormone distribution, further exacerbating the functional impairments seen in these models. It is plausible that, in addition to their impact on cell-cell adhesion and aggregation, the inactivation of Itgb1 and Ctnna1 may also interfere with the proper integration of β-cells with the islet vasculature. This perspective adds another layer to our understanding of the complex interplay between cellular adhesion, aggregation, and the vasculature in islet morphology and function.</p><p>The onset of the proendocrine cell program triggers the expression of Ngn3, a factor thought to stimulate the activation of ECM signaling. This signaling pathway is regarded as a key regulatory mechanism controlling the delamination and migration of proendocrine cells away from ductal progenitor cords (<xref ref-type="bibr" rid="bib68">Rosenberg et al., 2010</xref>). In the case of <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> mice, the deactivation of ECM signaling in these endocrine progenitors leads to a noticeable decrease in their migration distances. Consequently, differentiated endocrine cells remain entangled with ducts post-differentiation from as early as E15.5, highlighting the role of ECM signaling in facilitating endocrine progenitor migration during initial developmental stages. Interestingly, this phenomenon of reduced migration is not observed in <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> islets, suggesting the impact of ECM signaling on cell migration may be more specific to the progenitor stage. Supporting this hypothesis, studies utilizing <italic>Ins-Cre</italic> or <italic>RIP-Cre</italic> to ablate Itgb1 in post-differentiated insulin-producing cells have reported no discernible migration defects (<xref ref-type="bibr" rid="bib21">Diaferia et al., 2013</xref>; <xref ref-type="bibr" rid="bib100">Win et al., 2020</xref>). During the limited time window of endocrine cell development, islet cell radial migration is also modulated by semaphorin signaling (<xref ref-type="bibr" rid="bib62">Pauerstein et al., 2017</xref>). The remodeling of actin, induced by semaphorin, is associated with changes in the cell anchorage to the ECM (<xref ref-type="bibr" rid="bib4">Alto and Terman, 2017</xref>). This suggests that the chemoattractant system, where semaphorin signaling occurs, could potentially intersect with the activation of Itgb1 signaling. This intersection of signaling pathways may guide the migration of islet progenitor cells toward the periphery and away from the ducts. Thus, the chemoattractant system where semaphorin signaling occurs may involve the activation of Itgb1 signaling to control islet progenitor cell migration toward the periphery, and away from the ducts. Whether the migration of endocrine progenitors toward the periphery affects their function remains to be tested. However, the role of ECM-integrin signaling extends beyond the scope of cell migration. In adult stages, ECM-integrin signaling continues to have a significant impact on differentiated endocrine cells within pancreatic islets (<xref ref-type="bibr" rid="bib29">Gan et al., 2018</xref>). Therefore, when we use the term ‘endocrine cells’ in this study, we refer to both progenitor and differentiated cells, and the significance of ECM-integrin signaling spans across multiple cellular processes, not being confined to migration alone.</p><p>Despite the endocrine subtype ratios being different in human versus rodent islets, the precise differences in the stereotypical architectures in the two species have been debated. Studies using different imaging modalities have yielded different conclusions (<xref ref-type="bibr" rid="bib24">Dybala et al., 2020</xref>). In mice, it is proposed that spatiotemporal collinearity leads to the typical core-mantle architecture of the spherical islet in which α-cells, the first to develop, form the peninsular outer layer, and β-cells subsequently form beneath them (<xref ref-type="bibr" rid="bib76">Sharon et al., 2019a</xref>). Our current study has not directly tested this hypothesis, yet our observations suggest that differential cell adhesion is critical for developing this structure. Our data support a model in which randomly allocated α- and β-cells are specified and sorted into the final islet architecture based on differential adhesion. It remains to be tested whether the differential cell adhesion is also involved in the development of islet architectures in human. In addition, studies have shown that the Roundabout (Robo)/Slit signaling axis plays a role in determining islet stereotypical architecture. The secreted ligand, Slit, is often associated with the ECM, and binds to Robo receptors to control various cellular responses via cytoplasmic kinases and the regulation of actin and microtubule cytoskeleton (<xref ref-type="bibr" rid="bib42">Jiang et al., 2022</xref>; <xref ref-type="bibr" rid="bib91">Tong et al., 2019</xref>). Mice lacking <italic>Robo1</italic> and <italic>Robo2</italic> in all endocrine cells, or selectively in β-cells, show complete loss of endocrine cell type sorting in the islets (<xref ref-type="bibr" rid="bib2">Adams et al., 2021</xref>; <xref ref-type="bibr" rid="bib1">Adams et al., 2018</xref>; <xref ref-type="bibr" rid="bib30">Gilbert et al., 2020</xref>). Interestingly, Robo1/2 DKO islets exhibit adhesion defects and are prone to dissociate upon isolation (<xref ref-type="bibr" rid="bib1">Adams et al., 2018</xref>), similar to the <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> islets. Similar observations have been shown in stem cell sorting and cancer cell migration; binding of Slit to Robo receptors leads to the modulation of Ncad- or Ecad-mediated cell adhesion (<xref ref-type="bibr" rid="bib86">Stine et al., 2014</xref>; <xref ref-type="bibr" rid="bib91">Tong et al., 2019</xref>). We speculate that Robo/Slit signaling regulates endocrine cell type sorting in islets by controlling cell adhesive properties to establish the islet architecture.</p><sec id="s3-1"><title>Limitation of the study</title><p>Our study’s potential limitation is the use of the <italic>Ngn3-Cre</italic> driver for targeted gene deletion. While commonly used for pancreatic endocrine progenitor and its lineage-specific gene deletion, <italic>Ngn3</italic> is also expressed in other tissues such as the brain and gastrointestinal tract (<xref ref-type="bibr" rid="bib73">Schonhoff et al., 2004</xref>; <xref ref-type="bibr" rid="bib83">Simon-Areces et al., 2010</xref>). Deletion of genes using this driver could impact these other tissues and create unintended consequences. Previous studies show that <italic>Ctnna1</italic> deletion in neuronal progenitor cells in the brain can lead to altered neural cell proliferation and differentiation (<xref ref-type="bibr" rid="bib54">Lien et al., 2006</xref>). Although we did not investigate the potential effects of <italic>Itgb1</italic> and <italic>Ctnna1</italic> deletion in these other tissues, further studies are necessary to comprehend the role of ECM signaling and cell adhesion in these other tissues and the potential consequences of their deletion using the <italic>Ngn3-Cre</italic> driver.</p><p>We acknowledge the intricate interplay between cell-ECM and cell-cell interactions and understand that the loss of one type of interaction does not universally enhance the other. This complexity was exemplified in our DKO model, which did not exhibit the expected compensatory behaviors. While our in vitro cell adhesion assay provided some insight, we recognize its limitations in fully mirroring the dynamic and sophisticated changes occurring in vivo. Consequently, our observations serve as preliminary findings that pave the way for more comprehensive investigation. Further research, particularly in more complex, dynamic models, will be vital in elucidating the precise nature of these interactions and their role in cell development and function. The dynamic nature of islet aggregation and endocrine subtype sorting would require more in-depth live imaging analysis. Obtaining 3D cellular information in developing islets would provide insights into these dynamic and complex phenomena, and further our understanding of the process of islet development and morphogenesis. We anticipate that using pancreas slice cultures (<xref ref-type="bibr" rid="bib61">Panzer et al., 2020</xref>) to develop an imaging platform to monitor the development of live neonatal islets would provide a framework for understanding how islets develop, and offer novel ways to harness this understanding in the search for clinical alternatives to treat diabetes.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Key reagents</title><p>Details regarding reagents, equipment, and software used in this study are included in the ‘Key Resources Table’ file.</p></sec><sec id="s4-2"><title>Mouse strains</title><p>All animal experiments described herein were approved by the City of Hope Institutional Animal Care and Use Committee (Protocol 15041) and Institutional Biosafety Committee (Protocol 16002). Mice carrying <italic>Ngn3-Cre</italic> (<xref ref-type="bibr" rid="bib73">Schonhoff et al., 2004</xref>) (RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:006333">IMSR_JAX:006333</ext-link>), <italic>Gcg-iCre</italic> (<xref ref-type="bibr" rid="bib82">Shiota et al., 2017</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:030663">IMSR_JAX:030663</ext-link>), <italic>Itgb1<sup>flox</sup></italic> (<xref ref-type="bibr" rid="bib63">Raghavan et al., 2000</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004605">IMSR_JAX:004605</ext-link>), <italic>Ctnna1<sup>flox</sup></italic> (<xref ref-type="bibr" rid="bib95">Vasioukhin et al., 2001</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004604">IMSR_JAX:004604</ext-link>), <italic>Ins-Cre</italic> (<xref ref-type="bibr" rid="bib90">Thorens et al., 2015</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:026801">IMSR_JAX:026801</ext-link>), <italic>Rosa26<sup>mT/mG</sup></italic> (<xref ref-type="bibr" rid="bib59">Muzumdar et al., 2007</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX007676">IMSR_JAX007676</ext-link>), <italic>Rosa26<sup>EYFP</sup></italic> (<xref ref-type="bibr" rid="bib85">Srinivas et al., 2001</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:006148">IMSR_JAX:006148</ext-link>), and <italic>Ucn3-cre</italic> (<xref ref-type="bibr" rid="bib36">Harris et al., 2014</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC_037417-UCD">MMRRC_037417-UCD</ext-link>) alleles have been previously described. Additional information for the mouse lines used in this study is listed in Key Resources Table.</p></sec><sec id="s4-3"><title>Whole-mount IF</title><p>A standard whole-mount staining protocol was utilized to analyze pancreas 3D morphology, as previously described (<xref ref-type="bibr" rid="bib55">Maldonado et al., 2020</xref>). Briefly, pancreas tissue was dissected and fixed overnight in 4% paraformaldehyde (PFA). The tissue was dehydrated with serial methanol washes, bleached with a Dent’s Bleach solution, and rehydrated using an inverse series of methanol washes. Samples were blocked followed by incubation with primary antibodies for PECAM(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_393571">AB_393571</ext-link>), ChrA (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_789299">AB_789299</ext-link>), and secreted phosphoprotein 1 (Spp1) (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2194992">AB_2194992</ext-link>). Samples were then washed in a 0.15% Triton-X-PBS solution and stained with secondary antibodies overnight. Following additional washes with 0.15% Triton-X-PBS, samples were fixed with 4% PFA, and dehydrated with serial ethanol washes. Finally, samples were immersed in a BABB clearing solution (two parts benzyl benzoate and one part benzyl alcohol) and imaged using a Zeiss LSM880 confocal microscope.</p></sec><sec id="s4-4"><title>Confocal microscopy</title><p>All images were collected with a Zeiss LSM880 confocal microscope equipped with a 10X0.45 NA plan apochromat objective at ×2 magnification, as standard for AiryscanFast collection. All tiled Z-stacks were acquired in AiryscanFast mode, the acquisition method set to Z-stack (per channel), and with a 2.0 µm step size. Scans were conducted using 405, 488, 561, and 633 nm laser lines, and emissions were collected using standard Airyscan filters and the Airyscan detector, in Zen Black 2.3 SP1 (Carl Zeiss, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013672">SCR_013672</ext-link>). Final voxel sizes were 0.22 × 0.22 × 1.98 µm<sup>3</sup>, and no digital gain or detector offset was used. Detector gains and laser intensities were consistent across all samples.</p></sec><sec id="s4-5"><title>Image segmentation/analysis</title><p>Data sets were first Airyscan processed in Zen Black using the ‘Auto’ setting using a 2D sample image as a base for Batch mode. After processing, the files were converted to IMS format and analyzed in Imaris 9.5 (Bitplane, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007370">SCR_007370</ext-link>). Analysis consisted of manually selecting thresholds that could be consistently applied between samples, and best fit the biology. Due to variations in the depth of the sample, amount of tissue the light had to pass through, and orientation, thresholds were chosen which most accurately represented the objects being analyzed. The ducts were first segmented using a ‘Surface’ with a 2.00 µm surface grain size, and a fixed threshold. We limited the analysis to areas where ducts were present by segmenting the duct channel a second time (again as a Surface) with a grain size of 10 µm and a much lower threshold, generating a ‘bubble’ area of interest around the ducts. Within this volume, endocrine positive staining was then segmented as another surface and its distance from the ducts quantified using the median value of the distance transform from the surface of the original ducts. Any endocrine cells contained entirely or mostly within the ducts were considered to have a distance of zero from the ducts.</p></sec><sec id="s4-6"><title>Immunofluorescence</title><p>Pancreas tissues were collected from littermate control and mutant mice, ensuring consistency in the sample source. IF staining was performed as previously described (<xref ref-type="bibr" rid="bib78">Shih et al., 2007</xref>). Briefly, pancreata were fixed in 4% PFA in PBS, equilibrated in 30% sucrose in PBS, and cryoembedded in Tissue-Tek OCT. To ensure the reliability and accuracy of the findings, we used littermate control and mutant mice, collecting and processing their pancreas samples concurrently. This included fixing and embedding the samples into the same cryo-block, sectioning, and preparing them for IF staining on the same slide. This process ensured identical staining conditions for all samples. Samples were then sectioned at 10 μm intervals from the same cryo-block, facilitating identical staining conditions for all samples. For IF staining, sections were blocked for 1 hr before the addition of primary antibodies diluted in the same buffer. Following washes, secondary antibodies, diluted in blocking buffer, were applied to sections and stained for 2 hr at room temperature. The respective dilutions of primary and secondary antibodies are noted in the Key Resources Table.</p><p>Images were taken on a Zeiss Axio-Observer-Z1 microscope with Apotome, and figures were created in Adobe Photoshop/Illustrator CC2020. Morphometric analyses were conducted using Image-Pro Premier v.9.2 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016497">SCR_016497</ext-link>) and Qupath software v.0.2.3 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_108257">SCR_108257</ext-link>), available at <ext-link ext-link-type="uri" xlink:href="https://qupath.github.io">https://qupath.github.io</ext-link>. High-resolution image acquisition was achieved with a Zeiss LSM900 confocal microscope with Airyscan. For images intended for direct comparison, the exposure time was kept constant, and changes in digital gain were avoided to prevent distortion of results. Upon image acquisition, linear adjustment processing was applied uniformly across all comparable samples. These adjustments were made using a linear display with Min/Max rescaling. This adjustment approach was to carefully balance avoiding oversaturation while preserving the accuracy of marker expressions. This approach ensures that the full data range is properly utilized, optimizing the full range of possible intensity values. Specifically, the darkest pixel in the image is adjusted to black (minimum value), the brightest pixel to white (maximum value), and all other pixels are rescaled based on these new extremes.</p></sec><sec id="s4-7"><title>α-Cell localization analysis</title><p>The islets were imaged from three serial sections per mouse, taken at 150 μm (P7) or 200 μm (8 weeks) intervals. Manual cell counting was performed using QuPath (version 0.2.3). Islets with a minimum of 40 endocrine cells and at least 10 α-cells were included in the analysis. At the postnatal stage, α-cell localization within the islet was determined according to previously described criteria (<xref ref-type="bibr" rid="bib1">Adams et al., 2018</xref>). Peripheral α-cells were defined as those within the first two layers, while α-cells in any layers beyond the first two were considered to be in the core.</p></sec><sec id="s4-8"><title>Intraperitoneal glucose tolerance test</title><p>Six- to 16-week-old or 6- to 12-month-old mice were fasted for 6–16 hr. Basal blood glucose was measured, and mice were injected intraperitoneally (i.p.) with 2 mg/g body weight dextrose solution. Blood glucose was measured at 15, 30, 60, 90, and 120 min after glucose challenge. The experiments were performed by the Comprehensive Metabolic Phenotyping (CMP) Core at City of Hope.</p></sec><sec id="s4-9"><title>Insulin secretion in vivo</title><p>The β-cell function was assessed by quantifying insulin secretion in vivo with hyperglycemic clamps. Surgical procedures have been described in detail previously (<xref ref-type="bibr" rid="bib6">Ayala et al., 2011</xref>; <xref ref-type="bibr" rid="bib11">Berglund et al., 2008</xref>). Briefly, mice were anesthetized with isoflurane, and the carotid artery and jugular vein were catheterized. Free catheter ends were tunneled under the skin to the back of the neck and externalized with a MASA (Mouse Antenna for Sampling Access), which permits arterial sampling from an indwelling catheter in conscious mice without handling stress. Mice were individually housed and allowed to recover for 4 days during which body weight returned to within ∼10% of presurgical body weight.</p><p>For the hyperglycemic clamps, mice were fasted for 5 hr and connected to a swivel. Saline-washed erythrocytes were infused (5–6 μl/min) during the experimental period to prevent a &gt;5% fall in hematocrit. Blood samples were collected from the arterial catheter in tubes containing EDTA and centrifuged, and plasma was stored at −20°C until analyzed. At t=0 min, mice received a priming glucose infusion rate (GIR, 100 mg/kg/min) for 2 min to stimulate first-phase insulin secretion. The GIR was then adjusted to achieve and maintain blood glucose at ∼15.0 mmol/l. Blood glucose (5 μl) was measured at t = −15,–5, 5, 10, 15, and 20 min and then every 10 min until t=120 min with an Alpha Trak glucometer (Abbott Laboratories, Abbott Park, IL, USA). Larger blood samples (100 μl) to measure plasma insulin were taken at various timepoints.</p></sec><sec id="s4-10"><title>Isolation of mouse pancreatic islets</title><p>Pancreatic islets were isolated as previously described (<xref ref-type="bibr" rid="bib89">Taylor et al., 2013</xref>). Briefly, mouse pancreatic islets were isolated using 2.5 mg/ml collagenase (Sigma-Aldrich) as the digestion method. Islets were collected under a stereomicroscope and allowed to recover overnight in PIM(R) 32A (Prodo Labs) medium with 5% HSA, Gentamicin-AmphotericinB, and 5.8 mmol/l glucose.</p></sec><sec id="s4-11"><title>RNA-seq</title><p>Total RNA was isolated using the RNeasy Micro Kit (QIAGEN) with 10–30 isolated islets and processed per manufacturer’s instructions. cDNA libraries were prepared using the KAPA RNA HyperPrep Kit with RiboErase (HMR) according to the manufacturer’s instructions. Libraries were subjected to high-throughput sequencing on Illumina HiSeq 2500 (50 bp, single-ended) and subsequent data analysis was completed by the Integrative Genomics Core at City of Hope. For sequence alignment and gene counts, RNA-seq reads were trimmed to remove sequencing adapters using Trimmomatic (<xref ref-type="bibr" rid="bib13">Bolger et al., 2014</xref>) and polyA tails using FASTP (<xref ref-type="bibr" rid="bib16">Chen et al., 2018</xref>). The processed reads were mapped back to the mouse genome (mm10) using STAR software (v. 020201) (<xref ref-type="bibr" rid="bib23">Dobin et al., 2013</xref>). The featureCount software (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_012919">SCR_012919</ext-link>) was applied to generate the count matrix, with default parameters (<xref ref-type="bibr" rid="bib53">Liao et al., 2019</xref>). Between two sets of samples (control vs mutant), differential expression analysis was conducted, in R, by adjusting read counts to normalized expression values using TMM normalization method and by correcting batch effects using a design matrix (<xref ref-type="bibr" rid="bib65">Robinson et al., 2010</xref>). Genes with an FDR-adjusted p-value less than 0.05 and with an FC greater than 2 or less than 0.5 were considered as significant up- and down-regulated genes, respectively. Pathway analysis was conducted using DAVID (v. 6.8) (<xref ref-type="bibr" rid="bib39">Huang et al., 2009a</xref>; <xref ref-type="bibr" rid="bib40">Huang et al., 2009b</xref>) and GSEAPreranked algorithm using GSEA Desktop program in Java (<xref ref-type="bibr" rid="bib87">Subramanian et al., 2005</xref>). The former requires a list of up- and down-regulated genes, while the latter a ranked list of whole genes according to their log2 FC and p-values. Raw data and processed data files are available at the GEO database: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153187">GSE153187</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190788">GSE190788</ext-link>.</p></sec><sec id="s4-12"><title>Quantitative real-time PCR</title><p>RNA extraction and purification were performed using the RNeasy Micro Kit (QIAGEN) in accordance with the manufacturer’s protocol. The quality and quantity of the total RNA were assessed using a Bioanalyzer 2100 (Agilent Technologies). Samples with an RNA integrity number (RIN) of at least six were used for cDNA synthesis with the SuperScript First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen). Real-time PCR was conducted using PowerUp SYBR Green Master mix (Applied Biosystems) in a QuantStudio 6 Flex machine (Applied Biosystems). Each reaction contained 1 ng cDNA (total RNA equivalent). Relative mRNA expression levels were calculated by normalizing target genes to <italic>Cyclophilin A</italic> (<italic>Ppia</italic>) as an internal control. All primers were designed using the CDS of the target genes by the PrimerBank online tool (<ext-link ext-link-type="uri" xlink:href="https://pga.mgh.harvard.edu/primerbank/">https://pga.mgh.harvard.edu/primerbank/</ext-link>).</p></sec><sec id="s4-13"><title>Aggregation assay</title><p>Neonatal <italic>Ngn3-Cre; Rosa26mT/mG; Itgb1<sup>+/f</sup></italic> (control) or <italic>Ngn3-Cre; Rosa26mT/mG; Itgb1<sup>f/f</sup></italic> (mutant) pancreata were dissociated into a single cell suspension using TrypLE (Thermo Fisher). Enzymatic activity was neutralized using FACS buffer (10% fetal bovine serum and 2 mM EDTA in CMRL media). Cells were passed through a 40 µm cell strainer and DAPI was used to stain dead cells prior to FACS. Prior to cell seeding, 96-well round-bottom plates were coated with either BSA (no ECM) or Matrigel and fibronectin (+ECM). 3000 cells per well were added into no ECM or +ECM wells and cultured for 48 hr.</p></sec><sec id="s4-14"><title>Ex vivo pancreas explants</title><p>Pancreas explants are described previously (<xref ref-type="bibr" rid="bib80">Shih and Sander, 2014</xref>). After 24 hr of culture, the explants were placed on the microscope stage in 37°C culture chambers with a controlled atmosphere of humidified 5% CO<sub>2</sub>. Time-lapse imaging was performed using a Zeiss LSM880 inverted confocal microscope with a C-Apochromat 20×/0.75 objective lens. Explants were optically sectioned every 2.5 µm in a 512×512 format with up to 80 µm Z-stacks every 10 min for 72 hr. Images were acquired with Zen software and then reconstructed in 3D with Imaris 9.5 (Bitplane) software. The contrast was adjusted and selected optical planes or <italic>z</italic>-projections of sequential optical sections were used to assemble time-lapse movies.</p></sec><sec id="s4-15"><title>Electron microscopy sample preparation</title><p>Sample blocks were prepared following the NCMIR protocol (<xref ref-type="bibr" rid="bib20">Deerinck et al., 2010</xref>). Briefly, small pieces (1–2 mm<sup>3</sup>) of mouse pancreatic tissues were dissected and immediately fixed in 0.2 M cacodylate buffer pH 7.4 containing 2.5% glutaraldehyde and 2% PFA with 3 mM calcium chloride. After primary aldehyde fixation the samples were rinsed in 0.15 M sodium cacodylate pH 7.4 containing 2 mM calcium chloride and post-fixed in 1.5% potassium ferrocyanide-reduced 2% osmium tetroxide in 0.15 M cacodylate buffer for 1 hr. Tissue was then rinsed in distilled water and treated with 0.1% aqueous thiocarbohydrazide for 20 min. After further rinsing in distilled water the tissue was again treated with 2% osmium tetroxide for 30 min, rinsed in distilled water, dehydrated in an ethanol series, and infiltrated with Durcupan ACM resin. Ultra-thin sections (70 nm thick) were acquired by ultramicrotomy and examined on an FEI Tecnai 12 transmission electron microscope equipped with a Gatan OneView CMOS camera.</p></sec><sec id="s4-16"><title>Statistics</title><p>Statistical analyses were conducted using GraphPad Prism (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>). Unless otherwise specified, comparisons between groups were made using a one-way analysis of variance (ANOVA) and a two-tailed Student’s t-test. Each condition was tested with at least three independent measurements. Except where otherwise indicated, all data are represented as the mean ± standard error of the mean (SEM).</p><p>Every experiment was independently replicated in the laboratory a minimum of three times. Samples were assigned to experimental groups either pairwise (for wild-type cells with or without treatment) or based on their genotypes (wild-type vs knockout). Detailed information about the replicates, including the number of replicates and sample sizes, can be found in the figure legends and is also outlined in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p><p>Raw data and statistical calculations for intraperitoneal glucose tolerance test, glucose-stimulated insulin secretion, morphometric measurements, and cell population counts for each figure are systematically organized and made available in the ‘Source Data’ files within the Supplementary files.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Formal analysis</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con9"><p>Data curation</p></fn><fn fn-type="con" id="con10"><p>Data curation</p></fn><fn fn-type="con" id="con11"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con12"><p>Data curation, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Formal analysis, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Data curation, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments described herein were approved by the City of Hope Institutional Animal Care and Use Committee (Protocol 15041) and Institutional Biosafety Committee (Protocol 16002).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of Itgb1-regulated genes in 6-week-old islets.</title><p>This table provides a comprehensive catalogue of gene expression differences observed between islets isolated from control mice and those from <italic>Itgb1<sup>ΔEndo/Δendo</sup></italic> mice.</p></caption><media xlink:href="elife-90006-supp1-v2.zip" mimetype="application" mime-subtype="zip"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>List of Ctnna1-regulated genes in 8-week-old islets.</title><p>This table provides a comprehensive catalogue of gene expression differences observed between islets isolated from control mice and those from <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> mice.</p></caption><media xlink:href="elife-90006-supp2-v2.zip" mimetype="application" mime-subtype="zip"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>List of replicates and statistical analysis.</title><p>This table provides detailed information about the replicates, including the number of replicates and sample sizes. It also includes the types of statistical analyses performed.</p></caption><media xlink:href="elife-90006-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-90006-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession numbers GSE153187 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153187">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153187</ext-link>) and GSE190788 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190788">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190788</ext-link>). In addition, two spreedsheets of the RNA-seq data are provided as <xref ref-type="supplementary-material" rid="supp1 supp2">Supplementary files 1 and 2</xref>. Source data files have been provided for all figures. Each experiment was replicated in the laboratory at least three times. Samples were allocated into experimental groups either pairwise (for WT cells with or without treatment) or based on the genotypes (WT vs KO). All the replicate information and the number of replicates and sample sizes can be found in figure legends or in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>The role of Itgb1 in islet development</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153187">GSE153187</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Tixi</surname><given-names>W</given-names></name><name><surname>Shih</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Investigating the role of cell adhesion molecule alpha-catenin during islet development</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190788">GSE190788</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>DiGruccio</surname><given-names>MR</given-names></name><name><surname>Mawla</surname><given-names>AM</given-names></name><name><surname>Donaldson</surname><given-names>CJ</given-names></name><name><surname>Noguchi</surname><given-names>GM</given-names></name><name><surname>Vaughan</surname><given-names>J</given-names></name><name><surname>Cowing-Zitron</surname><given-names>C</given-names></name><name><surname>van der Meulen</surname><given-names>T</given-names></name><name><surname>Huising</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80673">GSE80673</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We acknowledge the support of City of Hope Core Facilities: Dr. Brain Armstrong from the Microscopy Core, Dr. Zhuo Li from the Electron Microscopy Core, Drs. Xiwei Wu and Min-Hsuan Chen from the Integrative Genomics Core, Dr. Patrick Fueger from the Comprehensive Metabolic Phenotyping Core at City of Hope. We thank Dr. Maike Sander for sharing the anti-Ngn3 antiserum and Dr. Rupangi Vasavada for sharing the <italic>Ins-Cre</italic> mouse strain. The California Institute for Regenerative Medicine (CIRM) Training Grant EDUC4-12772 to WT; JDRF postdoctoral fellowship 3-PDF-2019-742-A-N to MM; NSERC Discovery Grant (RGPIN-2016-04276), CIHR New Investigator Award Msh-147794, and MSFHR Scholar Award 18309 to JLK, NIH/NIDDK 1R01DK110276 to MOH; NIH/NIDDK 1R01DK120523, Human Islet Research Network (HIRN) New investigator Award (subaward via UC4DK104162), and a grant from the Wanek Family Foundation to Cure Type 1 Diabetes to SD; Wanek Family Foundation to Cure Type 1 Diabetes and NIH/NIDDK 1R01DK119590 to HPS. We acknowledge the assistance of OpenAI’s ChatGPT in refining the language and grammar of our manuscript during resubmission. The contributions of this AI model were strictly limited to textual improvements, with no role in generating or modifying the scientific content and findings of the study.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>M.T.</given-names></name><name><surname>Gilbert</surname><given-names>JM</given-names></name><name><surname>Hinojosa Paiz</surname><given-names>J</given-names></name><name><surname>Bowman</surname><given-names>FM</given-names></name><name><surname>Blum</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endocrine cell type sorting and mature architecture in the islets of Langerhans require expression of Roundabout receptors in β cells</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>10876</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-29118-x</pub-id><pub-id pub-id-type="pmid">30022126</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>MT</given-names></name><name><surname>Dwulet</surname><given-names>JM</given-names></name><name><surname>Briggs</surname><given-names>JK</given-names></name><name><surname>Reissaus</surname><given-names>CA</given-names></name><name><surname>Jin</surname><given-names>E</given-names></name><name><surname>Szulczewski</surname><given-names>JM</given-names></name><name><surname>Lyman</surname><given-names>MR</given-names></name><name><surname>Sdao</surname><given-names>SM</given-names></name><name><surname>Kravets</surname><given-names>V</given-names></name><name><surname>Nimkulrat</surname><given-names>SD</given-names></name><name><surname>Ponik</surname><given-names>SM</given-names></name><name><surname>Merrins</surname><given-names>MJ</given-names></name><name><surname>Mirmira</surname><given-names>RG</given-names></name><name><surname>Linnemann</surname><given-names>AK</given-names></name><name><surname>Benninger</surname><given-names>RK</given-names></name><name><surname>Blum</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Reduced synchroneity of intra-islet Ca2+ oscillations in vivo in Robo-deficient β cells</article-title><source>eLife</source><volume>10</volume><elocation-id>e61308</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.61308</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>M.T.</given-names></name><name><surname>Blum</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Determinants and dynamics of pancreatic islet architecture</article-title><source>Islets</source><volume>14</volume><fpage>82</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1080/19382014.2022.2030649</pub-id><pub-id pub-id-type="pmid">35258417</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alto</surname><given-names>LT</given-names></name><name><surname>Terman</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Semaphorins and their signaling mechanisms</article-title><source>Methods in Molecular Biology</source><volume>1493</volume><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6448-2_1</pub-id><pub-id pub-id-type="pmid">27787839</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrojo e Drigo</surname><given-names>R</given-names></name><name><surname>Ali</surname><given-names>Y</given-names></name><name><surname>Diez</surname><given-names>J</given-names></name><name><surname>Srinivasan</surname><given-names>DK</given-names></name><name><surname>Berggren</surname><given-names>P-O</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>New insights into the architecture of the islet of Langerhans: a focused cross-species assessment</article-title><source>Diabetologia</source><volume>58</volume><fpage>2218</fpage><lpage>2228</lpage><pub-id pub-id-type="doi">10.1007/s00125-015-3699-0</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname><given-names>JE</given-names></name><name><surname>Bracy</surname><given-names>DP</given-names></name><name><surname>Malabanan</surname><given-names>C</given-names></name><name><surname>James</surname><given-names>FD</given-names></name><name><surname>Ansari</surname><given-names>T</given-names></name><name><surname>Fueger</surname><given-names>PT</given-names></name><name><surname>McGuinness</surname><given-names>OP</given-names></name><name><surname>Wasserman</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice</article-title><source>Journal of Visualized Experiments</source><elocation-id>3188</elocation-id><pub-id pub-id-type="doi">10.3791/3188</pub-id><pub-id pub-id-type="pmid">22126863</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balboa</surname><given-names>D</given-names></name><name><surname>Barsby</surname><given-names>T</given-names></name><name><surname>Lithovius</surname><given-names>V</given-names></name><name><surname>Saarimäki-Vire</surname><given-names>J</given-names></name><name><surname>Omar-Hmeadi</surname><given-names>M</given-names></name><name><surname>Dyachok</surname><given-names>O</given-names></name><name><surname>Montaser</surname><given-names>H</given-names></name><name><surname>Lund</surname><given-names>P-E</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Ibrahim</surname><given-names>H</given-names></name><name><surname>Näätänen</surname><given-names>A</given-names></name><name><surname>Chandra</surname><given-names>V</given-names></name><name><surname>Vihinen</surname><given-names>H</given-names></name><name><surname>Jokitalo</surname><given-names>E</given-names></name><name><surname>Kvist</surname><given-names>J</given-names></name><name><surname>Ustinov</surname><given-names>J</given-names></name><name><surname>Nieminen</surname><given-names>AI</given-names></name><name><surname>Kuuluvainen</surname><given-names>E</given-names></name><name><surname>Hietakangas</surname><given-names>V</given-names></name><name><surname>Katajisto</surname><given-names>P</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name><name><surname>Carlsson</surname><given-names>P-O</given-names></name><name><surname>Barg</surname><given-names>S</given-names></name><name><surname>Tengholm</surname><given-names>A</given-names></name><name><surname>Otonkoski</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells</article-title><source>Nature Biotechnology</source><volume>40</volume><fpage>1042</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1038/s41587-022-01219-z</pub-id><pub-id pub-id-type="pmid">35241836</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>CS</given-names></name><name><surname>Franco</surname><given-names>SJ</given-names></name><name><surname>Müller</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Extracellular matrix: functions in the nervous system</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>3</volume><elocation-id>a005108</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a005108</pub-id><pub-id pub-id-type="pmid">21123393</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastidas-Ponce</surname><given-names>A</given-names></name><name><surname>Tritschler</surname><given-names>S</given-names></name><name><surname>Dony</surname><given-names>L</given-names></name><name><surname>Scheibner</surname><given-names>K</given-names></name><name><surname>Tarquis-Medina</surname><given-names>M</given-names></name><name><surname>Salinno</surname><given-names>C</given-names></name><name><surname>Schirge</surname><given-names>S</given-names></name><name><surname>Burtscher</surname><given-names>I</given-names></name><name><surname>Böttcher</surname><given-names>A</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Lickert</surname><given-names>H</given-names></name><name><surname>Bakhti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive single cell mRNA profiling reveals a detailed roadmap for pancreatic endocrinogenesis</article-title><source>Development</source><volume>146</volume><elocation-id>dev173849</elocation-id><pub-id pub-id-type="doi">10.1242/dev.173849</pub-id><pub-id pub-id-type="pmid">31160421</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bechard</surname><given-names>ME</given-names></name><name><surname>Bankaitis</surname><given-names>ED</given-names></name><name><surname>Hipkens</surname><given-names>SB</given-names></name><name><surname>Ustione</surname><given-names>A</given-names></name><name><surname>Piston</surname><given-names>DW</given-names></name><name><surname>Yang</surname><given-names>Y-P</given-names></name><name><surname>Magnuson</surname><given-names>MA</given-names></name><name><surname>Wright</surname><given-names>CVE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Precommitment low-level Neurog3 expression defines a long-lived mitotic endocrine-biased progenitor pool that drives production of endocrine-committed cells</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>1852</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.1101/gad.284729.116</pub-id><pub-id pub-id-type="pmid">27585590</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berglund</surname><given-names>ED</given-names></name><name><surname>Li</surname><given-names>CY</given-names></name><name><surname>Poffenberger</surname><given-names>G</given-names></name><name><surname>Ayala</surname><given-names>JE</given-names></name><name><surname>Fueger</surname><given-names>PT</given-names></name><name><surname>Willis</surname><given-names>SE</given-names></name><name><surname>Jewell</surname><given-names>MM</given-names></name><name><surname>Powers</surname><given-names>AC</given-names></name><name><surname>Wasserman</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Glucose metabolism in vivo in four commonly used inbred mouse strains</article-title><source>Diabetes</source><volume>57</volume><fpage>1790</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.2337/db07-1615</pub-id><pub-id pub-id-type="pmid">18398139</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>B</given-names></name><name><surname>Roose</surname><given-names>AN</given-names></name><name><surname>Barrandon</surname><given-names>O</given-names></name><name><surname>Maehr</surname><given-names>R</given-names></name><name><surname>Arvanites</surname><given-names>AC</given-names></name><name><surname>Davidow</surname><given-names>LS</given-names></name><name><surname>Davis</surname><given-names>JC</given-names></name><name><surname>Peterson</surname><given-names>QP</given-names></name><name><surname>Rubin</surname><given-names>LL</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway</article-title><source>eLife</source><volume>3</volume><elocation-id>e02809</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.02809</pub-id><pub-id pub-id-type="pmid">25233132</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname><given-names>AM</given-names></name><name><surname>Lohse</surname><given-names>M</given-names></name><name><surname>Usadel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title><source>Bioinformatics</source><volume>30</volume><fpage>2114</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><pub-id pub-id-type="pmid">24695404</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>JE</given-names></name><name><surname>Newgard</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mechanisms controlling pancreatic islet cell function in insulin secretion</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>22</volume><fpage>142</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-00317-7</pub-id><pub-id pub-id-type="pmid">33398164</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>TR</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Braren</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cell-autonomous requirement for beta1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice</article-title><source>Development</source><volume>135</volume><fpage>2193</fpage><lpage>2202</lpage><pub-id pub-id-type="doi">10.1242/dev.016378</pub-id><pub-id pub-id-type="pmid">18480158</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title><source>Bioinformatics</source><volume>34</volume><fpage>i884</fpage><lpage>i890</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id><pub-id pub-id-type="pmid">30423086</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirulli</surname><given-names>V</given-names></name><name><surname>Beattie</surname><given-names>GM</given-names></name><name><surname>Klier</surname><given-names>G</given-names></name><name><surname>Ellisman</surname><given-names>M</given-names></name><name><surname>Ricordi</surname><given-names>C</given-names></name><name><surname>Quaranta</surname><given-names>V</given-names></name><name><surname>Frasier</surname><given-names>F</given-names></name><name><surname>Ishii</surname><given-names>JK</given-names></name><name><surname>Hayek</surname><given-names>A</given-names></name><name><surname>Salomon</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells</article-title><source>The Journal of Cell Biology</source><volume>150</volume><fpage>1445</fpage><lpage>1460</lpage><pub-id pub-id-type="doi">10.1083/jcb.150.6.1445</pub-id><pub-id pub-id-type="pmid">10995448</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottle</surname><given-names>L</given-names></name><name><surname>Gan</surname><given-names>WJ</given-names></name><name><surname>Gilroy</surname><given-names>I</given-names></name><name><surname>Samra</surname><given-names>JS</given-names></name><name><surname>Gill</surname><given-names>AJ</given-names></name><name><surname>Loudovaris</surname><given-names>T</given-names></name><name><surname>Thomas</surname><given-names>HE</given-names></name><name><surname>Hawthorne</surname><given-names>WJ</given-names></name><name><surname>Kebede</surname><given-names>MA</given-names></name><name><surname>Thorn</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Structural and functional polarisation of human pancreatic beta cells in islets from organ donors with and without type 2 diabetes</article-title><source>Diabetologia</source><volume>64</volume><fpage>618</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1007/s00125-020-05345-8</pub-id><pub-id pub-id-type="pmid">33399909</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>U</given-names></name><name><surname>Sjødin</surname><given-names>A</given-names></name><name><surname>Semb</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Cadherins regulate aggregation of pancreatic beta-cells in vivo</article-title><source>Development</source><volume>122</volume><fpage>2895</fpage><lpage>2902</lpage><pub-id pub-id-type="doi">10.1242/dev.122.9.2895</pub-id><pub-id pub-id-type="pmid">8787762</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="report"><person-group person-group-type="author"><name><surname>Deerinck</surname><given-names>TJ</given-names></name><name><surname>Thor</surname><given-names>EB</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2010">2010</year><source>NCMIR methods for 3D EM: A new protocol for preparation of biological specimens for serial block face scanning electron microscopy</source><publisher-name>National Center for Microscopy and Imaging Research, University of California, San Diego</publisher-name></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaferia</surname><given-names>GR</given-names></name><name><surname>Jimenez-Caliani</surname><given-names>AJ</given-names></name><name><surname>Ranjitkar</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Hardiman</surname><given-names>G</given-names></name><name><surname>Rhodes</surname><given-names>CJ</given-names></name><name><surname>Crisa</surname><given-names>L</given-names></name><name><surname>Cirulli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>β1 integrin is a crucial regulator of pancreatic β-cell expansion</article-title><source>Development</source><volume>140</volume><fpage>3360</fpage><lpage>3372</lpage><pub-id pub-id-type="doi">10.1242/dev.098533</pub-id><pub-id pub-id-type="pmid">23863477</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiGruccio</surname><given-names>MR</given-names></name><name><surname>Mawla</surname><given-names>AM</given-names></name><name><surname>Donaldson</surname><given-names>CJ</given-names></name><name><surname>Noguchi</surname><given-names>GM</given-names></name><name><surname>Vaughan</surname><given-names>J</given-names></name><name><surname>Cowing-Zitron</surname><given-names>C</given-names></name><name><surname>van der Meulen</surname><given-names>T</given-names></name><name><surname>Huising</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets</article-title><source>Molecular Metabolism</source><volume>5</volume><fpage>449</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2016.04.007</pub-id><pub-id pub-id-type="pmid">27408771</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dybala</surname><given-names>MP</given-names></name><name><surname>Butterfield</surname><given-names>JK</given-names></name><name><surname>Hendren-Santiago</surname><given-names>BK</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pancreatic islets and gestalt principles</article-title><source>Diabetes</source><volume>69</volume><fpage>1864</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.2337/db20-0304</pub-id><pub-id pub-id-type="pmid">32669392</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elghazi</surname><given-names>L</given-names></name><name><surname>Gould</surname><given-names>AP</given-names></name><name><surname>Weiss</surname><given-names>AJ</given-names></name><name><surname>Barker</surname><given-names>DJ</given-names></name><name><surname>Callaghan</surname><given-names>J</given-names></name><name><surname>Opland</surname><given-names>D</given-names></name><name><surname>Myers</surname><given-names>M</given-names></name><name><surname>Cras-Méneur</surname><given-names>C</given-names></name><name><surname>Bernal-Mizrachi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Importance of β-Catenin in glucose and energy homeostasis</article-title><source>Scientific Reports</source><volume>2</volume><elocation-id>693</elocation-id><pub-id pub-id-type="doi">10.1038/srep00693</pub-id><pub-id pub-id-type="pmid">23012647</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esni</surname><given-names>F</given-names></name><name><surname>Täljedal</surname><given-names>IB</given-names></name><name><surname>Perl</surname><given-names>AK</given-names></name><name><surname>Cremer</surname><given-names>H</given-names></name><name><surname>Christofori</surname><given-names>G</given-names></name><name><surname>Semb</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Neural cell adhesion molecule (N-CAM) is required for cell type segregation and normal ultrastructure in pancreatic islets</article-title><source>The Journal of Cell Biology</source><volume>144</volume><fpage>325</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1083/jcb.144.2.325</pub-id><pub-id pub-id-type="pmid">9922458</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagotto</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The cellular basis of tissue separation</article-title><source>Development</source><volume>141</volume><fpage>3303</fpage><lpage>3318</lpage><pub-id pub-id-type="doi">10.1242/dev.090332</pub-id><pub-id pub-id-type="pmid">25139853</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foty</surname><given-names>RA</given-names></name><name><surname>Steinberg</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The differential adhesion hypothesis: a direct evaluation</article-title><source>Developmental Biology</source><volume>278</volume><fpage>255</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.11.012</pub-id><pub-id pub-id-type="pmid">15649477</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>WJ</given-names></name><name><surname>Do</surname><given-names>OH</given-names></name><name><surname>Cottle</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Kosobrodova</surname><given-names>E</given-names></name><name><surname>Cooper-White</surname><given-names>J</given-names></name><name><surname>Bilek</surname><given-names>M</given-names></name><name><surname>Thorn</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Local integrin activation in pancreatic β cells targets insulin secretion to the vasculature</article-title><source>Cell Reports</source><volume>24</volume><fpage>2819</fpage><lpage>2826</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.035</pub-id><pub-id pub-id-type="pmid">30208309</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>JM</given-names></name><name><surname>Adams</surname><given-names>MT</given-names></name><name><surname>Sharon</surname><given-names>N</given-names></name><name><surname>Jayaraaman</surname><given-names>H</given-names></name><name><surname>Blum</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Morphogenesis of the Islets of Langerhans Is Guided by Extra-Endocrine Slit2/3 Signals</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.15.153353</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonschior</surname><given-names>H</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Super-resolution imaging of tight and adherens junctions: Challenges and open questions</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>744</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21030744</pub-id><pub-id pub-id-type="pmid">31979366</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouzi</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Katsumoto</surname><given-names>K</given-names></name><name><surname>Johansson</surname><given-names>K</given-names></name><name><surname>Grapin-Botton</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neurogenin3 initiates stepwise delamination of differentiating endocrine cells during pancreas development</article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>589</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22544</pub-id><pub-id pub-id-type="pmid">21287656</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>G</given-names></name><name><surname>Dubauskaite</surname><given-names>J</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors</article-title><source>Development</source><volume>129</volume><fpage>2447</fpage><lpage>2457</lpage><pub-id pub-id-type="doi">10.1242/dev.129.10.2447</pub-id><pub-id pub-id-type="pmid">11973276</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halban</surname><given-names>PA</given-names></name><name><surname>Powers</surname><given-names>SL</given-names></name><name><surname>George</surname><given-names>KL</given-names></name><name><surname>Bonner-Weir</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Spontaneous reassociation of dispersed adult rat pancreatic islet cells into aggregates with three-dimensional architecture typical of native islets</article-title><source>Diabetes</source><volume>36</volume><fpage>783</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.2337/diab.36.7.783</pub-id><pub-id pub-id-type="pmid">3556277</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannigan</surname><given-names>G</given-names></name><name><surname>Troussard</surname><given-names>AA</given-names></name><name><surname>Dedhar</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Integrin-linked kinase: a cancer therapeutic target unique among its ILK</article-title><source>Nature Reviews. Cancer</source><volume>5</volume><fpage>51</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nrc1524</pub-id><pub-id pub-id-type="pmid">15630415</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>JA</given-names></name><name><surname>Hirokawa</surname><given-names>KE</given-names></name><name><surname>Sorensen</surname><given-names>SA</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Mills</surname><given-names>M</given-names></name><name><surname>Ng</surname><given-names>LL</given-names></name><name><surname>Bohn</surname><given-names>P</given-names></name><name><surname>Mortrud</surname><given-names>M</given-names></name><name><surname>Ouellette</surname><given-names>B</given-names></name><name><surname>Kidney</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Dang</surname><given-names>C</given-names></name><name><surname>Sunkin</surname><given-names>S</given-names></name><name><surname>Bernard</surname><given-names>A</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Anatomical characterization of Cre driver mice for neural circuit mapping and manipulation</article-title><source>Frontiers in Neural Circuits</source><volume>8</volume><elocation-id>76</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2014.00076</pub-id><pub-id pub-id-type="pmid">25071457</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinis</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>M-T</given-names></name><name><surname>Ilc</surname><given-names>K</given-names></name><name><surname>Mazure</surname><given-names>NM</given-names></name><name><surname>Pouysségur</surname><given-names>J</given-names></name><name><surname>Scharfmann</surname><given-names>R</given-names></name><name><surname>Duvillié</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha</article-title><source>Diabetes</source><volume>59</volume><fpage>662</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.2337/db09-0891</pub-id><pub-id pub-id-type="pmid">20009089</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henseleit</surname><given-names>KD</given-names></name><name><surname>Nelson</surname><given-names>SB</given-names></name><name><surname>Kuhlbrodt</surname><given-names>K</given-names></name><name><surname>Hennings</surname><given-names>JC</given-names></name><name><surname>Ericson</surname><given-names>J</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>NKX6 transcription factor activity is required for alpha- and beta-cell development in the pancreas</article-title><source>Development</source><volume>132</volume><fpage>3139</fpage><lpage>3149</lpage><pub-id pub-id-type="doi">10.1242/dev.01875</pub-id><pub-id pub-id-type="pmid">15944193</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id><pub-id pub-id-type="pmid">19033363</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamora</surname><given-names>C</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Intercellular adhesion, signalling and the cytoskeleton</article-title><source>Nature Cell Biology</source><volume>4</volume><fpage>E101</fpage><lpage>E108</lpage><pub-id pub-id-type="doi">10.1038/ncb0402-e101</pub-id><pub-id pub-id-type="pmid">11944044</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Role of slit/robo signaling pathway in bone metabolism</article-title><source>International Journal of Biological Sciences</source><volume>18</volume><fpage>1303</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.7150/ijbs.66931</pub-id><pub-id pub-id-type="pmid">35173554</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez-Caliani</surname><given-names>AJ</given-names></name><name><surname>Pillich</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Diaferia</surname><given-names>GR</given-names></name><name><surname>Meda</surname><given-names>P</given-names></name><name><surname>Crisa</surname><given-names>L</given-names></name><name><surname>Cirulli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>αE-catenin is a positive regulator of pancreatic islet cell lineage differentiation</article-title><source>Cell Reports</source><volume>20</volume><fpage>1295</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.07.035</pub-id><pub-id pub-id-type="pmid">28793255</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>J</given-names></name><name><surname>Kilimnik</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Periwal</surname><given-names>V</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Formation of pancreatic islets involves coordinated expansion of small islets and fission of large interconnected islet-like structures</article-title><source>Biophysical Journal</source><volume>101</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2011.06.042</pub-id><pub-id pub-id-type="pmid">21806924</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Jo</surname><given-names>J</given-names></name><name><surname>Kilimnik</surname><given-names>G</given-names></name><name><surname>Wojcik</surname><given-names>P</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Islet architecture: A comparative study</article-title><source>Islets</source><volume>1</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.4161/isl.1.2.9480</pub-id><pub-id pub-id-type="pmid">20606719</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kragl</surname><given-names>M</given-names></name><name><surname>Schubert</surname><given-names>R</given-names></name><name><surname>Karsjens</surname><given-names>H</given-names></name><name><surname>Otter</surname><given-names>S</given-names></name><name><surname>Bartosinska</surname><given-names>B</given-names></name><name><surname>Jeruschke</surname><given-names>K</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Alsteens</surname><given-names>D</given-names></name><name><surname>Kuss</surname><given-names>O</given-names></name><name><surname>Speier</surname><given-names>S</given-names></name><name><surname>Eberhard</surname><given-names>D</given-names></name><name><surname>Müller</surname><given-names>DJ</given-names></name><name><surname>Lammert</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The biomechanical properties of an epithelial tissue determine the location of its vasculature</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>13560</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms13560</pub-id><pub-id pub-id-type="pmid">27995929</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Fellows</surname><given-names>GF</given-names></name><name><surname>Rosenberg</surname><given-names>L</given-names></name><name><surname>Goodyer</surname><given-names>CG</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrin {alpha}3, but not {beta}1, regulates islet cell survival and function via PI3K/Akt signaling pathways</article-title><source>Endocrinology</source><volume>152</volume><fpage>424</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1210/en.2010-0877</pub-id><pub-id pub-id-type="pmid">21177833</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>HR</given-names></name><name><surname>Nelson</surname><given-names>DA</given-names></name><name><surname>DeSantis</surname><given-names>KA</given-names></name><name><surname>Morrissey</surname><given-names>JM</given-names></name><name><surname>Larsen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endothelial cell regulation of salivary gland epithelial patterning</article-title><source>Development</source><volume>144</volume><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1242/dev.142497</pub-id><pub-id pub-id-type="pmid">28096213</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammert</surname><given-names>E</given-names></name><name><surname>Gu</surname><given-names>G</given-names></name><name><surname>McLaughlin</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Brekken</surname><given-names>R</given-names></name><name><surname>Murtaugh</surname><given-names>LC</given-names></name><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Role of VEGF-A in vascularization of pancreatic islets</article-title><source>Current Biology</source><volume>13</volume><fpage>1070</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(03)00378-6</pub-id><pub-id pub-id-type="pmid">12814555</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>HL</given-names></name><name><surname>Grapin-Botton</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The molecular and morphogenetic basis of pancreas organogenesis</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>66</volume><fpage>51</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.01.005</pub-id><pub-id pub-id-type="pmid">28089869</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemaire</surname><given-names>K</given-names></name><name><surname>Thorrez</surname><given-names>L</given-names></name><name><surname>Schuit</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Disallowed and allowed gene expression: Two faces of mature islet beta cells</article-title><source>Annual Review of Nutrition</source><volume>36</volume><fpage>45</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1146/annurev-nutr-071715-050808</pub-id><pub-id pub-id-type="pmid">27146011</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The role of extracellular matrix, integrins, and cytoskeleton in mechanotransduction of centrifugal loading</article-title><source>Molecular and Cellular Biochemistry</source><volume>309</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/s11010-007-9641-0</pub-id><pub-id pub-id-type="pmid">18026855</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads</article-title><source>Nucleic Acids Research</source><volume>47</volume><elocation-id>e47</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkz114</pub-id><pub-id pub-id-type="pmid">30783653</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lien</surname><given-names>WH</given-names></name><name><surname>Klezovitch</surname><given-names>O</given-names></name><name><surname>Fernandez</surname><given-names>TE</given-names></name><name><surname>Delrow</surname><given-names>J</given-names></name><name><surname>Vasioukhin</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway</article-title><source>Science</source><volume>311</volume><fpage>1609</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1126/science.1121449</pub-id><pub-id pub-id-type="pmid">16543460</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maldonado</surname><given-names>M</given-names></name><name><surname>Serrill</surname><given-names>JD</given-names></name><name><surname>Shih</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Painting the pancreas in three dimensions: Whole-mount immunofluorescence method</article-title><source>Methods in Molecular Biology</source><volume>2155</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0655-1_16</pub-id><pub-id pub-id-type="pmid">32474878</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>TH</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Kaur</surname><given-names>R</given-names></name><name><surname>Belyea</surname><given-names>BC</given-names></name><name><surname>Walker</surname><given-names>PD</given-names></name><name><surname>Gomez</surname><given-names>RA</given-names></name><name><surname>Sequeira-Lopez</surname><given-names>MLS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Renin-expressing cells require β1-integrin for survival and for development and maintenance of the renal vasculature</article-title><source>Hypertension</source><volume>76</volume><fpage>458</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.14959</pub-id><pub-id pub-id-type="pmid">32594804</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mui</surname><given-names>KL</given-names></name><name><surname>Chen</surname><given-names>CS</given-names></name><name><surname>Assoian</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The mechanical regulation of integrin-cadherin crosstalk organizes cells, signaling and forces</article-title><source>Journal of Cell Science</source><volume>129</volume><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1242/jcs.183699</pub-id><pub-id pub-id-type="pmid">26919980</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murtaugh</surname><given-names>LC</given-names></name><name><surname>Law</surname><given-names>AC</given-names></name><name><surname>Dor</surname><given-names>Y</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Beta-catenin is essential for pancreatic acinar but not islet development</article-title><source>Development</source><volume>132</volume><fpage>4663</fpage><lpage>4674</lpage><pub-id pub-id-type="doi">10.1242/dev.02063</pub-id><pub-id pub-id-type="pmid">16192304</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzumdar</surname><given-names>MD</given-names></name><name><surname>Tasic</surname><given-names>B</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A global double-fluorescent Cre reporter mouse</article-title><source>Genesis</source><volume>45</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/dvg.20335</pub-id><pub-id pub-id-type="pmid">17868096</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>GG</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name><name><surname>Russ</surname><given-names>HA</given-names></name><name><surname>Tran</surname><given-names>S</given-names></name><name><surname>Saxton</surname><given-names>MS</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Juang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>M-L</given-names></name><name><surname>Nguyen</surname><given-names>VQ</given-names></name><name><surname>Giacometti</surname><given-names>S</given-names></name><name><surname>Puri</surname><given-names>S</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Szot</surname><given-names>GL</given-names></name><name><surname>Oberholzer</surname><given-names>J</given-names></name><name><surname>Bhushan</surname><given-names>A</given-names></name><name><surname>Hebrok</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Author Correction: Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0316-3</pub-id><pub-id pub-id-type="pmid">30914825</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panzer</surname><given-names>JK</given-names></name><name><surname>Cohrs</surname><given-names>CM</given-names></name><name><surname>Speier</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Using pancreas tissue slices for the study of islet physiology</article-title><source>Methods in Molecular Biology</source><volume>2128</volume><fpage>301</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0385-7_20</pub-id><pub-id pub-id-type="pmid">32180201</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauerstein</surname><given-names>PT</given-names></name><name><surname>Tellez</surname><given-names>K</given-names></name><name><surname>Willmarth</surname><given-names>KB</given-names></name><name><surname>Park</surname><given-names>KM</given-names></name><name><surname>Hsueh</surname><given-names>B</given-names></name><name><surname>Efsun Arda</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Aghajanian</surname><given-names>H</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis</article-title><source>Development</source><volume>144</volume><fpage>3744</fpage><lpage>3754</lpage><pub-id pub-id-type="doi">10.1242/dev.148684</pub-id><pub-id pub-id-type="pmid">28893946</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghavan</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>C</given-names></name><name><surname>Mundschau</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Conditional ablation of beta1 integrin in skin: severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination</article-title><source>The Journal of Cell Biology</source><volume>150</volume><fpage>1149</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1083/jcb.150.5.1149</pub-id><pub-id pub-id-type="pmid">10974002</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinert</surname><given-names>RB</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Hong</surname><given-names>JY</given-names></name><name><surname>Plank</surname><given-names>JL</given-names></name><name><surname>Aamodt</surname><given-names>K</given-names></name><name><surname>Prasad</surname><given-names>N</given-names></name><name><surname>Aramandla</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name><name><surname>Levy</surname><given-names>SE</given-names></name><name><surname>Pozzi</surname><given-names>A</given-names></name><name><surname>Labosky</surname><given-names>PA</given-names></name><name><surname>Wright</surname><given-names>CVE</given-names></name><name><surname>Brissova</surname><given-names>M</given-names></name><name><surname>Powers</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Vascular endothelial growth factor coordinates islet innervation via vascular scaffolding</article-title><source>Development</source><volume>141</volume><fpage>1480</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1242/dev.098657</pub-id><pub-id pub-id-type="pmid">24574008</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romer</surname><given-names>AI</given-names></name><name><surname>Sussel</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pancreatic islet cell development and regeneration</article-title><source>Current Opinion in Endocrinology, Diabetes, and Obesity</source><volume>22</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1097/MED.0000000000000174</pub-id><pub-id pub-id-type="pmid">26087337</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roscioni</surname><given-names>SS</given-names></name><name><surname>Migliorini</surname><given-names>A</given-names></name><name><surname>Gegg</surname><given-names>M</given-names></name><name><surname>Lickert</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Impact of islet architecture on β-cell heterogeneity, plasticity and function</article-title><source>Nature Reviews. Endocrinology</source><volume>12</volume><fpage>695</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2016.147</pub-id><pub-id pub-id-type="pmid">27585958</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>LC</given-names></name><name><surname>Lafon</surname><given-names>ML</given-names></name><name><surname>Pedersen</surname><given-names>JK</given-names></name><name><surname>Yassin</surname><given-names>H</given-names></name><name><surname>Jensen</surname><given-names>JN</given-names></name><name><surname>Serup</surname><given-names>P</given-names></name><name><surname>Hecksher-Sørensen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The transcriptional activity of Neurog3 affects migration and differentiation of ectopic endocrine cells in chicken endoderm</article-title><source>Developmental Dynamics</source><volume>239</volume><fpage>1950</fpage><lpage>1966</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22329</pub-id><pub-id pub-id-type="pmid">20549731</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rulifson</surname><given-names>IC</given-names></name><name><surname>Karnik</surname><given-names>SK</given-names></name><name><surname>Heiser</surname><given-names>PW</given-names></name><name><surname>ten Berge</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name><name><surname>Hebrok</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Wnt signaling regulates pancreatic beta cell proliferation</article-title><source>PNAS</source><volume>104</volume><fpage>6247</fpage><lpage>6252</lpage><pub-id pub-id-type="doi">10.1073/pnas.0701509104</pub-id><pub-id pub-id-type="pmid">17404238</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Larsen</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Fibronectin requirement in branching morphogenesis</article-title><source>Nature</source><volume>423</volume><fpage>876</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1038/nature01712</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheppke</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>EA</given-names></name><name><surname>Zarpellon</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>JJ</given-names></name><name><surname>Merkulova</surname><given-names>A</given-names></name><name><surname>Shields</surname><given-names>DJ</given-names></name><name><surname>Weis</surname><given-names>SM</given-names></name><name><surname>Byzova</surname><given-names>TV</given-names></name><name><surname>Ruggeri</surname><given-names>ZM</given-names></name><name><surname>Iruela-Arispe</surname><given-names>ML</given-names></name><name><surname>Cheresh</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane</article-title><source>Blood</source><volume>119</volume><fpage>2149</fpage><lpage>2158</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-04-348706</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiesser</surname><given-names>JV</given-names></name><name><surname>Loudovaris</surname><given-names>T</given-names></name><name><surname>Thomas</surname><given-names>HE</given-names></name><name><surname>Elefanty</surname><given-names>AG</given-names></name><name><surname>Stanley</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrin αvβ5 heterodimer is a specific marker of human pancreatic beta cells</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>8315</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-87805-8</pub-id><pub-id pub-id-type="pmid">33859325</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schonhoff</surname><given-names>SE</given-names></name><name><surname>Giel-Moloney</surname><given-names>M</given-names></name><name><surname>Leiter</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types</article-title><source>Developmental Biology</source><volume>270</volume><fpage>443</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.03.013</pub-id><pub-id pub-id-type="pmid">15183725</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scully</surname><given-names>KM</given-names></name><name><surname>Skowronska-Krawczyk</surname><given-names>D</given-names></name><name><surname>Krawczyk</surname><given-names>M</given-names></name><name><surname>Merkurjev</surname><given-names>D</given-names></name><name><surname>Taylor</surname><given-names>H</given-names></name><name><surname>Livolsi</surname><given-names>A</given-names></name><name><surname>Tollkuhn</surname><given-names>J</given-names></name><name><surname>Stan</surname><given-names>RV</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epithelial cell integrin β1 is required for developmental angiogenesis in the pituitary gland</article-title><source>PNAS</source><volume>113</volume><fpage>13408</fpage><lpage>13413</lpage><pub-id pub-id-type="doi">10.1073/pnas.1614970113</pub-id><pub-id pub-id-type="pmid">27810956</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seymour</surname><given-names>PA</given-names></name><name><surname>Bennett</surname><given-names>WR</given-names></name><name><surname>Slack</surname><given-names>JMW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Fission of pancreatic islets during postnatal growth of the mouse</article-title><source>Journal of Anatomy</source><volume>204</volume><fpage>103</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7580.2004.00265.x</pub-id><pub-id pub-id-type="pmid">15032917</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>N</given-names></name><name><surname>Chawla</surname><given-names>R</given-names></name><name><surname>Mueller</surname><given-names>J</given-names></name><name><surname>Vanderhooft</surname><given-names>J</given-names></name><name><surname>Whitehorn</surname><given-names>LJ</given-names></name><name><surname>Rosenthal</surname><given-names>B</given-names></name><name><surname>Gürtler</surname><given-names>M</given-names></name><name><surname>Estanboulieh</surname><given-names>RR</given-names></name><name><surname>Shvartsman</surname><given-names>D</given-names></name><name><surname>Gifford</surname><given-names>DK</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Melton</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets</article-title><source>Cell</source><volume>176</volume><fpage>790</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.12.003</pub-id><pub-id pub-id-type="pmid">30661759</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>N</given-names></name><name><surname>Vanderhooft</surname><given-names>J</given-names></name><name><surname>Straubhaar</surname><given-names>J</given-names></name><name><surname>Mueller</surname><given-names>J</given-names></name><name><surname>Chawla</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Engquist</surname><given-names>EN</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Gifford</surname><given-names>DK</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Wnt signaling separates the progenitor and endocrine compartments during pancreas development</article-title><source>Cell Reports</source><volume>27</volume><fpage>2281</fpage><lpage>2291</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.083</pub-id><pub-id pub-id-type="pmid">31116975</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>HP</given-names></name><name><surname>Gross</surname><given-names>MK</given-names></name><name><surname>Kioussi</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch</article-title><source>PNAS</source><volume>104</volume><fpage>5907</fpage><lpage>5912</lpage><pub-id pub-id-type="doi">10.1073/pnas.0701122104</pub-id><pub-id pub-id-type="pmid">17384148</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>HP</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pancreas organogenesis: from lineage determination to morphogenesis</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>29</volume><fpage>81</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-101512-122405</pub-id><pub-id pub-id-type="pmid">23909279</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>HP</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pancreas development ex vivo: culturing embryonic pancreas explants on permeable culture inserts, with fibronectin-coated glass microwells, or embedded in three-dimensional Matrigel</article-title><source>Methods in Molecular Biology</source><volume>1210</volume><fpage>229</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-1435-7_17</pub-id><pub-id pub-id-type="pmid">25173172</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>HP</given-names></name><name><surname>Panlasigui</surname><given-names>D</given-names></name><name><surname>Cirulli</surname><given-names>V</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ECM signaling regulates collective cellular dynamics to control pancreas branching morphogenesis</article-title><source>Cell Reports</source><volume>14</volume><fpage>169</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.027</pub-id><pub-id pub-id-type="pmid">26748698</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiota</surname><given-names>C</given-names></name><name><surname>Prasadan</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Fusco</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Gittes</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Gcg <sup>CreERT2</sup> knockin mice as a tool for genetic manipulation in pancreatic alpha cells</article-title><source>Diabetologia</source><volume>60</volume><fpage>2399</fpage><lpage>2408</lpage><pub-id pub-id-type="doi">10.1007/s00125-017-4425-x</pub-id><pub-id pub-id-type="pmid">28884202</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon-Areces</surname><given-names>J</given-names></name><name><surname>Membrive</surname><given-names>G</given-names></name><name><surname>Garcia-Fernandez</surname><given-names>C</given-names></name><name><surname>Garcia-Segura</surname><given-names>LM</given-names></name><name><surname>Arevalo</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Neurogenin 3 cellular and subcellular localization in the developing and adult hippocampus</article-title><source>The Journal of Comparative Neurology</source><volume>518</volume><fpage>1814</fpage><lpage>1824</lpage><pub-id pub-id-type="doi">10.1002/cne.22304</pub-id><pub-id pub-id-type="pmid">20235092</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speicher</surname><given-names>T</given-names></name><name><surname>Siegenthaler</surname><given-names>B</given-names></name><name><surname>Bogorad</surname><given-names>RL</given-names></name><name><surname>Ruppert</surname><given-names>R</given-names></name><name><surname>Petzold</surname><given-names>T</given-names></name><name><surname>Padrissa-Altes</surname><given-names>S</given-names></name><name><surname>Bachofner</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>DG</given-names></name><name><surname>Koteliansky</surname><given-names>V</given-names></name><name><surname>Fässler</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3862</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4862</pub-id><pub-id pub-id-type="pmid">24844558</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivas</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>CS</given-names></name><name><surname>William</surname><given-names>CM</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus</article-title><source>BMC Developmental Biology</source><volume>1</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/1471-213x-1-4</pub-id><pub-id pub-id-type="pmid">11299042</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stine</surname><given-names>RR</given-names></name><name><surname>Greenspan</surname><given-names>LJ</given-names></name><name><surname>Ramachandran</surname><given-names>KV</given-names></name><name><surname>Matunis</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Coordinate regulation of stem cell competition by Slit-Robo and JAK-STAT signaling in the <italic>Drosophila</italic> testis</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004713</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004713</pub-id><pub-id pub-id-type="pmid">25375180</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sznurkowska</surname><given-names>MK</given-names></name><name><surname>Hannezo</surname><given-names>E</given-names></name><name><surname>Azzarelli</surname><given-names>R</given-names></name><name><surname>Chatzeli</surname><given-names>L</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Philpott</surname><given-names>A</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tracing the cellular basis of islet specification in mouse pancreas</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5037</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18837-3</pub-id><pub-id pub-id-type="pmid">33028844</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>BL</given-names></name><name><surname>Liu</surname><given-names>FF</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells</article-title><source>Cell Reports</source><volume>4</volume><fpage>1262</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.08.010</pub-id><pub-id pub-id-type="pmid">24035389</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorens</surname><given-names>B</given-names></name><name><surname>Tarussio</surname><given-names>D</given-names></name><name><surname>Maestro</surname><given-names>MA</given-names></name><name><surname>Rovira</surname><given-names>M</given-names></name><name><surname>Heikkilä</surname><given-names>E</given-names></name><name><surname>Ferrer</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ins1(Cre) knock-in mice for beta cell-specific gene recombination</article-title><source>Diabetologia</source><volume>58</volume><fpage>558</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1007/s00125-014-3468-5</pub-id><pub-id pub-id-type="pmid">25500700</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>M</given-names></name><name><surname>Jun</surname><given-names>T</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The role of the slit/robo signaling pathway</article-title><source>Journal of Cancer</source><volume>10</volume><fpage>2694</fpage><lpage>2705</lpage><pub-id pub-id-type="doi">10.7150/jca.31877</pub-id><pub-id pub-id-type="pmid">31258778</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meulen</surname><given-names>T</given-names></name><name><surname>Huising</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3</article-title><source>The Review of Diabetic Studies</source><volume>11</volume><fpage>115</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1900/RDS.2014.11.115</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meulen</surname><given-names>T</given-names></name><name><surname>Donaldson</surname><given-names>CJ</given-names></name><name><surname>Cáceres</surname><given-names>E</given-names></name><name><surname>Hunter</surname><given-names>AE</given-names></name><name><surname>Cowing-Zitron</surname><given-names>C</given-names></name><name><surname>Pound</surname><given-names>LD</given-names></name><name><surname>Adams</surname><given-names>MW</given-names></name><name><surname>Zembrzycki</surname><given-names>A</given-names></name><name><surname>Grove</surname><given-names>KL</given-names></name><name><surname>Huising</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion</article-title><source>Nature Medicine</source><volume>21</volume><fpage>769</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1038/nm.3872</pub-id><pub-id pub-id-type="pmid">26076035</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meulen</surname><given-names>T</given-names></name><name><surname>Mawla</surname><given-names>AM</given-names></name><name><surname>DiGruccio</surname><given-names>MR</given-names></name><name><surname>Adams</surname><given-names>MW</given-names></name><name><surname>Nies</surname><given-names>V</given-names></name><name><surname>Dólleman</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Ackermann</surname><given-names>AM</given-names></name><name><surname>Cáceres</surname><given-names>E</given-names></name><name><surname>Hunter</surname><given-names>AE</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Donaldson</surname><given-names>CJ</given-names></name><name><surname>Huising</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Virgin beta cells persist throughout life at a neogenic niche within pancreatic islets</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>911</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.03.017</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasioukhin</surname><given-names>V</given-names></name><name><surname>Bauer</surname><given-names>C</given-names></name><name><surname>Degenstein</surname><given-names>L</given-names></name><name><surname>Wise</surname><given-names>B</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Hyperproliferation and defects in epithelial polarity upon conditional ablation of α-catenin in skin</article-title><source>Cell</source><volume>104</volume><fpage>605</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00246-X</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakae-Takada</surname><given-names>N</given-names></name><name><surname>Xuan</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Meda</surname><given-names>P</given-names></name><name><surname>Leibel</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular basis for the regulation of islet beta cell mass in mice: the role of E-cadherin</article-title><source>Diabetologia</source><volume>56</volume><fpage>856</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1007/s00125-012-2824-6</pub-id><pub-id pub-id-type="pmid">23354125</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sekiguchi</surname><given-names>R</given-names></name><name><surname>Daley</surname><given-names>WP</given-names></name><name><surname>Yamada</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Patterned cell and matrix dynamics in branching morphogenesis</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>559</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1083/jcb.201610048</pub-id><pub-id pub-id-type="pmid">28174204</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Lish</surname><given-names>SR</given-names></name><name><surname>Cartagena-Rivera</surname><given-names>AX</given-names></name><name><surname>Yamada</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Budding epithelial morphogenesis driven by cell-matrix versus cell-cell adhesion</article-title><source>Cell</source><volume>184</volume><fpage>3702</fpage><lpage>3716</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.05.015</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>GF</given-names></name><name><surname>Bjerke</surname><given-names>MA</given-names></name><name><surname>DeSimone</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrins and cadherins join forces to form adhesive networks</article-title><source>Journal of Cell Science</source><volume>124</volume><fpage>1183</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1242/jcs.064618</pub-id><pub-id pub-id-type="pmid">21444749</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Win</surname><given-names>PW</given-names></name><name><surname>Oakie</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Beta-cell β1 integrin deficiency affects in utero development of islet growth and vascularization</article-title><source>Cell and Tissue Research</source><volume>381</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1007/s00441-020-03179-9</pub-id><pub-id pub-id-type="pmid">32060653</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Ehling</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Kanai</surname><given-names>K</given-names></name><name><surname>van Lessen</surname><given-names>M</given-names></name><name><surname>Frye</surname><given-names>M</given-names></name><name><surname>Zeuschner</surname><given-names>D</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Vestweber</surname><given-names>D</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Integrin β1 controls VE-cadherin localization and blood vessel stability</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6429</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7429</pub-id><pub-id pub-id-type="pmid">25752958</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yashpal</surname><given-names>NK</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>MB</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Expression of {beta}1 integrin receptors during rat pancreas development--sites and dynamics</article-title><source>Endocrinology</source><volume>146</volume><fpage>1798</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.1210/en.2004-1292</pub-id><pub-id pub-id-type="pmid">15618357</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>C</given-names></name><name><surname>Mulas</surname><given-names>F</given-names></name><name><surname>Sui</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>N</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Carrano</surname><given-names>AC</given-names></name><name><surname>Huising</surname><given-names>MO</given-names></name><name><surname>Shirihai</surname><given-names>OS</given-names></name><name><surname>Yeo</surname><given-names>GW</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pseudotemporal ordering of single cells reveals metabolic control of postnatal β cell proliferation</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>1160</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.04.014</pub-id><pub-id pub-id-type="pmid">28467932</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zito</surname><given-names>E</given-names></name><name><surname>Chin</surname><given-names>K-T</given-names></name><name><surname>Blais</surname><given-names>J</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ERO1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis</article-title><source>The Journal of Cell Biology</source><volume>188</volume><fpage>821</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1083/jcb.200911086</pub-id><pub-id pub-id-type="pmid">20308425</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-<break/>Pancreatic Polypeptide/PP</td><td align="left" valign="bottom">Novus Biologicals</td><td align="left" valign="bottom">Cat# NB100-1793 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2268669">AB_2268669</ext-link></td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal <break/>anti-Glucagon</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# G2654 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_259852">AB_259852</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-Glucagon <break/>Antibody (N-17)</td><td align="left" valign="bottom">Santa Cruz <break/>Biotechnology</td><td align="left" valign="bottom">Cat# sc-7780 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_641025">AB_641025</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Guinea Pig polyclonal <break/>anti-Insulin</td><td align="left" valign="bottom">Dakocytomation</td><td align="left" valign="bottom">Cat# A0564 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10013624">AB_10013624</ext-link></td><td align="left" valign="bottom">IHC (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit monoclonal <break/>anti-Insulin</td><td align="left" valign="bottom">Cell Signaling <break/>Technology</td><td align="left" valign="bottom">Cat# 3014 S <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2126503">AB_2126503</ext-link></td><td align="left" valign="bottom">IHC &amp; WMIHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal <break/>anti-Chromogranin A</td><td align="left" valign="bottom">Novus Biologicals</td><td align="left" valign="bottom">Cat# NB120-15160 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_789299">AB_789299</ext-link></td><td align="left" valign="bottom">IHC &amp; WMIHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal <break/>anti-Chromogranin A</td><td align="left" valign="bottom">Santa Cruz <break/>Biotechnology</td><td align="left" valign="bottom">Cat# sc-1488 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2276319">AB_2276319</ext-link></td><td align="left" valign="bottom">IHC &amp; WMIHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-Somatostatin</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-7819 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2302603">AB_2302603</ext-link></td><td align="left" valign="bottom">IHC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-Mouse CD31</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 550274 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_393571">AB_393571</ext-link></td><td align="left" valign="bottom">IHC &amp; WMIHC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-PECAM-1</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat# AF3628 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2161028">AB_2161028</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-<break/>Osteopontin/OPN (Spp1)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat# AF808 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2194992">AB_2194992</ext-link></td><td align="left" valign="bottom">IHC &amp; WMIHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Guinea Pig polyclonal anti-Neurogenin3</td><td align="left" valign="bottom">A generous gift of Maike Sander (<xref ref-type="bibr" rid="bib38">Henseleit et al., 2005</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-Nkx6.1</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Cat# F55A10 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_532378">AB_532378</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-Pdx1</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab47267 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_777179">AB_777179</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-Laminin (Lam1)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# L9393 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477163">AB_477163</ext-link></td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-EPCAM</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Cat# G8.8 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2098655">AB_2098655</ext-link></td><td align="left" valign="bottom">IHC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-E-cadherin</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat# AF748 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_355568">AB_355568</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-MafA</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab26405 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_776146">AB_776146</ext-link></td><td align="left" valign="bottom">IHC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-Urocortin3 (Ucn3)</td><td align="left" valign="bottom">A generous gift of Mark Huising (<xref ref-type="bibr" rid="bib93">van der Meulen et al., 2015</xref>)</td><td align="left" valign="bottom"><break/><break/></td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat polyclonal anti-Glut2</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-7580 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_641066">AB_641066</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-CD29 (Itgβ1)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 550531 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_393729">AB_393729</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit monoclonal anti-Ki67</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">Cat# 12202 S (D3B5) <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2620142">AB_2620142</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-Sox9 antibody</td><td align="left" valign="bottom">EMD Millipore</td><td align="left" valign="bottom">Cat# AB5535 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2239761">AB_2239761</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-ERO1b antiserum</td><td align="left" valign="bottom">A generous gift of David Ron (<xref ref-type="bibr" rid="bib104">Zito et al., 2010</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">IHC (1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3 AffiniPure Donkey <break/>Anti-Goat IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 705-165-147 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2307351">AB_2307351</ext-link></td><td align="left" valign="bottom">IHC (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 <break/>AffiniPure Donkey <break/>Anti-Goat IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 705-545-147 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2336933">AB_2336933</ext-link></td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 <break/>AffiniPure Donkey <break/>Anti-Goat IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 705-605-147 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340437">AB_2340437</ext-link></td><td align="left" valign="bottom">IHC (1:200–500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3 AffiniPure <break/>Donkey Anti-Guinea <break/>Pig IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 706-165-148 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340460">AB_2340460</ext-link></td><td align="left" valign="bottom">IHC (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 <break/>AffiniPure Donkey Anti-<break/>Guinea Pig IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 706-545-148 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340472">AB_2340472</ext-link></td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 AffiniPure <break/>Donkey Anti-Guinea Pig IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 706-605-148 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340476">AB_2340476</ext-link></td><td align="left" valign="bottom">IHC (1:200–500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3 AffiniPure Donkey <break/>Anti-Rabbit IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 711-165-152 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2307443">AB_2307443</ext-link></td><td align="left" valign="bottom">IHC (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 AffiniPure Donkey Anti-Rabbit IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 711-545-152 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2313584">AB_2313584</ext-link></td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 AffiniPure <break/>Donkey Anti-Rabbit IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 711-605-152 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2492288">AB_2492288</ext-link></td><td align="left" valign="bottom">IHC (1:200–500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3 AffiniPure Donkey <break/>Anti-Rat IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 712-165-153 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340667">AB_2340667</ext-link></td><td align="left" valign="bottom">IHC (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 AffiniPure <break/>Donkey Anti-Rat IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 712-545-153 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340684">AB_2340684</ext-link></td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 AffiniPure <break/>Donkey Anti-Rat IgG (H+L) (donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 712-605-153 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340694">AB_2340694</ext-link></td><td align="left" valign="bottom">IHC (1:200–500)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Dolichos Biflorus Agglutinin (DBA), Biotinylated</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">Cat# B1035 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2314288">AB_2314288</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Dolichos Biflorus Agglutinin (DBA), Rhodamine</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">Cat# RL-1032–2 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2336396">AB_2336396</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat# D1306</td><td align="left" valign="bottom">IHC (1:2000)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Phalloidin-iFluor 647 Reagent</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab176759</td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Alexa Fluor 647 Streptavidin</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 016-600-084</td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Cy3 Streptavidin (for IHC 1:500)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 016-160-084 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2337244">AB_2337244</ext-link></td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tween 20, Fisher BioReagents</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">BP337-500</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Triton X-100</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">X100-1L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">VectaShield Mounting Medium for Fluorescence</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">H-1000</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">P6148-500G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Methanol</td><td align="left" valign="bottom">VWR Chemical</td><td align="left" valign="bottom">BDH1135-4LP</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMSO</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">4 X-5</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hydrogen Peroxide, ACS, 30%, Stabilized</td><td align="left" valign="bottom">VWR Chemical</td><td align="left" valign="bottom">BDH7690-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Benzyl Benzoate (ACROS organics)</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">AC105862500</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Benzyl Alcohol</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">100-51-6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">D-Glucose</td><td align="left" valign="bottom">Mallinckrodt</td><td align="left" valign="bottom">4192</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bovine Albumin Fraction V (7.5% Solution)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">15260037</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TrypLE Express, with phenol red, Gibco</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">12605–010</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EDTA, 0.5 M, pH 8.0</td><td align="left" valign="bottom">Corning</td><td align="left" valign="bottom">46–034 CI</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fetal Bovine Serum</td><td align="left" valign="bottom">Biofluid Technologies</td><td align="left" valign="bottom">BT-101–500-D</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Heparin sodium salt from <break/>porcine intestinal mucosa</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">H3149-100KU</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CMRL 1066, Supplemented <break/>CIT Modification</td><td align="left" valign="bottom">Mediatech</td><td align="left" valign="bottom">98–304-CV</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RNase-Free DNase Set</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">79254</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Penicillin-Streptomycin</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">15070–063</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM/F12, HEPES, no phenol red</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">11-039-21</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Roche Blocking</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">17091700</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Donor Donkey Serum</td><td align="left" valign="bottom">Gemini Bio</td><td align="left" valign="bottom">100-151-500</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cacodylic Acid, Sodium Salt, trihydrate</td><td align="left" valign="bottom">TedPella Inc</td><td align="left" valign="bottom">18851</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Glutaraldehyde, 25% EM grade</td><td align="left" valign="bottom">TedPella Inc</td><td align="left" valign="bottom">18426</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Thiocarbohydrazide ≥98.0%</td><td align="left" valign="bottom">VWR International</td><td align="left" valign="bottom">TCT1136-25G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Buffer RLT Plus Lysis Buffer</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">1053393</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">2-Mercaptoethanol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">M3148-25ML</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ethanol, Absolute 200 proof</td><td align="left" valign="bottom">Fisher BioReagents</td><td align="left" valign="bottom">BP2818100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Fibronectin Human Protein, Plasma</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">33016–015</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">AlphaTrak2 Blood Glucose Test Strips</td><td align="left" valign="bottom">Zoetis</td><td align="left" valign="bottom">71681–01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">AlphaTrak2 Meter</td><td align="left" valign="bottom">Zoetis</td><td align="left" valign="bottom">71676–01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Streptavidin/Biotin Blocking Kit</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">SP-2002</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Rneasy Micro Kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">74304</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Rnase Zap</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">AM9780</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">KAPA RNA HyperPrep Kit with RiboErase (HMR)</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">KK8560</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">AxyPrep Mag PCR Clean-up kit</td><td align="left" valign="bottom">Axigen</td><td align="left" valign="bottom">MAG-PCR-CL-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">NovaSeq 6000 Reagent Kit</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">DeadEnd Fluorometric TUNEL System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">G3250</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">M.O.M. (Mouse on Mouse) Immunodetection Kit, Basic</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">BMK-2202</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">PowerUp SYBR Green Master mix</td><td align="left" valign="bottom">Applied Biosystems</td><td align="left" valign="bottom">A25742</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">SuperScript First-Strand Synthesis SuperMix for qRT-PCR</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">11752–050</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Ultrasensitive Mouse Insulin ELISA</td><td align="left" valign="bottom">Mercodia</td><td align="left" valign="bottom">10-1249-01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">RNA sequencing data of Itgb1 KO murine pancreatic islets.</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link></td><td align="left" valign="bottom">GSE153187</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">RNA sequencing data of Ctnna1 KO murine pancreatic islets.</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link></td><td align="left" valign="bottom">GSE190788</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Mouse: B6.FVB(Cg)-Tg(Neurog3-cre)C1Able/J</td><td align="left" valign="bottom">Jackson Laboratory, Bar Harbor, ME</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:006333">IMSR_JAX:006333</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Mouse: B6;129-Itgb1<sup>tm1Efu</sup>/J</td><td align="left" valign="bottom">Jackson Laboratory, Bar Harbor, ME</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004605">IMSR_JAX:004605</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Mouse: B6;129-Ctnna1<sup>tm1Efu</sup>/J</td><td align="left" valign="bottom">Jackson Laboratory, Bar Harbor, ME</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004604">IMSR_JAX:004604</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Mouse: B6;129S-Gcg<sup>tm1.1(icre)Gkg</sup>/J</td><td align="left" valign="bottom">Jackson Laboratory, Bar Harbor, ME</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:030663">IMSR_JAX:030663</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Mouse: B6(Cg)-Ins1<sup>tm1.1(cre)Thor</sup>/J</td><td align="left" valign="bottom">Jackson Laboratory, Bar Harbor, ME</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:026801">IMSR_JAX:026801</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Mouse: B6.129(Cg)-Gt(ROSA)26Sor<sup>tm4(ACTB-tdTomato,-EGFP)Luo</sup>/J</td><td align="left" valign="bottom">Jackson Laboratory, Bar Harbor, ME</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007676">IMSR_JAX:007676</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Mouse: B6.129X1-Gt(ROSA)26Sor<sup>tm1(EYFP)Cos</sup>/J</td><td align="left" valign="bottom">Jackson Laboratory, Bar Harbor, ME</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:006148">IMSR_JAX:006148</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">B6.FVB(Cg)-Tg(Ucn3-cre)<break/>KF43Gsat/Mmucd</td><td align="left" valign="bottom">Mutant Mouse Resource &amp; Research Centers, Novi, MI</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC_037417-UCD">MMRRC_037417-UCD</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Generic Cre</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR1084</td><td align="left" valign="bottom">GCG GTC TGG CAG TAA AAA CTA TC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Generic Cre</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR1085</td><td align="left" valign="bottom">GTG AAA CAG CAT TGC TGT CAC TT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Generic Cre</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR7338</td><td align="left" valign="bottom">CTA GGC CAC AGA ATT GAA AGA TCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Generic Cre</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR7339</td><td align="left" valign="bottom">GTA GGT GGA AAT TCT AGC ATC ATC C</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">β1 integrin floxed</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR1906</td><td align="left" valign="bottom">CGG CTC AAA GCA GAG TGT CAG TC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">β1 integrin floxed</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR1907</td><td align="left" valign="bottom">CCA CAA CTT TCC CAG TTA GCT CTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">α-catenin floxed</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR1902</td><td align="left" valign="bottom">CAT TTC TGT CAC CCC CAA AGA CAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">α-catenin floxed</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR1903</td><td align="left" valign="bottom">GCA AAA TGA TCC AGC GTC CTG GG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Gcg<sup>iCre</sup></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR7338</td><td align="left" valign="bottom">CTA GGC CAC AGA ATT GAA AGA TCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Gcg<sup>iCre</sup></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR7339</td><td align="left" valign="bottom">GTA GGT GGA AAT TCT AGC ATC ATC C</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Gcg<sup>iCre</sup></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR9266</td><td align="left" valign="bottom">AGA TGC CAG GAC ATC AGG AAC CTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Gcg<sup>iCre</sup></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR9267</td><td align="left" valign="bottom">ATC AGC CAC ACC AGA CAC AGA GAT C</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rosa<sup>mT/mG</sup></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer 9655</td><td align="left" valign="bottom">CCA GGC GGG CCA TTT ACC GTA AG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rosa<sup>mT/mG</sup></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR8545</td><td align="left" valign="bottom">AAA GTC GCT CTG AGT TGT TAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rosa<sup>mT/mG</sup></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer oIMR8546</td><td align="left" valign="bottom">GGA GCG GGA GAA ATG GAT ATG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">R26R-EYFP</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer 21306</td><td align="left" valign="bottom">CTG GCT TCT GAG GAC CG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">R26R-EYFP</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer 24500</td><td align="left" valign="bottom">CAG GAC AAC GCC CAC ACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">R26R-EYFP</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer 24951</td><td align="left" valign="bottom">AGG GCG AGG AGC TGT TCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">R26R-EYFP</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR Primer 24952</td><td align="left" valign="bottom">TGA AGT CGA TGC CCT TCA G</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mItgb1-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 52,722 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">ATGCCAAATCTTGCGGAGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mItgb1-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 52,722 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TTTGCTGCGATTGGTGACATT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mSlc2a2-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 13654262 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TCAGAAGACAAGATCACCGGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mSlc2a2-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 13654262 a1t</td><td align="left" valign="bottom"><named-content content-type="sequence">GCTGGTGTGACTGTAAGTGGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mUcn3-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 21492632 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">AAGCCTCTCCCACAAGTTCTA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mUcn3-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 21492632 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GAGGTGCGTTTGGTTGTCATC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mMafA-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 23503735 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">AGGAGGAGGTCATCCGACTG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mMafA-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 23503735 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">CTTCTCGCTCTCCAGAATGTG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mMafB-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 23308601 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TTCGACCTTCTCAAGTTCGACG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mMafB-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 23308601 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TCGAGATGGGTCTTCGGTTCA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mArx-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 26024213 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GGCCGGAGTGCAAGAGTAAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mArx-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 26024213 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TGCATGGCTTTTTCCTGGTCA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mEtv1-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 26328055 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TTAAGTGCAGGCGTCTTCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mEtv1-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 26328055 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GGAGGCCATGAAAAGCCAAA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mAldh1a3-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 31542123 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GGGTCACACTGGAGCTAGGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mAldh1a3-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 31542123 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">CTGGCCTCTTCTTGGCGAA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mHk1-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 309289 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">CGGAATGGGGAGCCTTTGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mHk1-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 309289 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GCCTTCCTTATCCGTTTCAATGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mLdhA-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6754524 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TGTCTCCAGCAAAGACTACTGT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mLdhA-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6754524 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GACTGTACTTGACAATGTTGGGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mCtnna1-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6753294 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">AAGTCTGGAGATTAGGACTCTGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mCtnna1-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6753294 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">ACGGCCTCTCTTTTTATTAGACG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mSlc27a2-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6755548 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TCCTCCAAGATGTGCGGTACT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mSlc27a2-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6755548 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TAGGTGAGCGTCTCGTCTCG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mPeg10-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 31376257 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TGCTTGCACAGAGCTACAGTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mPeg10-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 31376257 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">AGTTTGGGATAGGGGCTGCT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mSst-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6678035 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">ACCGGGAAACAGGAACTGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mSst-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6678035 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">TTGCTGGGTTCGAGTTGGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mAldh1a1-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 7304881 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">ATACTTGTCGGATTTAGGAGGCT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mAldh1a1-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 7304881 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GGGCCTATCTTCCAAATGAACA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mCxcl14-F</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 9625004 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">GAAGATGGTTATCGTCACCACC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mCxcl14-R</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 9625004 a1</td><td align="left" valign="bottom"><named-content content-type="sequence">CGTTCCAGGCATTGTACCACT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mPPIA-Fw</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6679438 c1</td><td align="left" valign="bottom"><named-content content-type="sequence">GAGCTGTTTGCAGACAAAGTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mPPIA-Rv</td><td align="left" valign="bottom">PrimerBank</td><td align="left" valign="bottom">qPCR primer Primer <break/>Bank ID: 6679438 c1</td><td align="left" valign="bottom"><named-content content-type="sequence">CCCTGGCACATGAATCCTGG</named-content></td></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">Image-Pro Premier v.9.2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.bioimager.com/product/image-pro-premier-software/">https://www.bioimager.com/product/image-pro-premier-software/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016497">SCR_016497</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">Imaris Microscopy Image Analysis Software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imaris.oxinst.com/">https://imaris.oxinst.com/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007370">SCR_007370</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">QuPath Quantitative Pathology &amp; Bioimage Analysis</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://qupath.github.io/">https://qupath.github.io/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018257">SCR_018257</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">ZEISS ZEN Microscope Software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.zeiss.com/microscopy/en_us/products/microscope-software/zen.html#introduction">http://www.zeiss.com/microscopy/en_us/products/microscope-software/zen.html#introduction</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013672">SCR_013672</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">Star software (v.020201)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://code.google.com/p/rna-star/">http://code.google.com/p/rna-star/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_004463">SCR_004463</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">DAVID software (v.6.8)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/">http://david.abcc.ncifcrf.gov/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001881">SCR_001881</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">Featurecount software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://bioinf.wehi.edu.au/featureCounts/">http://bioinf.wehi.edu.au/featureCounts/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_012919">SCR_012919</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">R-Project for Statistical Computing</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001905">SCR_001905</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">GraphPad Prism Statistical <break/>Analysis Software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com/">http://www.graphpad.com/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithms</td><td align="left" valign="bottom">Applied Biosystems QuantStudio 6 Real Time PCR System - QuantStudio Real-Time PCR Software v1.3</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/us/en/home/global/forms/life-science/quantstudio-6-7-flex-software.html">https://www.thermofisher.com/us/en/home/global/forms/life-science/quantstudio-6-7-flex-software.html</ext-link></td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_020239">SCR_020239</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90006.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sussel</surname><given-names>Lori</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03wmf1y16</institution-id><institution>University of Colorado Anschutz Medical Campus</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>This important study advances our knowledge regarding how islet endocrine cells interact with one another and with surrounding blood vessels during embryonic development and in adult mice. The evidence supporting this work is convincing, with complementary microscopy, functional and transcriptomic data. The authors' conclusions are supported by the data with sample size and quantitative analyses. These data should be of broad interest to islet biologists.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90006.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sussel</surname><given-names>Lori</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03wmf1y16</institution-id><institution>University of Colorado Anschutz Medical Campus</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Yechoor</surname><given-names>Vijay</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Hull-Meichle</surname><given-names>Rebecca</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cvxb145</institution-id><institution>University of Washington</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]</p><p>Thank you for submitting the paper &quot;Coordination between ECM and cell-cell adhesion regulates the development of islet aggregation, architecture, and functional maturation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individuals involved in the review of your submission has agreed to reveal their identity: Rebecca Hull-Meichle (Reviewer #2); Vijay Yechoor (Reviewer #3).</p><p>Comments to the Authors:</p><p>We are sorry to say that, after consultation with the reviewers, we have decided that this work will not be considered further for publication by <italic>eLife</italic>.</p><p>Overall, the reviewers thought the study was of interest and had the potential to provide novel insights into how cell-matrix and cell-cell interactions contribute to the development and function of pancreatic islets. However, there were several issues raised about experimental numbers, statistical analysis, and image quality. Additional experiments would also be needed to support the conclusions related to the role of hypoxia and cell-ECM interactions. There is also a need for a more extensive analysis of the RNA-Seq data and rationale for following up on CTNNA1. More extensive analysis is especially important given some of the discrepancies of this study's findings/interpretations with past studies in the literature.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors of this manuscript conducted a series of sophisticated gene deletion experiments that aimed to understand the relative contribution of cell-cell and cell-matrix interactions in the development and function of pancreatic islets. Despite the importance of the questions being asked in their study, the data are over-interpreted, and some conclusions are not supported by the data presented or by the current literature on the subject. Specific examples include the misinterpretation of basic mechanisms of cell interactions such as the model of differential adhesion suggesting that Ctnna1-null β-cells merge into the core of islet clusters due to weaker adhesion. The model proposed by Foty and Steinberg (validated in numerous developing epithelia) predicts the opposite, i.e. cells with weaker adhesion are pushed outward by cells with stronger adhesion.</p><p>In experiments reporting on the phenotype of double KO animals in which both α-catenin and beta1 integrin were simultaneously deleted, the interpretation of the results is clearly affected by the profound alterations of cell-cell and cell-matrix interactions, making it difficult to draw conclusions about normal pancreas development.</p><p>Strengths include the sophisticated animal models permitting cell lineage tracing experiments for live imaging, and state-of-the-art techniques used for the analysis of the pancreatic phenotype. However, the manuscript presents data that are either incompletely analyzed or insufficient to support the authors' claims. As a result, it is unlikely that this study, in its current presentation, will significantly advance our knowledge of the function of these two distinct mechanisms of cell interactions in pancreas development.</p><p>The authors of this manuscript conducted a series of sophisticated gene deletion experiments that aimed to understand the relative contribution of cell-cell and cell-matrix interactions in the development and function of pancreatic islets.</p><p>Despite the importance of the questions being asked in their study, as presented, the manuscript presents several weaknesses.</p><p>Specific examples are listed below:</p><p>The cell lineage tracing experiments with the mT/mG reporter are superficially described, and the data presented are not vetted by solid statistical analysis.</p><p>The authors do not provide any information about the number of mice studied for each animal model, the number of tissue sections stained and analyzed, number of experiments performed. This is critical information that should be provided both in the methods and in the legend of the figures.</p><p>Most immunofluorescence images provided in the figures are oversaturated, making it difficult to discriminate, at least qualitatively, levels of expression of the different markers.</p><p>In Figure 2, data shown in panel N are difficult to interpret given the large scale on the Y axis, for the relatively low counts reported in the plot. Is it really possible to have a *** statistical significance between control cells and integrin beta1 KO when the values are almost identical? What type of statistical method was used? It is also unclear how many of such experiments were performed (n=?).</p><p>In the manuscript, (lines 433-435), the authors state: &quot;… ECM-Integrin signaling is critical for endocrine cell migration, and that the time window for endocrine cell initiation is small.&quot; According to the data presented, and some of the literature cited, it is the &quot;endocrine progenitors&quot; and not the &quot;endocrine cells&quot; that rely on the ECM-Integrin signaling for cell migration. It is also inaccurate to state that ECM-Integrin signaling does not occur in endocrine cells once they have differentiated. Thus, while the function of this interaction may or may not translate into cell migration, integrin signaling continues to play important roles in differentiated cells in multiple tissues.</p><p>Experiments conducted with the Ucn3-Cre;Itgb1f/f mice are superficially described. A more detailed presentation and discussion of the phenotype of these mice is necessary to draw conclusions about the role of Itgb1 in β cells after they have differentiated. This is especially important for comparison with other studies if one considers that could reveal important information compared to previous studies that used the insulin promoter as a driver of Cre. This is important since the Ucn3 and Insulin genes are expressed at different times and at different levels during β cell development.</p><p>The RNA-seq data, although interesting, are only superficially analyzed, nor validated. Experiments of immunofluorescence do not really validate the most interesting alterations of genes found affected by the gene deletions, since it is not very quantitative. It would have been helpful to confirm at the protein level by Western blotting the expression of some of the most interesting genes, or at least by qPCR. The authors would be surprised to discover that RNA-seq does not necessarily translate into the same order of magnitude of mRNA levels when testing the same samples by qPCR.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The goal of this study was to uncover mechanisms that govern the aggregation and &quot;self-assembly&quot; of islets during embryonic development and postnatally, a process that is not well understood. The authors focused on the role of integrin-β 1 (Itgb1), a key mediator of cell-extracellular matrix (ECM) interactions, and on α-catenin (Ctnna1), a hub protein that links cell adhesion molecules with the cytoskeleton. They used conditional knockout models (Ngn3-Cre and Ucn3-Cre), microscopy and morphometric image analysis, and transcriptomic, and functional measures of glucose metabolism. They found that loss of Itgb1 from endocrine precursor cells resulted in premature aggregation of islets and impaired migration of islets from pancreatic ducts resulting in disturbed islet morphology. Additionally, they observed loss of islet vascularization and decreased expression of markers of endocrine cell identity, which together resulted in glucose intolerance. On the other hand, loss of Ctnna1 resulted in smaller, hypervascularized islets which also expressed fewer markers of differentiated endocrine cell identity resulting in an age-dependent loss of glucose tolerance. Ctnna1 mice also exhibited loss of glucagon and somatostatin-positive islets cells, with loss of glucagon+ cells occurring postnatally. The authors concluded from these studies that a balance exists between cell-ECM and cell-cell interactions, and that loss of one of these interactions (as occurs in Itgb1 and Ctnna1 deficient mice, respectively) may result in an increase in the other. However, the loss of both Itgb1 and Ctnna1 from endocrine precursor cells resulted in an almost complete loss of islet aggregation and severe glucose intolerance.</p><p>The conclusions of this paper are mostly supported by the data. Strengths include the thorough characterization of mice, especially the Itgb1 mice with the Ngn3-Cre driver. The work shows a clear effect of both Itgb1 and Ctnna1 to modulate islet aggregation/morphology without affecting cell specification or overall abundance (during development). The study provides compelling evidence for the role of these cell adhesion molecules in governing islet aggregation, morphology, identity, and function and is impactful for the field.</p><p>The weaknesses are generally minor, with support for some statements being made using a small amount of data (single images in some cases); although most of these do not detract from the main message of the work. For the in vitro aggregation study in the Itgb1 deficient cells, while true that these cells seem to be able to form small aggregates after short-term plating on ECM, further aggregation was inhibited. This illustrates that other mediators of cell-ECM interactions may also be important, a point that was not fully acknowledged in this study. The work on cell shape and cell-cell adhesion in the Itgb1 mice is not as strongly supported by data as the other components of that work. For the Ctnna1 work, the details regarding F-actin localization are hard to appreciate from the images provided. The concept that glucagon+ cells may undergo cell death due to detachment from surrounding cells is exciting, but it is not clear whether the current data fully support that hypothesis.</p><p>Together, these data show that both cell-ECM and cell-cell interactions are critical for normal aggregation, morphology, and vascularization of islets and that disturbances in either, or both, have substantial effects on cell identity and function. This work will be impactful for the islet biology field.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Pancreatic islet morphogenesis is a complex interplay between endocrine cell-intrinsic signaling coupled with external cues from ECM and neighboring cells. Defining the specific pathways and the developmental window when they are critical to the eventual islet architecture and function still remains unclear. This study adds to the body of evidence that the ECM-Integrin signaling and cell-cell adhesion signaling mediated via α-catenin has a critical combinatorial role in determining the islet cell aggregation, vascularization, and eventual function.</p><p>Strengths:</p><p>The reciprocal regulation of the ECM-integrin pathway and cell-cell adhesion via the α-catenin pathway identified in this study provides insight into how the external cues for developing endocrine cells are processed and integrated to eventually allow mouse islets to develop a core of β-cells and the mantle comprising of other endocrine cells. The detailed dissection to identify the developmental window using in vivo studies complemented with explant studies with lineage tracing is compelling strength of this study.</p><p>The predicted changes in mouse islet (mantle-core) architecture due to changes in cell-cell adhesion strength as validated by the combination of the models that the authors use in this study provides a better understanding of the dynamics of islet morphogenesis.</p><p>Weakness:</p><p>The authors suggest that hypoxia resulting from changes in the vasculature is a potential cause of functional immaturity stemming from the expression of disallowed genes and enrichment of genes in RNA-seq involved in Hypoxic responses. Experimental demonstration of hypoxia and its causative role in these models is however lacking to substantiate this explanation.</p><p>Many other groups have previously demonstrated the importance of α-catenin and β-integrin 1 in islet morphogenesis and function, using earlier (Pdx1 promoter-driven Cre) and later (various insulin promoter-driven Cre) developmental windows. Though this study narrows down the window to when the endocrine lineage is determined by Ngn3 and suggests that the altered cell adhesion leads to changes in function and aggregation, intracellular signaling pathways suggested by other studies, such as the sonic hedgehog pathway, PARP, and others remain unexplored in the current context to provide more mechanistic insight.</p><p>While the regulation of the vascularization of the islets in both these mutant models (Itfb1 and Ctnna1) individually and in combination is very convincing, the authors note that this was with no change in angiogenic factor expression. While their explanation invoking the alterations of cortical tension by changes in actin cytoskeleton is certainly plausible and intriguing, it is not demonstrated experimentally and remains to be established in future work.</p><p>1. Concurrent measurement of insulin and glucose during the GTT provides compelling evidence of a β-cell defect. Adding this with the GTT data in Figures 1, 4, and S6 would add to the strength of the study.</p><p>2. The glucose and functional phenotype of the Ucn-Cre mediated Itgb1ΔMatureβ/ΔMatureβ has not been described. Since this is a new model generated by the authors, it is important to describe the phenotype and also compare and contrast it to the other previously described mature β-cell ITGB knockouts that the authors allude to in their discussion.</p><p>3. Page 6, Line 219 – Should be 'Figure 2K, 2L' and not 'Figure 1K, 1l.'</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90006.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>[Editors’ note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors’ response to the first round of review.]</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The authors of this manuscript conducted a series of sophisticated gene deletion experiments that aimed to understand the relative contribution of cell-cell and cell-matrix interactions in the development and function of pancreatic islets. Despite the importance of the questions being asked in their study, the data are over-interpreted, and some conclusions are not supported by the data presented or by the current literature on the subject. Specific examples include the misinterpretation of basic mechanisms of cell interactions such as the model of differential adhesion suggesting that Ctnna1-null β-cells merge into the core of islet clusters due to weaker adhesion. The model proposed by Foty and Steinberg (validated in numerous developing epithelia) predicts the opposite, i.e. cells with weaker adhesion are pushed outward by cells with stronger adhesion.</p></disp-quote><p>We would like to express our gratitude to the reviewer for taking the time to carefully review our manuscript and for providing valuable feedback. We apologize for any confusion that may have arisen from our previous statements and for any misinterpretation that may have occurred. To clarify, we had never stated that the model of differential adhesion suggests that <italic>Ctnna1</italic>-null β-cells merge into the core of islet clusters due to weaker adhesion.</p><p>As we stated in our previous submission, our findings support the differential adhesion hypothesis (DAH), which predicts that weaker adhesion in non-β-cells will lead to their dispersion into the islet mantles, while stronger adhesion between β-cells may lead to them bundling into islet cores. We believe that our findings were largely aligned with the differential adhesion hypothesis. Our prediction that Ctnna1-expressing α-cells would cluster together and become more concentrated towards the center of <italic>Ctnna1<sup>Δβ/Δβ</sup></italic> islets due to weaker adhesion in β-cells lacking Ctnna1 was based on the principle that cells with different adhesive properties will tend to sort themselves to maximize adhesive bonding. We have now provided supporting evidence to validate this prediction, including a statistical analysis that clearly shows a significant decrease in α-cells at the periphery and an increase in their density at the core of the islets (Figure 5B, 5F, 5I).</p><p>We also quantified the cellular location in α-cell-specific Ctnna1-deletion (<italic>Ctnna1<sup>Δα/Δα</sup></italic>) islets and observed a reduction in α-cells at the periphery and an increase in their frequency in the islet core (Figure 5D, 5H, 5J). While this was unexpected based on the predictions of DAH, we acknowledge that the role of Ctnna1 in regulating cellular distribution within the islets may be more complex than the simple attractor-repeller mechanism proposed by DAH. Our observation that the core-located Ctnna1-deficient α-cells were mostly scattered as single cells without clustering together in the islet of <italic>Ctnna1<sup>Δα/Δα</sup></italic> mice (Figure 5H) supports this idea.</p><p>Overall, our findings support the concept that differential adhesion between endocrine subtypes is a contributing factor in establishing the islet architecture during development. The weaker cell adhesion in the peripheral islet layers leads to the specific loss of these cell types in <italic>Ctnna1</italic><sup>Δ<italic>Endo/</italic>Δ<italic>Endo</italic></sup> islets. We appreciate the opportunity to address the reviewer's concerns and have revised our manuscript accordingly to provide more clarity and evidence to support our conclusions.</p><disp-quote content-type="editor-comment"><p>In experiments reporting on the phenotype of double KO animals in which both α-catenin and beta1 integrin were simultaneously deleted, the interpretation of the results is clearly affected by the profound alterations of cell-cell and cell-matrix interactions, making it difficult to draw conclusions about normal pancreas development.</p><p>Strengths include the sophisticated animal models permitting cell lineage tracing experiments for live imaging, and state-of-the-art techniques used for the analysis of the pancreatic phenotype. However, the manuscript presents data that are either incompletely analyzed or insufficient to support the authors' claims. As a result, it is unlikely that this study, in its current presentation, will significantly advance our knowledge of the function of these two distinct mechanisms of cell interactions in pancreas development.</p></disp-quote><p>We thank the reviewer for his/her insightful comment. We greatly appreciate the depth of reviewer’s analysis concerning the complex cell-cell and cell-matrix interactions in our <italic>Itgb1; Ctnna1 DKO</italic> mice model, and fully acknowledge the potential challenges these factors could introduce when interpreting our results. It appears, however, that there might be a small misapprehension regarding the specific focus of our research. Our study is primarily oriented towards understanding islet development, utilizing the <italic>Ngn3-Cre</italic> driver expressed in pancreatic endocrine progenitors. We did not intend, in our prior submission, to make broader conclusions about the overall development of the pancreas. We absolutely concur with the reviewer's intriguing suggestion about the interrelation of islet morphogenesis and the formation of the exocrine pancreas. Indeed, we share this curiosity, and it forms the basis of our follow-up study. However, as this question extends beyond the boundaries of the present report, we chose not to include these aspects in the current manuscript.</p><p>We sincerely hope this provides a clearer understanding of our study's intent and specificity. If there are any further points the reviewer would like us to elaborate on, we would be more than pleased to do so.</p><disp-quote content-type="editor-comment"><p>The authors of this manuscript conducted a series of sophisticated gene deletion experiments that aimed to understand the relative contribution of cell-cell and cell-matrix interactions in the development and function of pancreatic islets.</p><p>Despite the importance of the questions being asked in their study, as presented, the manuscript presents several weaknesses.</p><p>Specific examples are listed below:</p><p>The cell lineage tracing experiments with the mT/mG reporter are superficially described, and the data presented are not vetted by solid statistical analysis.</p><p>The authors do not provide any information about the number of mice studied for each animal model, the number of tissue sections stained and analyzed, number of experiments performed. This is critical information that should be provided both in the methods and in the legend of the figures.</p></disp-quote><p>In our initial submission, we included the Materials Design Analysis Reporting (MDAR) Checklist and provided a Source Data spreadsheet in an Excel format. In these two supplementary documents, the details of the statistical analyses and all raw data used for each figure were provided. However, we understand that these details may have been overlooked in the main text/legends etc., and we acknowledge reviewer’s concerns.</p><p>To address these concerns, we have made several revisions. Firstly, we have provided all relevant details, including statistical numbers and individual data points, in the figure labels or legends. Additionally, we have revised the “List of Replicates and Statistical Analysis” and “Source Data spreadsheet “ in Supplementary files to assist reviewers in accessing the raw data points. We hope that these revisions will provide a clearer understanding of our methods and results and address reviewer’s concerns. We appreciate the feedback provided by the reviewer, which has helped us improve the quality of our manuscript.</p><disp-quote content-type="editor-comment"><p>Most immunofluorescence images provided in the figures are oversaturated, making it difficult to discriminate, at least qualitatively, levels of expression of the different markers.</p></disp-quote><p>We appreciate the reviewer's insightful observation concerning the oversaturation of the immunofluorescence images in our initial submission. We understand that this might have complicated the qualitative discrimination of different marker expression levels.</p><p>In response to this valuable feedback, we now present several new images and have also performed readjustments to the intensity of most existing ones. These adjustments were made using a linear display with Min/Max rescaling, a common image processing technique that adjusts the intensity values in the images. Our aim with this adjustment approach was to carefully balance avoiding oversaturation while preserving the accuracy of marker expressions. This approach ensures that the full data range is properly utilized, optimizing the full range of possible intensity values. Specifically, the darkest pixel in the image is adjusted to black (minimum value), the brightest pixel to white (maximum value), and all other pixels are rescaled based on these new extremes. This approach enhances the contrast and visibility of features in the images, making them more suitable for publication or presentation. We believe that these modifications significantly improve the visual clarity of our results, facilitating a more straightforward qualitative comparison of different marker expressions.</p><p>We would also like to emphasize the meticulous semi-quantitative approach employed in our study. To ensure the reliability and accuracy of our findings, we used littermate control and mutant mice, collecting and processing their pancreas samples concurrently. This included fixing and embedding the samples into the same cryo-block, sectioning, and preparing them for immunofluorescence staining on the same slide. This process ensured identical staining conditions for all samples.</p><p>During the imaging process, we took particular care to maintain consistency. For images intended for direct comparison, we kept the exposure time constant and avoided the use of any digital gain that could potentially distort our results. Upon image acquisition, we applied linear adjustment processing uniformly across all comparable samples. This rigorous methodology provides a robust foundation for our comparative analysis, enabling us to confidently attribute observed differences to genetic variations rather than procedural inconsistencies. We also provide this information in our revised method section under ‘Immunofluorescence (IF)’ paragraph.</p><disp-quote content-type="editor-comment"><p>In Figure 2, data shown in panel N are difficult to interpret given the large scale on the Y axis, for the relatively low counts reported in the plot. Is it really possible to have a *** statistical significance between control cells and integrin beta1 KO when the values are almost identical? What type of statistical method was used? It is also unclear how many of such experiments were performed (n=?).</p></disp-quote><p>We appreciate the reviewer's keen observation regarding Figure 2N from our previous submission. We agree that the Y-axis scale may have presented difficulties in data interpretation. For clarity, we have revised this figure, using the same data set in the resubmission. This data was obtained from an equal number of control and mutant mice (three each). The statistical analysis was performed utilizing GraphPad Prism software. Group comparisons were made using one-way analysis of variance (ANOVA) and a two-tailed student's t-test. To enhance transparency, all figures have been revised to include biological replicates (N). All raw data, replicates and numbers are provided in the &quot;List of Replicates and Statistical Analysis&quot; and “Source Data spreadsheet” in Supplementary files. We are confident that these revisions will offer clearer insight into our methodology and results.</p><disp-quote content-type="editor-comment"><p>In the manuscript, (lines 433-435), the authors state: &quot;… ECM-Integrin signaling is critical for endocrine cell migration, and that the time window for endocrine cell initiation is small.&quot; According to the data presented, and some of the literature cited, it is the &quot;endocrine progenitors&quot; and not the &quot;endocrine cells&quot; that rely on the ECM-Integrin signaling for cell migration. It is also inaccurate to state that ECM-Integrin signaling does not occur in endocrine cells once they have differentiated. Thus, while the function of this interaction may or may not translate into cell migration, integrin signaling continues to play important roles in differentiated cells in multiple tissues.</p></disp-quote><p>We appreciate the reviewer's detailed and insightful comments. We realize that our language in the cited lines could lead to confusion, and we regret any inaccuracies in our statements. Indeed, it is the &quot;endocrine progenitors,&quot; rather than the &quot;endocrine cells,&quot; that heavily rely on ECM-Integrin signaling for their migration. We also acknowledge that ECM-Integrin signaling continues to be active in differentiated endocrine cells, and it plays crucial roles in islets as many other studies have shown.</p><p>In the revised manuscript, we have corrected these inaccuracies and provided a more accurate reflection of the roles of ECM-Integrin signaling in both endocrine progenitors and differentiated endocrine cells. We appreciate the reviewer's attention to detail in ensuring the precision and clarity of our work.</p><disp-quote content-type="editor-comment"><p>Experiments conducted with the Ucn3-Cre;Itgb1f/f mice are superficially described. A more detailed presentation and discussion of the phenotype of these mice is necessary to draw conclusions about the role of Itgb1 in β cells after they have differentiated. This is especially important for comparison with other studies if one considers that could reveal important information compared to previous studies that used the insulin promoter as a driver of Cre. This is important since the Ucn3 and Insulin genes are expressed at different times and at different levels during β cell development.</p></disp-quote><p>We appreciate the reviewer's feedback and understand the need for a more in-depth explanation regarding the <italic>Ucn3-Cre;Itgb1<sup>f/f</sup></italic> (<italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic>) mice. Our hypothesis suggests that the Itgb1 deletion mediated by <italic>Ngn3-Cre</italic> occurs during early embryonic stages, indicating a key role for Itgb1 signaling in the migration and aggregation of progenitor cells in the endocrine lineage during islet development. This is supported by the absence of aggregation phenotypes in previous studies using the insulin promoter as a Cre driver for Itgb1 ablation.</p><p>To further explore whether Itgb1 signaling continues to maintain islet cell aggregation following β-cell maturation and islet formation, we implemented a <italic>Ucn3-Cre</italic>-mediated deletion of Itgb1, creating the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> model. Our choice of <italic>Ucn3-Cre</italic> is deliberate as Ucn3 is a late β-cell-specific maturity marker in mouse islets, initiating its expression perinatally and becoming prevalent by 3 weeks of age (as per (Blum et al., 2014; van der Meulen and Huising, 2014)). In our revised manuscript, we provide a more detailed explanation of our rationale for using <italic>Ucn3-Cre</italic>. Interestingly, the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> mice showed no observable abnormalities in blood glucose, aligning with earlier studies that used <italic>RIP-Cre</italic> to inactivate Itgb1 solely in β-cells. In addition, we conducted extensive studies on insulin secretion from the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> islets and found no significant differences between the control and mutant littermates. The consistency between our findings and those of previous studies using the <italic>RIP-Cre; Itgb1</italic> deletion model underscores the robustness of the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> phenotype. It provides strong support to our hypothesis that Itgb1-dependent islet aggregation is primarily regulated during early developmental stages, and Itgb1 signaling doesn't seem to be critical for establishing islet aggregation once the β-cells have fully matured.</p><p>In response to the reviewer's comments, we have included a statistical analysis of the relative β-cell population in our revised manuscript. This additional data corroborates our findings and bolsters our argument. Given the striking similarities between the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> and the <italic>RIP-Cre; Itgb1</italic> deletion models, as well as the robustness of our current and new data, we did not deem it necessary to conduct additional experiments on the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> islets. We believe our current evidence, supplemented by the statistical analysis and in alignment with prior studies, presents a compelling case that should address the reviewer's concerns effectively.</p><disp-quote content-type="editor-comment"><p>The RNA-seq data, although interesting, are only superficially analyzed, nor validated. Experiments of immunofluorescence do not really validate the most interesting alterations of genes found affected by the gene deletions, since it is not very quantitative. It would have been helpful to confirm at the protein level by Western blotting the expression of some of the most interesting genes, or at least by qPCR. The authors would be surprised to discover that RNA-seq does not necessarily translate into the same order of magnitude of mRNA levels when testing the same samples by qPCR.</p></disp-quote><p>We agree that immunofluorescence, while providing valuable visual and spatial information, is not the most quantitative method for validating gene expression changes. We also agree that RNA-seq data does not always correlate precisely with mRNA levels as determined by other methods like qPCR.</p><p>In our study, we have considered the immunofluorescence technique as 'semi-quantitative', referring to the careful methodological approach we have adopted. This method allows us to observe relative expression changes of key genes essential for endocrine cell maturation, which align with our RNA-seq results. While it may not be possible to validate every differentially expressed gene due to experimental constraints, this method gives us a reasonable estimate of their behavior. In response to the reviewer’s suggestion, we have included qPCR analysis in our revised manuscript to offer a more quantitative measure of gene expression changes. Due to the challenge of isolating a sufficient quantity of islets from mutant mice, Western blotting was not feasible in this context. Thus, we used qPCR analysis to study relative gene expression between controls and both <italic>Itgb1<sup>ΔEndo/ΔEndo</sup></italic> (Figure S2A) and <italic>Ctnna1<sup>ΔEndo/ΔEndo</sup></italic> (Figure S6A) islets We selected a set of up-regulated and down-regulated genes (total of 10), all of which are crucial for endocrine cell lineage and function.</p><p>Importantly, our qPCR results align well with our RNA-seq findings, further supporting the observed defects in endocrine cell lineages and functional gene expression in mutant islets. We hope that these additional data and clarifications address the reviewer's concerns and provide a more comprehensive view of our work.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The goal of this study was to uncover mechanisms that govern the aggregation and &quot;self-assembly&quot; of islets during embryonic development and postnatally, a process that is not well understood. The authors focused on the role of integrin-β 1 (Itgb1), a key mediator of cell-extracellular matrix (ECM) interactions, and on α-catenin (Ctnna1), a hub protein that links cell adhesion molecules with the cytoskeleton. They used conditional knockout models (Ngn3-Cre and Ucn3-Cre), microscopy and morphometric image analysis, and transcriptomic, and functional measures of glucose metabolism. They found that loss of Itgb1 from endocrine precursor cells resulted in premature aggregation of islets and impaired migration of islets from pancreatic ducts resulting in disturbed islet morphology. Additionally, they observed loss of islet vascularization and decreased expression of markers of endocrine cell identity, which together resulted in glucose intolerance. On the other hand, loss of Ctnna1 resulted in smaller, hypervascularized islets which also expressed fewer markers of differentiated endocrine cell identity resulting in an age-dependent loss of glucose tolerance. Ctnna1 mice also exhibited loss of glucagon and somatostatin-positive islets cells, with loss of glucagon+ cells occurring postnatally. The authors concluded from these studies that a balance exists between cell-ECM and cell-cell interactions, and that loss of one of these interactions (as occurs in Itgb1 and Ctnna1 deficient mice, respectively) may result in an increase in the other. However, the loss of both Itgb1 and Ctnna1 from endocrine precursor cells resulted in an almost complete loss of islet aggregation and severe glucose intolerance.</p><p>The conclusions of this paper are mostly supported by the data. Strengths include the thorough characterization of mice, especially the Itgb1 mice with the Ngn3-Cre driver. The work shows a clear effect of both Itgb1 and Ctnna1 to modulate islet aggregation/morphology without affecting cell specification or overall abundance (during development). The study provides compelling evidence for the role of these cell adhesion molecules in governing islet aggregation, morphology, identity, and function and is impactful for the field.</p></disp-quote><p>We are grateful for the reviewer’s detailed review and recognition of the significance of our research. We appreciate her feedback emphasizing the value of our findings on the roles of Itgb1 and Ctnna1 in islet aggregation, morphology, identity, and function, and the impact of this work on the islet biology field.</p><p>In response to these comments, and similar feedback from other reviewers, we have made significant revisions in our resubmission. To address the need for more comprehensive statistical evidence, we now provide thorough statistical analyses, including all pertinent numerical values, in Supplementary files, entitled “List of Replicates and Statistical Analysis” and “Source Data spreadsheet”.</p><p>We agree with the reviewer's assertion that other mediators of cell-ECM interactions may play crucial roles in islet aggregation. While Itgb1 is pivotal for these interactions, compensatory mechanisms involving other integrins, such as beta3, beta4, beta5, beta6, and alpha3, alpha6, and alphaV integrins (Cirulli et al., 2000; Krishnamurthy et al., 2011; Schiesser et al., 2021; Yashpal et al., 2005), might maintain cell-ECM interaction in Itgb1-deficient islets and be essential for islet survival and function. We have incorporated these points into the discussion in our resubmitted manuscript.</p><p>We have also revised our figures with high-resolution Airyscan images, providing a clearer depiction of cell shape alterations and cell-cell adhesion in <italic>Itgb1</italic> mutant islets. Furthermore, we have now included evidence of an increased number of TUNEL<sup>+</sup> apoptotic glucagon-expressing α cells in <italic>Ctnna1</italic> mutant islets (Figure 4L-4N), which further bolsters our conclusion. We sincerely appreciate the reviewer's insightful comments, which have strengthened our manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>Pancreatic islet morphogenesis is a complex interplay between endocrine cell-intrinsic signaling coupled with external cues from ECM and neighboring cells. Defining the specific pathways and the developmental window when they are critical to the eventual islet architecture and function still remains unclear. This study adds to the body of evidence that the ECM-Integrin signaling and cell-cell adhesion signaling mediated via α-catenin has a critical combinatorial role in determining the islet cell aggregation, vascularization, and eventual function.</p><p>Strengths:</p><p>The reciprocal regulation of the ECM-integrin pathway and cell-cell adhesion via the α-catenin pathway identified in this study provides insight into how the external cues for developing endocrine cells are processed and integrated to eventually allow mouse islets to develop a core of β-cells and the mantle comprising of other endocrine cells. The detailed dissection to identify the developmental window using in vivo studies complemented with explant studies with lineage tracing is compelling strength of this study.</p><p>The predicted changes in mouse islet (mantle-core) architecture due to changes in cell-cell adhesion strength as validated by the combination of the models that the authors use in this study provides a better understanding of the dynamics of islet morphogenesis.</p><p>Weakness:</p><p>The authors suggest that hypoxia resulting from changes in the vasculature is a potential cause of functional immaturity stemming from the expression of disallowed genes and enrichment of genes in RNA-seq involved in Hypoxic responses. Experimental demonstration of hypoxia and its causative role in these models is however lacking to substantiate this explanation.</p><p>Many other groups have previously demonstrated the importance of α-catenin and β-integrin 1 in islet morphogenesis and function, using earlier (Pdx1 promoter-driven Cre) and later (various insulin promoter-driven Cre) developmental windows. Though this study narrows down the window to when the endocrine lineage is determined by Ngn3 and suggests that the altered cell adhesion leads to changes in function and aggregation, intracellular signaling pathways suggested by other studies, such as the sonic hedgehog pathway, PARP, and others remain unexplored in the current context to provide more mechanistic insight.</p><p>While the regulation of the vascularization of the islets in both these mutant models (Itfb1 and Ctnna1) individually and in combination is very convincing, the authors note that this was with no change in angiogenic factor expression. While their explanation invoking the alterations of cortical tension by changes in actin cytoskeleton is certainly plausible and intriguing, it is not demonstrated experimentally and remains to be established in future work.</p></disp-quote><p>We greatly appreciate the insightful feedback from the reviewer, and we value the recognition of the strengths of our study. Regarding the critiques, we acknowledge the gaps in our study and are thankful for the constructive suggestions that have helped us to improve our work.</p><p>Firstly, we concur that our current study does not provide direct experimental validation of hypoxia as the cause for functional immaturity in <italic>Itgb1</italic> and <italic>Ctnna1</italic> mutant models. This interpretation is speculative, stemming from observed changes in vasculature and gene enrichment in hypoxic responses. To better reflect this point, we have revised our discussion to clearly state that the involvement of hypoxia is a hypothesis based on these observations and requires further investigation.</p><p>Secondly, we acknowledge the important role of Ctnna1 and Itgb1 in islet morphogenesis, as demonstrated by previous research using <italic>Pdx1</italic>-promoter-driven Cre and insulin promoter-driven Cre. Our study contributes to these findings by narrowing down the developmental window to the point at which the endocrine lineage is determined by Ngn3. While we recognize the potential relevance of other intracellular signaling pathways, such as the sonic hedgehog pathway and PARP, our RNA-seq data did not indicate significant changes in these pathways in our models. We have, however, included in our discussion the possibility of other intracellular signaling pathways playing a role, and we aim to further investigate these in future studies.</p><p>Finally, we agree with the reviewer that our proposed mechanism involving alterations in cortical tension due to changes in the actin cytoskeleton remains speculative. While the involvement of actin cytoskeleton alterations in vascularization is an intriguing possibility, we consider it beyond the scope of the current work. We have included this speculation in the discussion.</p><p>Once again, we thank the reviewer for his constructive feedback. His comments not only enhance the quality of our present work but also help guide our future research directions.</p><disp-quote content-type="editor-comment"><p>1. Concurrent measurement of insulin and glucose during the GTT provides compelling evidence of a β-cell defect. Adding this with the GTT data in Figures 1, 4, and S6 would add to the strength of the study.</p></disp-quote><p>We acknowledge the significance of concurrent measurements of insulin and glucose during the Glucose Tolerance Test (GTT) and appreciate the reviewer's suggestion. In line with this, we have incorporated GTT data for the mutant mice and depicted defective insulin secretion during glucose challenge in <italic>Itgb1<sup>∆endo/∆endo</sup></italic> (Figure 1K) and <italic>Ctnna1; Itgb1<sup>∆endo/∆endo</sup></italic> (Figure 7J) mice.</p><p>We observed mild glucose intolerance in <italic>Ctnna1<sup>∆endo/∆endo</sup></italic> mice at 8 weeks (Figure 4B); however, insulin content quantification in serum after glucose challenge did not demonstrate any substantial defect in insulin secretion for the <italic>Ctnna1<sup>∆endo/∆endo</sup></italic> mice (Figure 4C). Given the mild glucose intolerance in the <italic>Ctnna1<sup>∆endo/∆endo</sup></italic> mice, we considered the possibility that conventional serum insulin measurements might not adequately represent alterations in β-cell function. To better understand this, we employed a more sensitive detection method, the hyperglycemic clamp technique, to quantify in vivo insulin secretion. Employing this assay, we noticed a trend toward diminished overall insulin secretion in the <italic>Ctnna1<sup>∆endo/∆endo</sup></italic> mice at 8 weeks (Figure S6B,S6C), supplementing our evidence that Ctnna1-dependent islet cell aggregation influences β-cell function.</p><disp-quote content-type="editor-comment"><p>2. The glucose and functional phenotype of the Ucn-Cre mediated Itgb1ΔMatureβ/ΔMatureβ has not been described. Since this is a new model generated by the authors, it is important to describe the phenotype and also compare and contrast it to the other previously described mature β-cell ITGB knockouts that the authors allude to in their discussion.</p></disp-quote><p>We appreciate the reviewer's insightful comment on the <italic>Ucn3-Cre</italic> mediated <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> model. As previously explained, the <italic>Ucn3-Cre</italic> driver follows the expression of Urocortin 3 (Ucn3), a specific marker of mature β-cell. Its expression begins during the perinatal period and becomes widespread around 3 weeks of age, as documented by van der Meulen et al., 2014, and Blum et al., 2014. Consequently, we utilized <italic>Ucn3-Cre</italic> for <italic>Itgb1</italic> deletion in our <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> model, enabling us to investigate the role of Itgb1 signaling in preserving islet cell aggregation following β-cell maturation and islet formation.</p><p>In the revised manuscript, we've clarified this model choice and its implications by providing additional context in both the results and Discussion sections. Notably, we have included that our <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> mice exhibit no detectable metabolic issues. We also performed comprehensive metabolic analyses such as calcium imaging and found no observable functional phenotype. We have not included these data in the current manuscript as they go beyond the scope of this study. If the reviewer deems it necessary, we are more than willing to incorporate these findings in the revised version.</p><p>As for the lack of observable glucose and functional phenotype in the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> model, we find it consistent with what we might expect. Given that the <italic>RIP-Cre</italic> mediated <italic>Itgb1</italic> deletion encompasses a large proportion of the Ucn3<sup>+</sup> β-cells, it's reasonable that the <italic>Itgb1<sup>ΔMatureβ/ΔMatureβ</sup></italic> mice wouldn't show more pronounced phenotypes than the <italic>RIP-Cre</italic> mediated <italic>Itgb1</italic> deletion mice. We hope this explanation provides better understanding of our approach.</p><disp-quote content-type="editor-comment"><p>3. Page 6, Line 219 – Should be 'Figure 2K, 2L' and not 'Figure 1K, 1l.'</p></disp-quote><p>We appreciate the reviewer's careful eye for detail. We have corrected the figure references in the revised manuscript. Thank you for bringing this oversight to our attention.</p></body></sub-article></article>